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Abstract
Understanding how virus strains offer protection against closely related emerg-
ing strains is vital for creating effective vaccines. For many viruses, including
Foot-and-Mouth Disease Virus (FMDV) and the Influenza virus where mul-
tiple serotypes often co-circulate, in vitro testing of large numbers of vaccines
can be infeasible. Therefore the development of an in silico predictor of cross-
protection between strains is important to help optimise vaccine choice. Vac-
cines will offer cross-protection against closely related strains, but not against
those that are antigenically distinct. To be able to predict cross-protection
we must understand the antigenic variability within a virus serotype, dis-
tinct lineages of a virus, and identify the antigenic residues and evolutionary
changes that cause the variability. In this thesis we present a family of sparse
hierarchical Bayesian models for detecting relevant antigenic sites in virus
evolution (SABRE), as well as an extended version of the method, the ex-
tended SABRE (eSABRE) method, which better takes into account the data
collection process.
The SABRE methods are a family of sparse Bayesian hierarchical models that
use spike and slab priors to identify sites in the viral protein which are im-
portant for the neutralisation of the virus. In this thesis we demonstrate how
the SABRE methods can be used to identify antigenic residues within dif-
ferent serotypes and show how the SABRE method outperforms established
methods, mixed-effects models based on forward variable selection or `1 reg-
ularisation, on both synthetic and viral datasets. In addition we also test a
number of different versions of the SABRE method, compare conjugate and
semi-conjugate prior specifications and an alternative to the spike and slab
prior; the binary mask model. We also propose novel proposal mechanisms for
the Markov chain Monte Carlo (MCMC) simulations, which improve mixing
and convergence over that of the established component-wise Gibbs sampler.
The SABRE method is then applied to datasets from FMDV and the In-
fluenza virus in order to identify a number of known antigenic residue and to
provide hypotheses of other potentially antigenic residues. We also demon-
strate how the SABRE methods can be used to create accurate predictions of
the important evolutionary changes of the FMDV serotypes.
In this thesis we provide an extended version of the SABRE method, the
eSABRE method, based on a latent variable model. The eSABRE method
takes further into account the structure of the datasets for FMDV and the
Influenza virus through the latent variable model and gives an improvement
in the modelling of the error. We show how the eSABRE method outperforms
the SABRE methods in simulation studies and propose a new information cri-
terion for selecting the random effects factors that should be included in the
eSABRE method; block integrated Widely Applicable Information Criterion
(biWAIC). We demonstrate how biWAIC performs equally to two other meth-
ods for selecting the random effects factors and combine it with the eSABRE
method to apply it to two large Influenza datasets. Inference in these large
datasets is computationally infeasible with the SABRE methods, but as a re-
sult of the improved structure of the likelihood, we are able to show how the
eSABRE method offers a computational improvement, leading it to be used
on these datasets. The results of the eSABRE method show that we can use
the method in a fully automatic manner to identify a large number of anti-
genic residues on a variety of the antigenic sites of two Influenza serotypes,
as well as making predictions of a number of nearby sites that may also be
antigenic and are worthy of further experiment investigation.
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Chapter 1
Introduction
Influenza, more commonly known as flu, and Foot-and-Mouth Disease Virus (FMDV)
both come with considerable danger for those that are infected. Influenza comes in yearly
outbreaks which are estimated to result in 3-5 million cases of severe illness and about
250,00-500,000 deaths (WHO, 2009), while FMDV is endemic in sub-Saharan Africa
causing regular outbreaks in the cattle there (Reeve et al., 2010). Both viruses also cause
severe outbreaks of the disease. Influenza has caused three pandemics in the 20th century,
Spanish Influenza (1918), Asian Influenza (1958) and Hong Kong Influenza (1968), all of
which have resulted in more than a million deaths, with Spanish Influenza estimated to
have killed 40-50 million people alone (WHO, 2005). FMDV, as well as being endemic
in sub-Saharan Africa, has also caused major outbreaks throughout the world, with the
2001 United Kingdom (UK) outbreak estimated to have resulted in the deaths of 10
million sheep and cattle (through culling) and an economic cost of around £8 billion
(BBC, 2016).
To counter the effects of the virus and prevent the spread of the disease, vaccines
are usually used to protect people and animals against Influenza and FMDV. However
in both cases multiple strains often co-circulate and therefore vaccines must protect the
person or animal against a variety of virus strains. With the continuous evolution of virus
strains, vaccines only work for a short period of time. For instance the Influenza vaccine
must be updated yearly to protect against the virus strains that make up that year’s ‘Flu
Season’. When the virus strains that make up the vaccines do not match closely enough
to the currently circulating strains, the effectiveness of the vaccine is reduced and the
risk for the person or animal much increased.
The reason for the ever changing vaccines is to offer protection against the ever evolv-
ing strains of a particular virus. In both Influenza and FMDV there is high genetic
variability and this results in changes to the virus proteins giving new virus strains;
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Chapter 2. Changes in the virus proteins, known as antigenic proteins, result in differ-
ences between the virus strains, antigenic differences, and these reduce how antigenically
similar the strains are, affecting the ability of the host immune system to recognise the
virus; see Section 2.1. As a consequence of this antigenic variability, vaccines are only
effective against strains that are genetically related and antigenically similar to the vac-
cine (Mattion et al., 2004). This, along with the ever evolving virus strains, motivates
the need to continuously update the vaccine, however choosing the correct virus strains
to make into a vaccine can be time consuming and expensive. Understanding how cross-
protection, the protection against one strain conferred by previous exposure to another
strain either by infection or vaccination (Paton et al., 2005), is therefore vital for under-
standing the severity of an outbreak and how a particular vaccine will reduce the spread
of the disease.
Vaccines will not work across different serotypes, genetically and antigenically distinct
virus lineages between which there is no degree of cross-protection, and often vaccines
must be made up of virus strains from multiple serotypes. However within serotypes,
vaccines can offer protection against groups of antigenically similar virus strains, but
not against those that are antigenically distinct. Given the importance of Influenza
and FMDV it is important to understand which vaccines offer protection against which
currently circulating strains. To do this we must understand how genetic changes affect
antigenicity and within-serotype cross-protection. Biological experiments to identify both
the antigenic proteins which cause antigenic differences and the effective vaccines is time
consuming and expensive. Therefore the development of in silico models which can
predict both antigenic residues and the likely cross-protection offered by virus strains is
vital for directing these experiments in an efficient manner and reducing the number of
experiments that must be carried out.
The motivation behind this work is to develop models that can predict antigenically
significant residues within the different serotypes of Influenza and FMDV. Doing so can
lead to the identification of these antigenic residues and help guide the selection of vac-
cines, mitigating the effect of the circulating virus strains. In order to do this we can use
genetic data and in vitro measures of the antigenic variability between virus strains to un-
derstand how these genetic changes affect the ability of virus strains to cross react. The
measures of antigenic variability, Virus Neutralisation (VN) titre and Haemagglutina-
tion inhibition (HI) assay, approximate the extent to which one strain confers protection
against another by recording the maximum dilution at which the virus-specific antibody
in a sample of antiserum from a cow (VN titre) or ferret (HI assay) exposed to one
strain of the virus remains able to neutralise a sample of a second virus strain. To model
antigenic variability effectively we must account for the experimental effects inherent in
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these processes and then link the differences in the residues and evolutionary history
to the differences in the measured antigenic variability. To do this effectively we must
simultaneously account for the experimental variability and select which of residues have
an effect on the measured antigenic variability and are therefore likely to be antigenic
residues. Previous work, e.g. Reeve et al. (2010), has used basic statistical techniques
such as mixed-effects models to model antigenic variability but these methods are not
statistical optimal; see Chapter 3.
To achieve improved performance we propose a family of models, Sparse hierArchi-
cal Bayesian models for detecting Relevant antigenic sites in virus Evolution (SABRE),
which can simultaneously account for the experimental affects and select the residues and
evolutionary changes that affect the measured antigenic variability; Chapters 4 and 5.
The SABRE methods are Bayesian hierarchical models that can account for the experi-
mental affect of the data collection process through random effects, while simultaneously
selecting the significant residues and evolutionary changes through the integration of spike
and slab priors (Mitchell and Beauchamp, 1988). Spike and slab priors have been shown
to improve variable selection and avoid the excessive shrinkage incurred by alternative
methods from Chapter 3 (Mohamed et al., 2012), while hierarchical models allow consis-
tent inference of all parameters and hyperparameters, and inference borrows strength by
the systematic sharing and combination of information (Gelman et al., 2013a).
The advantages of the SABRE methods are fully discussed and demonstrated in
Chapters 4 and 5, where we show that in terms of correctly selecting variables the
SABRE methods outperform the alternative methods introduced in Chapter 3; classical
mixed-effects models, the mixed-effects Least Absolute Shrinkage and Selection Operator
(LASSO) and the mixed-effects elastic net. We additionally explore different versions of
the SABRE methods, in order to find the one that best works with our data. We provide
a first comparison between the binary mask model and models based on the slab and spike
prior, as well as looking at how different levels of conjugacy in the hierarchical models
can affect the models performance. Chapters 4 and 5 also look at various different ways
of improving the mixing and performance of the model, before finally applying a version
of the SABRE method to real life FMDV and Influenza datasets. Our results, compared
against those already available, show the significant improvement of the SABRE methods
and the improvement they offer in modelling antigenic variability and identifying anti-
genic residues. Our results identify a number of previously known antigenic residues, as
well as providing novel predictions of other residues that are potentially antigenic (Davies
et al., 2014, 2016a,b).
One problem with the SABRE methods is that they are computationally infeasible for
larger datasets meaning that data simplification must be carried out or more inaccurate
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methods used. To counter this drawback of the SABRE methods we have proposed the
extended SABRE (eSABRE) method; see Chapter 6. The eSABRE method is based on
the SABRE methods but better takes into account the structure of the data from the
FMDV and Influenza serotypes that we have available. In Chapter 7 we show how this
method outperforms the SABRE methods from Chapter 4 in terms of variable selection on
realistic simulated datasets and therefore also the alternative methods from Chapter 3.
We also show how the eSABRE methods allow us to gain a massive improvement in
terms computational efficiency, meaning that using the eSABRE becomes viable on the
larger datasets where the SABRE method was not. We demonstrate this on the large
datasets for the Influenza serotypes, identifying known antigenic residues and providing
novel predictions of potential antigenic residues.
The work of this thesis has taken on the challenges provided by antigenic variability
and the biological threat that it poses. We have proposed the SABRE methods which
provide a technique for understanding antigenic variability and cross-protection. We
have also further explored how differences between the different SABRE methods can
affect inference and shown how these methods outperform the standard methods that are
used. We have then proposed the eSABRE method which takes into account the data
generation process better and shown how it outperforms the SABRE methods in terms
of both variable selection and computational efficiency. Finally we have applied all of the
proposed models to real life FMDV and Influenza datasets and the predictions we have
made will help to identify more of the antigenic residues that cause antigenic variability
and in long term hopefully improve the selection of effective vaccines.
1.1 Thesis Overview
This thesis has demonstrated the effectiveness of multiple models for tackling the prob-
lems caused by antigenic variability. The structure of the thesis is in the following form:
Chapter 2 provides information about the biological problem, antigenic variability, and
gives details of the type of data we have available and the individual datasets used in
our studies. Chapter 3 introduces and discusses established methods that are used to
model antigenic variability, as well as introducing the Bayesian methods that are used to
construct the models proposed in this thesis. Chapter 4 introduces the SABRE methods
and Chapter 5 explores different specifications that can be used with the hierarchical
models proposed. Comparisons with the methods from Chapter 3 are also given and the
methods are applied to real life datasets to prove predictions of residues that are po-
tentially antigenic. Chapter 6 provides details of the eSABRE method, while Chapter 7
shows the improvements it offers over the SABRE methods, before applying it the real
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life Influenza and FMDV datasets. Finally Chapter 8 provides a summary of the work
that has been undertaken as part of this thesis and gives details of areas for potential
further work.
5
Chapter 2
Data
In this chapter we will provide information about the biological problem, antigenic vari-
ability, that has inspired the work in this thesis and motivates the need for statistical
models to help tackle the problem and make useful biological conclusions. In Section 2.1
we introduce the biological problem, explain what type of data is available to tackle it
and discuss how the data can be used to create statistical models to help understand
antigenic variability. We discuss where the data comes from and the experimental varia-
tion inherent in its collection (Section 2.1.1). We then look at how the surface structure
of the viruses (Section 2.1.2) and their evolutionary histories (Section 2.1.3) can be used
to understand antigenic variability.
In Sections 2.2 and 2.3, we discuss Foot-and-Mouth Disease Virus (FMDV) and the
Influenza (Flu) virus, and give details of the different datasets we have available for these
viruses. For each of the viruses we have datasets for different serotypes, genetically and
antigenically distinct virus lineages, and we introduce these and explain what dangers
the different viruses cause to human and animal populations.
The final part of the chapter, Section 2.4, discusses what information we have about
the antigenic sites of FMDV and Influenza serotypes introduced in Sections 2.2 and 2.3.
Section 2.4 summarises the experimental information we have about each of the viruses
and explains how we can use that, as well as information from other serotypes, to make
informed decisions about the plausibility of some of the biological results found by our
models in Chapters 5 and 7.
2.1 Antigenic Variability
Ribonucleic acid (RNA) viruses such as FMDV and Influenza have been shown to have
high genetic variability (Holland et al., 1982). This variability results in changes to the
6
2. Data
virus proteins that effect recognition by the host immune system, also known as anti-
genic differences. Differences in these proteins, also known as antigenic proteins, affect
how antigenically similar different viruses are. As a consequence of the antigenic vari-
ability in the viruses, vaccines are only effective against field strains that are genetically
related and antigenically similar to the vaccine strain (Mattion et al., 2004). This fea-
ture of FMDV and Influenza makes it important to estimate antigenic similarity among
strains and therefore cross-protection, the protection against one strain conferred by pre-
vious exposure to another strain by either infection or vaccination (Paton et al., 2005).
Understanding cross-protection is vital for predicting the severity of an outbreak and un-
derstanding how different vaccine strains will mitigate the spread of the disease. As the
testing of new candidate vaccines is expensive, the development of an in silico predictor
that can identify which strains are likely to give the broadest cross-protection is essential.
RNA viruses are classified into serotypes, genetically and antigenically distinct virus
lineages between which there is no effective degree of cross-protection. Individual vaccines
may protect against large groups of genetically diverse viruses within a serotype, however
there are antigenically distinct subtypes against which the vaccines do not work. Within
these serotypes are significant levels of antigenic variability, which allows us to examine
the relationship between genetic and antigenic variation and to determine which protein
changes affect recognition by the immune system. Given the importance of FMDV and
Influenza, as well as the difficulties with vaccination caused by antigenic variation, it is
vital to understand how genetic changes affect antigenicity and within-serotype cross-
protection. Biological experiments to confirm the effects of genetic changes are both time
consuming and expensive, therefore making accurate in silico predictions as to which
of the changes caused the antigenic variations is important to reduce the number of
experiments that must be carried out.
In order to infer the antigenic importance of specific genetic changes that have oc-
curred during the evolution of the virus, we require a measure of the antigenic similarity
of any two virus strains. Virus Neutralisation (VN) titre and Haemagglutination in-
hibition (HI) assay give in vitro measures of antigenic similarity between a protective,
i.e. a potential vaccine, and a challenge strain, i.e. a potential circulating virus (Hirst,
1942; WHO, 2011). They approximate the extent to which one strain confers protection
against another by recording the maximum dilution at which the virus-specific antibody
in a sample of antiserum from a cow (VN titre) or ferret (HI assay) exposed to one strain
of the virus (the protective strain) remains able to neutralise a sample of a second virus
strain (the challenge strain). Higher titres or assay measures indicate that the antiserum
still neutralises the challenge strains at greater dilution and therefore that the protective
and challenge strains are more antigenically similar. The highest VN titre or HI assay
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measurements will be when two identical strains are used as the challenge and protective
strains, with any difference between the strains causing antigenic difference and lower VN
titre or HI assay measurements. Gaining an effective understanding of why certain pairs
of virus strains produce higher measured antigenic variability means that we can use the
genetic data of newly emerging virus strains to understand the likely cross protection
offered by different vaccines.
The antigenic differences between different virus strains is caused primarily by changes
in the residues on the proteins on the surface of the capsid or virus shell; see Section 2.1.2.
Here changes in these residues mean that virus strains are less antigenically similar, re-
ducing the effectiveness of vaccines. However the antigenic similarity can also be affected
by how the viruses within the serotypes have evolved and this must also be considered;
Section 2.1.3. Finally the measured antigenic variability can be influenced by a number
of experimental factors and these can affect the accuracy of the VN titre and HI assay
and so must be accounted for; see Section 2.1.1. In terms of standard mixed-effects mod-
els, to be discussed in more detail in Section 3.1.1, the variables related to the residues
and evolutionary history would be considered fixed-effects variables and the experimental
factors would be random-effects factors.
2.1.1 Experimental Effects
The experiments to measure the antigenic variability between any two virus strains con-
tain experimental errors in the measured VN titre or HI assay that they produce. When
modelling the VN titre or HI assay it is important to take these experimental effects into
account, otherwise the way we interpret the antigenic similarity of the strains will be
inaccurate. The measured VN titre or HI assay can be affected by a number of things,
including which challenge strain, protective strain and antiserum were used when the data
was collected, as well as the date the experiment itself was completed. In the datasets we
have for FMDV and Influenza, information about the factors has been recorded and we
can use this in our models in Chapters 4 and 6. However not all datasets contain all the
desired information, so we are limited about which factors we can account for in some
datasets. The available factors are specified for each dataset in the individual sections of
Section 2.2 and 2.3.
The experimental affects need to be considered in our models for a number of reasons.
Individual challenge and protective strains can have different effects on the measured VN
titre or HI assay. For instance some challenge strains can be more reactive against
all strains causing higher measurements, while some protective strains can have higher
or lower measurements against all challenge strains regardless of antigenic similarity.
The animals from which the antisera come from can similarly produce different strength
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antisera and this can also affect the measured VN titre or HI assay. Finally it is possible
that the person doing the experiment can have an affect on the measurements and while
none of the datasets contain this information, we can account for it via a proxy; the date
of the experiment. Initial results from Reeve et al. (2010) suggested that the protective
strain did not affect the measured VN titre or HI assay, suggesting it should not be
included as a random effect factor. We have initially based our choice of random effect
factors on these results, but later tested which factors should be included as random effect
factors through the use of information criteria.
2.1.2 Antigenic Residues
In the outer capsid or virus shell, proteins influence antigenicity. Many areas of these pro-
teins are exposed on the surface of the capsid and among these are antigenic regions that
are recognised by the host immune system. Single amino acid substitutions (mutations)
within these antigenic regions can dramatically affect recognition by the immune system.
Identifying the specific amino acid residues that comprise these antigenic regions and
the substitutions that cause antigenic differences is critical to understanding antigenic
similarity among viruses and cross-protection within serotypes. Producing models which
can rank how likely residues are to have an antigenic affect is important as it can direct
the biological experiments to those residues which are most likely to affect antigenicity
and are therefore the most important to understand.
The data about the residues we have for the FMDV and Influenza virus looks at
whether a particular residue is different for the two virus strains for which the antigenic
variability is being measured, i.e. an amino acid substitution (mutation) has occurred
in the evolutionary path between the two virus strains. The data is recorded as 1 if a
mutation has occurred and 0 otherwise. The inclusion of a residue’s data in a model
from the methods in Chapters 3, 4 and 6 indicates that the particular variable has an
effect on antigenic variability and the corresponding residue is therefore predicted to be
antigenic. Given the virus strains tested throughout the dataset do not change during the
data collection period (all viral evolution happened before this point for the virus strains
in the datasets), the measurements of the residues will remain the same for a given pair
of virus strains for each VN titre or HI assay measurement that they are used to produce.
This however is not the case with the evolutionary data described in Section 2.1.3. The
evolutionary data only remains the same for a given challenge and protective strain, and
the data will not remain the same if the challenge strain is used as the protective strain
and vica versa (unlike the residue data where it will). It is this structure in the genetic
and evolutionary data that provided the motivation for the model described in Chapter 6.
Various pieces of information are known about the residues of the FMDV and Influenza
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serotypes in Sections 2.2 and 2.3 and more information about the residues of the individual
serotypes is given in Section 2.4 where we classify their plausibility of being antigenic.
As a general rule, residues can be classified based on there locations, with some regions
known to be antigenic or provide certain functions to the virus. Information can also
be taken from other serotypes of the same virus, as in many viruses certain regions can
be antigenic in all tested serotypes. For this reason residues are given by their common
alignment taken from Reeve et al. (2010) and Harvey et al. (2016).
2.1.3 Evolutionary History of Viruses
Changes in the antigenic proteins described in Section 2.1.2 occur as the strains within
each serotype evolved. The accumulation of these changes in geographically isolated virus
lineages allows for the division of serotypes into topotypes, groups of genetically similar
viruses associated with a particular geographic area (Knowles and Samuel, 2003). Strains
within topotypes share a common evolutionary history that is distinct from strains within
other topotypes. Accounting for the genetic differences between topotypes that have
arisen due to their significantly different evolutionary paths is necessary for understanding
antigenic variability (Reeve et al., 2010). Interpreting the antigenic consequences of
genetic differences between topotypes can improve our understanding of the evolutionary
history of serotypes, as well as the likely extent of vaccine coverage across topotypes.
When we observe antigenic differences between virus lineages that we are unable to
attribute to amino acid changes at any specific residue. In these cases we wish to relate the
changes to the evolutionary history of the virus. This evolutionary history is ordinarily
described by a phylogenetic tree, e.g. Figure 2.1, which maps the evolution of the sampled
viruses (the leaves) back to their most recent common ancestor (the root). The internal
vertices of the tree (the nodes) then represent inferred ancestors of the sampled viruses
(the leaves). The edges joining these nodes (the branches) connect ancestors and their
immediate evolutionary descendants, and are each associated with a set of amino acid
substitutions estimated to have occurred between the nodes they connect. Groups of
leaves separated from the root by a particular branch, are said to be a clade defined by
that branch, i.e. virus A and virus B in Figure 2.1 are a clade defined by branch x.
The reconstruction of phylogenetic trees is not the subject of this thesis, and therefore
for the datasets in Sections 2.2 and 2.3 we have used the trees generated from the paper
where the data on that serotype was originally presented. Within these trees, each branch
has the potential to explain antigenic differences and these are included as fixed-effects by
noting whether each branch lies between the challenge and protective strains (1) or not
(0) in an indicator variable, as in Reeve et al. (2010). For each pair of strains tested, it
does not make a difference which virus from the pair is the challenge or protective strain,
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Figure 2.1: Example Phylogentic Tree. The phylogentic tree was created in FigTree
v1.4.2. Marked on the tree are protective strains (*).
only that the branch lies between the two strains chosen. For example, in Figure 2.1,
the indicator variable for branch x would be 1 for a comparison between any virus in the
clade defined by branch x (virus A or B) and a virus outside of the clade (viruses C,
D or E ) regardless of which virus is the challenge or protective strain, and 0 otherwise.
Then if there is a significant antigenic difference between viruses A and B and viruses C,
D and E, the antigenic effect of branch x would be selected.
However, other non-antigenic properties of the virus can also affect the VN titre or HI
assay measurements, and these were introduced by Davies et al. (2016a). One of those
properties is that certain amino acid substitutions may increase (decrease) reactivity of
the challenge strains resulting in a lower (higher) VN titre or HI assay measurements
against all antisera. We call this a reactivity effect and include a second type of indicator
variable for this type of effect. This indicator variable for branch x in Figure 2.1 would
be 1 if the challenge strain is virus A or B and 0 if it is virus C, D or E. If challenge
strains in the clade defined by branch x show consistently higher or lower VN titre or HI
assay measurements regardless of their antigenic similarity to the protective strain, then
this second type of indicator variable will be selected.
Finally, amino acid substitutions can also alter the virus so that protective strains
carrying these amino acid substitutions produce antisera that have higher or lower VN
titres or HI assay measurements against all challenge viruses irrespective of antigenic
similarity. We call this third property an immunogenic effect, and include a third indicator
variable for this effect. This indicator variable for branch x in Figure 2.1 would be 1 if
the protective strain is virus A or B and 0 if it is virus C, D or E. If protective strains
in the clade defined by branch x show consistently higher or lower VN titre or HI assay
measurements regardless of their antigenic similarity to the challenge strain, then this
third type of indicator variable will be selected.
While we can distinguish these three properties in theory, it is not always possible to
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discriminate between them in practise. For a given branch, it is only possible to define all
of the properties when the clade defined by that branch includes at least one virus used
as a protective strain and one as a challenge strain. Note that not all protective strains
are used as challenge strains in our studies. For example, in Figure 2.1, it is possible
to distinguish the three properties for branch x whose clade includes both a protective
strain (virus B) and challenge strains (viruses A and B). However, the clade defined by
branch y only contains a challenge strain (virus A) and therefore an immunogenic effect,
an effect associated with protective strains, cannot be observed. Similarly as virus A is
not used as a protective strain it is not possible to determine whether any variation in
VN titre or HI assay measurements associated with its use as a challenge strain is the
result of the antigenic distinctiveness of the virus (i.e. an antigenic change in branch y)
or simply that the virus differs in its reactivity (i.e. a reactivity change in branch y).
Finally that it is worth noting the consistency of the evolutionary data for a given
pair of challenge and protective strains, re-enforcing the statements made at the end
of the second paragraph in Section 2.1.2. For a given pair of challenge and protective
strains the variables relating to the evolutionary history of the virus will remain the same.
However, unlike the residues data in Section 2.1.2, it does not remain the same when the
virus strains used as the challenge and protective strains are swapped. This is a result of
branches between pairs of virus strains having either reactivity or immunogenic affects
depending on which virus strain is used as the challenge strain and which the protective.
2.2 Foot-and-Mouth Disease Virus
There are seven serotypes of FMDV; A, C, O, Asia 1 and South African Territories types
1, 2 and 3 (SAT1, SAT2 and SAT3). The virus is endemic in sub-Saharan Africa where
six of the seven serotypes occur. Of these serotypes, SAT1 and SAT2 are responsible
for the majority of FMDV outbreaks in cattle in the region and also show high levels of
antigenic variability between virus strains. The significant levels of antigenic variability
in these serotypes makes it important to understand cross protection between strains so
that effective vaccines can be created. The high variability also allows us to examine the
relationship between genetic and antigenic variation using the data provided in Reeve
et al. (2010) and Maree et al. (2015).
2.2.1 SAT1 Serotype
There are two SAT1 datasets that have been available during the period in which the work
for this thesis was undertaken. The original SAT1 dataset is a smaller dataset originally
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Figure 2.2: Labelled phylogenetic tree for original SAT1 dataset described.
The labelled phylogenetic tree was created using BEAST v1.7.2 and FigTree v1.4.2
from aligned nucleotide sequence data with date of isolation. The leaves of the phy-
logenetic tree, see Section 2.1.3, give the SAT1 viruses strains contained in the data,
i.e. KNP/196/91. All strains are used as challenge strains and those used as protective
strains are marked with a *. Branches are labelled based on their evolutionary distance
from the leaves (observed virus strains). Leaf branches are denoted by numbers, while
internal branches are labelled by numbers and letters, where the numbers depend on the
maximum number of nodes (inferred ancestors) between this branch and any leaf which
is part of the clade defined by the branch.
collected and analysed in Reeve et al. (2010) and has been available throughout all the
work completed. This dataset has been used in Davies et al. (2014) and Davies et al.
(2016a). Further data was collected and analysed in Maree et al. (2015), and this data
became available at a later point in time and so was only analysed in Davies et al. (2016a)
and Davies et al. (2016b).
The original SAT1 dataset analysed in Reeve et al. (2010) is made up of 246 VN titre
measurements of comparisons between 3 protective and 20 challenge strains, where the
virus strains are the leaves of the phylogenetic tree, see Section 2.1.3, in Figure 2.2. For
each of these measurements, there are 754 residues in the amino acid sequence of the
structural proteins. Of these, 306 are exposed on the surface of the capsid, and 137 are
variable between the 20 test viruses, producing usable indicator variables to assess the
antigenic effect of amino acid substitutions. The phylogenetic tree given in Figure 2.2
contains 38 branches, and it is possible to include additional variables to account for
the different types of branch effect (see Section 2.1.3), resulting in 64 different indicator
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Figure 2.3: Labelled phylogenetic tree for extended SAT1 dataset. The labelled
phylogenetic tree was created using BEAST v1.7.2 and FigTree v1.4.2 from aligned nu-
cleotide sequence data with date of isolation. The leaves of the phylogenetic tree, see
Section 2.1.3, give the SAT1 viruses strains contained in the data, i.e. KNP/196/91. All
strains are used as challenge strains and those used as protective strains are marked with
a *. Branches are labelled based on their evolutionary distance from the leaves (observed
virus strains). Leaf branches are denoted by numbers, while internal branches are labelled
by numbers and letters, where the numbers depend on the maximum number of nodes
(inferred ancestors) between this branch and any leaf which is part of the clade defined
by the branch.
variables to help determine the effect of each branch and the evolution they represent.
Recorded experimental effects for the original SAT1 dataset include the challenge strain,
protective strain and antiserum, see Section 2.1.1, and these can be accounted for as
random effects in our models in Chapter 4.
After the analysis of the original SAT1 dataset in Reeve et al. (2010), more data
was collected, including additional strains and repeated experiments (Maree et al., 2015).
This dataset, to be known here as the extended SAT1 dataset, includes the original
SAT1 data and consists of a total of 2125 VN titre measurements with 5 protective and
42 challenge strains, where the virus strains are the leaves of the phylogenetic tree, see
Section 2.1.3, in Figure 2.3. Of the 306 surface exposed sites, the amino acid sequence
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Figure 2.4: Labelled phylogenetic tree for SAT2 dataset. The labelled phylogenetic
tree was created using BEAST v1.7.2 and FigTree v1.4.2 from aligned nucleotide sequence
data with date of isolation. The leaves of the phylogenetic tree, see Section 2.1.3, give
the SAT2 viruses strains contained in the data, i.e. KNP/2/89. All strains are used as
challenge strains and those used as protective strains are marked with a *. Branches are
labelled based on their evolutionary distance from the leaves (observed virus strains). Leaf
branches are denoted by numbers, while internal branches are labelled by numbers and
letters, where the numbers depend on the maximum number of nodes (inferred ancestors)
between this branch and any leaf which is part of the clade defined by the branch.
is variable between the viruses at 146. 132 variables associated with the phylogenetic
tree in Figure 2.3 are also used, with the variables representing a variety of evolutionary
effects (see Section 2.1.3). Recorded experimental effects for the extended SAT1 dataset
include the challenge strain, protective strain, antiserum and the date of the experiment,
see Section 2.1.1, and these can be accounted for as random effects in our models in
Chapter 4.
2.2.2 SAT2 Serotype
The SAT2 data was originally analysed in Reeve et al. (2010) and contains 320 VN titre
measurements of 4 protective and 22 challenge strains, where the virus strains are the
leaves of the phylogenetic tree, see Section 2.1.3, in Figure 2.4. It contains data on 128
variable surface exposed residues and 80 variables associated with the phylogenetic tree
in Figure 2.4, where the different type of evolutionary effects are taken into account (see
Section 2.1.3). Recorded experimental effects for the SAT2 dataset include the challenge
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strain, protective strain and antiserum, see Section 2.1.1, and these can be accounted for
as random effects in our models in Chapter 4.
2.3 Influenza Virus
Influenza, more commonly known as flu, is estimated to cause the death of between
250,000 and 500,000 people each year (WHO, 2009). Due to its particular danger to the
old and sick, countries like the United Kingdom (UK) provide regular vaccinations for
vulnerable people it an attempt to reduce the expected number of mortalities. For this
reason it is vital to choose the right virus strains to be made into vaccines in order to
reduce the risk of death from that year’s Influenza strains. In the UK these have usually
contained strains taken from three different serotypes; Influenza A (H1N1), Influenza A
(H3N2) and Influenza B. We have datasets for two of these serotypes which we can use
in an attempt to understand antigenic variability and the ability of different virus strains
to offer cross protection.
2.3.1 Influenza A (H1N1) Serotype
H1N1 viruses entered the human population in 1977 and co-circulated with a viruses of a
second influenza A subtype, H3N2, and influenza B viruses until their replacement by a
novel distantly related lineage of H1N1 viruses in the 2009 swine-origin pandemic (Barr
et al., 2014). During this period the influenza vaccine included a H1N1 strain which had
to be updated on nine occasions in order to remain antigenically matched to, and there-
fore capable of protecting the human population from, circulating strains. The dataset
analysed here comprises 43 H1N1 viruses collected from 1978 to 2009 that were each used
as both challenge and protective strains. There are 15,693 HI assay measurements, with
279 explanatory variables, 53 surface exposed residues and 226 variables related to the
phylogenetic data; the tree for an extended version of this H1N1 dataset can be found
in Harvey et al. (2016). Recorded experimental effects for the H1N1 dataset include the
challenge strain, protective strain and the date of the experiment, see Section 2.1.1, and
these can be accounted for as random effects in our models in Chapters 4 and 6.
2.3.2 Influenza A (H3N2) Serotype
H3N2 viruses emerged in the human population in 1968 and continue to circulate to the
present day. During this period H3N2 viruses have been responsible for the majority of
severe illness attributed to seasonal influenza, which is in part due to the increased rate
of antigenic change in these viruses relative to other influenza viruses (Barr et al., 2014).
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The H3N2 dataset includes 229 viruses collected from 1968 to 2013, of which 169 were
used as protective strains. There are 7,315 HI measurements with 1,777 pairs of challenge
and protective strains. There are are 1,264 explanatory variables which consists of 145
surface exposed antigenic residues and 1,119 variables relating to the evolutionary history
of the serotype. Finally there are recorded experimental effects for the challenge strain,
the protective strain and the date of the experiment, see Section 2.1.1, and these can be
accounted for as random effects in our models in Chapter 6.
2.4 Classifying Variables
Once we have used the methods in Chapters 4 and 6 to select the most statistically rele-
vant residues, it is important to validate our results and understand how likely our results
are to be biologically correct. Although knowledge of which residues are antigenically im-
portant is at least partially incomplete in all serotypes of FMDV and the Influenza virus,
for validation purposes we can use previous experimental results to assign residues for
each serotype (except the SAT2 FMDV serotype) to three different levels of plausibility,
proven, plausible and implausible, based on how likely they are to be antigenic.
2.4.1 SAT1 Serotype
For the SAT1 FMDV serotype, residues are included in the experimentally proven group
for three different reasons. Firstly we include any residues which have been experimentally
validated as important within the SAT1 serotype by monoclonal antibody escape mutant
studies (MAbs) (Grazioli et al., 2006). Secondly, we include those residues which are part
of cords of connected experimentally validated antigenic residues for four or more different
serotypes; VP1 140-169 (part of the VP1 G-H loop), VP1 200-224 (VP1 C terminus), VP2
70-82 (VP2 B-C loop) and VP3 56-61 (VP3 B-B knob) (Aktas and Samuel (2000); Barnett
et al. (1989); Crowther et al. (1993a); Baxt et al. (1989); Bolwell et al. (1989); Grazioli
et al. (2006); Grazioli et al. (2013); Lea et al. (1994); Kitson et al. (1990); Mateu (1995);
Saiz et al. (1991); Thomas et al. (1988a); Thomas et al. (1988b)). As antigenic sites
have been found in a large number of different individual locations, we include additional
information from other serotypes when classifying whole loops due the similar structure of
the different serotypes. Finally, we also include a number of topotype-defining branches
that are known to represent significant changes in the evolutionary history (Reeve et al.,
2010).
We define the plausible group to consist of residues from any protein loop where
residues have been identified in at least one FMDV serotype, excluding those residues
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that are already classified as proven. Additionally, any non-topotype-defining branches
of the phylogenetic trees are included in the plausible group, as it is unknown which of
the remaining branches may also be significant in evolutionary history of the serotype.
Finally we classify any residues not included in these groups as implausible.
2.4.2 SAT2 Serotype
Although knowledge of the SAT2 FMDV serotype is minimal and we do not classify
residues into different levels of plausibility, for minimal validation purposes we can ex-
ploit knowledge gained from other serotypes of FMDV and previous work on the SAT2
serotype. Grazioli et al. (2006) and Crowther et al. (1993b) has found evidence for anti-
genicity of the following three areas of the SAT2 capsid: VP1 140-169 (part of the VP1
G-H loop), VP1 200-224 (VP1 C terminus) and VP2 70-82 (VP2 B-C loop). Many re-
gions have also been found to be antigenic on multiple other FMDV serotypes and it is
also likely that they are in SAT2.
2.4.3 Influenza A (H1N1) Serotype
For influenza viruses, the haemagglutinin (HA) surface protein is responsible for binding
to host cells and is also the major target for neutralising antibodies (Skehel and Wiley,
2000). The structure of HA can be broadly be divided into the stalk domain which
connects to the virus capsid and a head domain which contains the residues involved in
binding to the host cell. Experimental studies have identified that the major antigenic
regions of HA are exposed areas in the head of the HA protein surrounding the receptor
binding site (Skehel and Wiley, 2000). For H1, these experiments have identified four
antigenic sites (Caton et al., 1982), however other sites are also known to be important
(McDonald et al., 2007). We classify residues as proven if they belong to any of the
four antigenic sites or have other experimental support for their role in antigenicity.
Other regions of the head domain are considered to be plausible residues, while residues
belonging to the stalk domain are considered unlikely to play a role in antigenic change.
2.4.4 Influenza A (H3N2) Serotype
The antigenicity of human H3N2 has been explored in greater depth than H1N1 due to
the greater burden of disease and faster rate of antigenic evolution in H3 viruses. Ex-
perimental studies have revealed the structure of the H3 HA and studies of antigenically
drifted mutant viruses generated in the laboratory have identified five distinct antigenic
sites (A-E) on the surface (Wiley and Skehel, 1987). These antigenic sites have been
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Table 2.1: Table of classification for correlated variables. The table gives the
classification of groups of completely correlated variables based on the different types
included. Ticks indicate which types of variables are in the group of correlated variables.
The same rules apply to proven and plausible variables, so these have been combined into
one group.
Proven/Plausible Implausible Branch Classification
Proven/Plausible
Implausible
Plausible
Implausible
subsequently been extended and the set of residues reported by Shih et al. (2007) are
classified as proven for model validation purposes. Structural and phylogenetic analysis
of the H3 HA has produced an extended set of potentially antigenic residues which are
classified as proven (Bush et al., 1999), with the remaining variables classified as implau-
sible. Additionally, we do not consider some residues where the reliability of the genetic
code is questionable. While initially included in the datasets, these have been excluded
when considering the selected residues.
2.4.5 Classification of Completely Correlated Variables
It is common that variables have correlation coefficients exactly equal to one. In this
case we only include one of the variables in the model and use Table 2.1 to guide the
classification into the proven, plausible and implausible groups.
When an amino acid substitution at a single residue only occurs once in the evolu-
tionary history of the virus, both the residue and branch variable explain that particular
mutation. In this case both variables are the same and only one variable is included
in the model. That variable then retains the classification given to that residue, either
proven/plausible (line 2 in Table 2.1) or implausible (line 3 in Table 2.1).
Alternatively it is also possible that several residues have an amino acid substitution
at only one point in the phylogenetic tree. In this case multiple residue variables are the
same as a single branch variable and it is impossible to tell which of these residues are
having the antigenic effect, so again only one variable is included in the model. If all
the residues have the same classification, either proven/plausible or implausible, then the
variable included in the model is given that classification (lines 2 and 3 in Table 2.1),
where we take proven over plausible. If there are both proven/plausible and implausible
variables, we have classified them as plausible to reflect our lack of knowledge of which
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residue is having the antigenic effect (line 4 in Table 2.1). The only exception to this rule
is when branches that are known to be significant changes in the evolutionary history
are selected by the model, in which case the variable is classified as proven regardless of
which residues are also selected, as we know one of these changes must be significant.
Conversely when residue variables are not the same as a branch variable, we should
be able to understand better their importance in explaining antigenic variability, as the
antigenic effect of the substitution at this residue has been seen at multiple points in
the evolutionary history of the virus. In this case if we have selected proven/plausible
and implausible variables that are identical, then we classify this selection as implausible
(line 5 in Table 2.1). This is because any genuinely significant change is unlikely to occur
in direct correlation with an implausible variable at multiple points in the evolutionary
history of the virus. It is possible that some of these variables are proven or plausible,
but it is not possible to determine this from the current data.
2.5 Discussion
In this chapter we have introduced the biological problem, antigenic variability, and
explained why it is important to understand it; Section 2.1. We have also motivated the
need for an in silico model which can predict antigenic variability and reduce the number
of in vitro experiments required to select an effective vaccine. We have then introduced a
number of FMDV and Influenza serotypes, explaining their relevance and why they cause
real biological problems, before giving details of the datasets we have available to analyse
these datasets; Sections 2.2 and 2.3. Finally we have provided the biological evidence
which we can use to validate the predictions we make and classify the plausibility of the
residues that the models in Chapters 4 and 6 select.
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Methods
In this chapter we introduce a number of standard methods which can be used to model
antigenicity. In Section 3.1 we introduce some classical methods that can account for
the experimental variation and have previously been used to model antigenicity, e.g.
the mixed-effects models of Reeve et al. (2010). We also discuss alternative Frequentist
methods, the Least Absolute Shrinkage and Selection Operator (LASSO) and elastic net,
as well as providing extensions to these methods in the form of the mixed-effects LASSO
and mixed-effects elastic net (Davies et al., 2016a; Schelldorfer et al., 2011) and detail
their implementation. These methods are used as a comparison for the more complex
methods introduced in Chapters 4 and 6. Section 3.2 provides details of some of the
Bayesian inference techniques used in Chapters 4 and 6, in particular Markov chain Monte
Carlo (MCMC). These methods are combined with the Bayesian sparsity methods from
Section 3.3 to create the Bayesian models introduced in Chapters 4 and 6. Finally we
look at evaluation (Section 3.4) and model selection (Section 3.5) methods, discussing
methods that measure the ability of a model in terms of prediction and variable selection,
as well as how to choose between different models.
3.1 Classical Methods
A variety of classical statistical methods have previously been applied in predicting anti-
genic variability in order to identify antigenic sites. In this section we review some of
these methods and propose variations which are applicable in the context of understand-
ing antigenic variability.
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3.1.1 Mixed-Effects Models
Classical mixed-effects models are a simple method which can be used to model antigenic
variability and account for the experimental variability inherent in the data, e.g. Reeve
et al. (2010). In classical mixed-effects models we define the response y = (y1, . . . , yN)
>
and denote the explanatory variables, X, as a matrix of J+1 columns and N rows, where
the first column is an intercept. Each column of explanatory variables, Xj, is then given
an associated regression (or fixed effects) coefficient, wj, to control its influence on the
response.
We further set the random-effects design matrix, Z, as the matrix of indicators with
N rows and ||b|| columns, where ||.|| indicates the dimension of the vector. The random-
effect coefficients are given as b = (b>1 , . . . ,b
>
G)
> and represent a vector of parame-
ters related to each of the groups g ∈ {1, . . . , G}. Each bg has length ||bg||, where
||b|| = ∑Gg=1 ||bg||, and follows a zero mean Gaussian distribution with a group depen-
dent variance, bg ∼ N(bg|0,σ2b,gI), where I is the identity matrix. This leads to the
random-effect coefficients having the following joint distribution b ∼ N(b|0,Σb), where
we define Σb = diag(σ
2
b) with σ
2
b = (σ
2
b,1, . . . , σ
2
b,G) where each element has length ||bg||.
See Pinheiro and Bates (2000) for more details on mixed-effects models.
We therefore define the mixed-effects model as:
y = Xw + Zb + ε where ε ∼ N(ε|0, σ2εI) (3.1)
where we assign the model independent and identically distributed Gaussian errors. Using
a simple application of Gaussian integrals (Bishop, 2006), we integrate over b to give the
likelihood:
L(w, σ2ε ,Σb|y,X,Z) = N(y|Xw,ZΣbZ> + σ2εI). (3.2)
In classical mixed-effects models, model comparison techniques are often used to choose
which variables are included within the model. To get a sparse model, Reeve et al. (2010)
used a form of forward inclusion, making an adjustment for multiple testing using the
Holm-Bonferroni correction (Holm, 1979). They firstly included terms to account for
the evolutionary history of the viruses based on their phylogenetic trees, before adding
variables corresponding to the surface exposed residues. The residue variables were added
one at a time, before checking for significance and removing so to test other variables.
Variables with a p-value of less than 0.05 were said to be significant and the corresponding
residue proposed to be antigenically important. This technique was used by Reeve et al.
(2010) on the SAT1 and SAT2 FMDV datasets (Sections 2.2.1 and 2.2.2) by Maree et al.
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Figure 3.1: Plot demonstrating the Sparsity caused by the LASSO Penalty. The
plot shows the contours of the unregularised error function along with the constrained
region for the LASSO (λ1, left) and ridge penalties (λ2, right) where the optimum value
of the regression parameters is given by w∗. The LASSO gives a sparse solution in which
w∗1 = 0. This figure is adapted from Bishop (2006).
(2015) on the extended SAT1 FMDV dataset (Section 2.2.1). Similar methods, but with
further manual intervention, has been used by Harvey et al. (2016) on the H1N1 Influenza
dataset (Section 2.3.1) and Harvey (2016) on the H3N2 dataset.
3.1.2 LASSO
A problem with the classical mixed-effects models of Reeve et al. (2010) is the reliance
on stepwise regression techniques, which do not explore all variable configurations and
can result in a non-optimal solution. A classical alternative to forward variable selection
which does allow for simultaneous variable selection is the LASSO of Tibshirani (1996,
2011). The LASSO achieves its variable selection through an `1 penalty (equivalent to a
Bayesian Laplace prior). In the simplest case of linear regression, this gives the following
parameter estimates:
wˆ = argmin
w
{
(y−Xw)2 + λ
J∑
j=1
|wj|
}
. (3.3)
In the linear case this is a convex optimisation problem where a variety of fast and effective
algorithms exist (e.g. Efron et al. (2004); Hastie et al. (2009)). The effect of (3.3) is
to simultaneously shrink and prune parameters w, thereby promoting a sparse model;
see Bishop (2006) for examples. The degree of sparsity depends on the regularization
parameter λ, which can be optimised via cross-validation or information criteria, e.g.
Bayesian Information Criterion (BIC).
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To see why the `1 penalty leads to a sparse model we first note that (3.3) is equivalent
to minimising the unregularised sum of squares error subject to the constraint:
J∑
j=1
|wj| ≤ η (3.4)
for an appropriate value of the parameter η (Bishop, 2006). The reason for the sparsity
can be seen by looking at Figure 3.1 which show the minimisation of the error function
subject to the constraint in (3.4), the LASSO penalty in the left panel of Figure 3.1 forces
one of the variables to equal zero, w∗1 = 0.
3.1.3 Elastic Net
A potential improvement over the LASSO is the elastic net of Zou and Hastie (2005).
It has several advantages over the LASSO including the ability to select more than N
variables in a J > N situation, whereas the LASSO saturates to at most N variables
(Zou and Hastie, 2005). More importantly for our application is that it also deals better
with groups of correlated variables. While the LASSO will arbitrarily select one of the
correlated variables, the penalty of the elastic net allows it to keep all of the variables
in the model. See Section 2.3 of Zou and Hastie (2005) for more information on the
grouping effect.
The elastic net combines `1 and `2 penalties and in the case of linear regression gives
the following parameter estimates:
wˆ = argmin
w
{
(y−Xw)2 + αλ
J∑
j=1
|wj|+ (1− α)λ
J∑
j=1
|wj|2
}
(3.5)
where λ is the penalty parameter and α controls the ratio of the `1 and `2 penalties.
When α = 1 the Elastic Net is equivalent to the LASSO and likewise ridge regression
when α = 0. We can fix α < 1 and the problem becomes strictly convex, so we have a
unique global minimum regardless of whether X is full rank. In practise Ruyssinck et al.
(2014) have found that the choice of α is not important provided it is 0 < α < 1 and we
have further explored this in the context of the mixed-effects elastic net (Section 3.1.5)
in Chapter 5.
3.1.4 Mixed-Effects LASSO
An extension of the standard LASSO is the mixed-effects LASSO proposed by Schelldorfer
et al. (2011), who estimate the regression coefficients w, random-effect variances σ2b and
24
3. Methods
the variance of the noise σ2ε as:
(wˆ, σˆ2b, σˆ
2
ε) = argmin
w,σ2b>0,σ
2
ε>0
{
1
2
log |V|+ 1
2
(y−Xw)>V−1(y−Xw) + λ
J∑
j=1
|wj|
}
(3.6)
where V = ZΣbZ
> + σεI. The mixed-effects LASSO can be combined with different
information criteria to select the penalty parameter, λ. In Chapter 4 we have used BIC
and the corrected Akaike Information Criterion (AICc) (Hurvich and Tsai, 1989).
A problem with the mixed-effects LASSO of Schelldorfer et al. (2011) is that the
method has only been developed for one random-effect factor. In order to deal with this
problem the Cartesian product of several random-effects factors can be mapped onto a
single random-effect factor. However this can lead to over-estimating the complexity of
the model, so we have developed our own mixed-effects LASSO which allows multiple
random effect factors in order to deal with this (Davies et al., 2016a). Our method uses a
conjugate gradient optimisation strategy available in R (R Core Team, 2013), but requires
a tolerance that must be determined by the user. In practise we have found this easy to
do, as for a sufficiently large λ and reasonably standardised data there will be a group
of regressors clearly grouped around zero. The tolerance can then be set such as to force
these values to zero, i.e. exclusion from the model, and other values of λ used. While this
may not be as effective as the purpose-built block coordinate descent scheme proposed in
Schelldorfer et al. (2011), we have found in practise that they achieve the same results.
3.1.5 Mixed-Effects Elastic Net
Like the LASSO, we can expand the elastic net into the context of a mixed-effects model
(Davies et al., 2016a):
(wˆ, σˆ2b, σˆ
2
ε) = argmin
w,σ2b>0,σ
2
ε>0
{
1
2
log |V|+1
2
(y−Xw)>V−1(y−Xw)
+ αλ
J∑
j=1
|wj|+ (1− α)λ
J∑
j=1
|wj|2
}
(3.7)
where V = ZΣbZ
> + σεI. Again we use the simple optimisation strategy we proposed
for the mixed-effects LASSO in Section 3.1.4.
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3.2 Bayesian Inference with Markov chain Monte
Carlo
In Bayesian inference the posterior distribution, the distribution which contains all the
current information about the parameters θ, is defined by Bayes theorem (Bayes, 1763).
For a given model specification, we define the likelihood to be the probability of the data,
D, given the model distribution, p(.), and model parameters, θ. To get the posterior
distribution the likelihood is multiplied by the prior distribution, p(θ), and normalised:
p(θ|D) = p(D|θ)p(θ)∫
p(D|θ)p(θ)dθ ∼ p(D|θ)p(θ). (3.8)
Usually integrating over θ is not possible in complex or high dimensional problems, but
the posterior distribution can be sampled from p(D|θ)p(θ) using MCMC methods.
MCMC methods are a family of estimation methods used to approximate a target dis-
tribution. They are used where integration over all model parameters is not analytically
tractable and can be used in Bayesian inference to sample from the posterior distribution
of a given model. The idea of the method is to sample values of the parameter, θ, from
approximate distributions and then correct those draws to better approximate the target
posterior distribution, p(θ|y). Samples are drawn such that they only depend on the last
value drawn and hence form a Markov chain. Doing this produces a sequence of samples
(chain) which converges to a stationary distribution at time t where:
θt+1|(θt ∼ p(.)) ∼ p(.). (3.9)
In Bayesian inference the stationary (or equilibrium) distribution is the posterior distri-
bution and is independent of the starting state. Samples from this distribution will come
from the target distribution (posterior).
As convergence to the stationary distribution (posterior) is not instant, we must
remove the period of samples before convergence has been achieved. This section of
samples is usually known as burn-in and convergence is often assessed by running multiple
chains and diagnosing convergence using Potential Scale Reduction Factors (PSRFs);
see Section 3.2.3. Additionally, samples from the posterior distribution can be highly
autocorrelated and samples are therefore often thinned, e.g. take every ith sample, in
order to get independent samples of the posterior and accurate estimates of θ.
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3.2.1 Metropolis-Hastings Algorithm
The Metropolis-Hastings (M-H) algorithm was introduced by Metropolis et al. (1953)
and Hastings (1970), and can be used as a method to sample parameters in the posterior
distribution through an acceptance and rejection step. Normally parameters are proposed
individually and put through the acceptance and rejection step which is based on the
ratio of the posterior and proposal distributions. In this sense parameters are gradually
updated throughout the MCMC chain.
To get the ith sample of θ, θi, via the M-H algorithm we firstly need to propose
a potential new value, θ∗. This is done through the proposal distribution q(θ∗|.). For
continuous variables the proposal distribution is usually centred around the previous value
of the sequence, θi−1, i.e. q(θ∗|θi−1) where q(.) is a Gaussian distribution, but this is not
always possible. The distribution of q(θ∗|.) can be freely chosen, but its choice affects the
speed of convergence and mixing. In the second step of the M-H algorithm the proposal
parameter value, θ∗, is accepted or rejected via the acceptance probability. This is given
as the ratio of posterior distributions of the proposed and previous parameter values, as
well as the forwards, q(θ∗|.), and backwards, q(θi−1|.), proposal densities:
α(θ∗, θi−1|D) = min
(
1,
p(θ∗|D)q(θi−1|.)
p(θi−1|D)q(θ∗|.)
)
. (3.10)
The proposed parameter value, θ∗, is then accepted if α(θ∗, θi−1|D) is greater than a
uniform random variable u, where u ∼ U[0, 1]. If the proposed parameter is accepted
then we set θi to be equal to θ∗ and if not set it such that θi = θi−1.
3.2.2 Gibbs Sampling
Gibbs sampling is a special case of the M-H algorithm proposed by Ripley (1979) and
Geman and Geman (1984). Unlike in the M-H algorithm, θj is not sampled from the
full posterior distribution, p(θ|D). Instead each parameter, θj ∈ θ, is sampled from
its conditional distribution, subject to θ−j ∈ θ. Gibbs sampling requires the conditional
distribution to follow a standard distribution and if not the sampling of θj should be done
through the M-H algorithm. Due to the conditional distribution of θj following a standard
form we can propose the value of θ∗ from the conditional distribution. This results in
q(θj|θ−j,D) = p(θj|θ−j,D) in (3.10), resulting in the acceptance rate equalling one,
α(θ∗, θi−1|D) = 1. In practise this means we can simply sample θ∗j from the conditional
distribution and immediately set θ∗j = θ
i
j.
To use Gibbs sampling and the M-H algorithm to sample the full posterior distri-
bution, we sample a new value for each parameter θj ∈ θ based on the current val-
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ues of θ−j ∈ θ. Each parameter is sampled from its conditional distribution θij ∼
p(θij|θi1, . . . , θij−1, θi−1j+1, . . . , θi−1J ,D), where the parameters conditioned on take the value
of their most recent sample. Where the conditional distribution is of a known form it
is standard to use Gibbs sampling, although alternative proposals can be used with the
M-H algorithm instead. If this is not the case then the M-H algorithm should be used.
The initial values of the parameters, θ1, are set to some arbitrary values in the correct pa-
rameter space. Under reasonable general conditions and a sufficient number of iterations,
i, the algorithm will converge to the target distribution.
3.2.3 Potential Scale Reduction Factors
PSRFs are a measure which quantifies the convergence of multiple MCMC chains as
introduced by Gelman and Rubin (1992). PSRFs are based on the assumption that
multiple chains using the same data should have the same variation within each chain as
they do between them, if this has not occurred then the chains have clearly not converged
(Gelman et al., 2013a).
The calculation of the PSRF for each parameter, θ, requires m parallel sequences,
each of length n. To calculate the PSRF of each of the model parameters we compute
the between-sequence, B, and within-sequence, W , variances:
B =
n
m− 1
m∑
j=1
(
θ¯j − θ¯
)2
, where θ¯j =
1
n
n∑
i=1
θij, θ¯ =
1
m
m∑
j=1
θ¯j (3.11)
W =
1
m
m∑
j=1
s2j , where s
2
j =
1
n− 1
n∑
i=1
(
θij − θ¯j
)2
. (3.12)
We can then estimate Var(θ|y), the marginal posterior variance of the parameter, by a
weighted average of W and B:
V̂ar
+
(θ|y) = n− 1
n
W +
1
n
B. (3.13)
This quantity overestimates the marginal posterior variance of the parameter, Var(θ|y),
while W underestimates it for finite n. From this the PSRF can be calculated as follows:
Rˆ =
√
V̂ar
+
(θ|y)
W
(3.14)
where the value declines to 1 as n → ∞. Large values of Rˆ indicate a lack of conver-
gence and values of less than 1.05 or 1.1 are generally said to indicate convergence, e.g.
Grzegorczyk and Husmeier (2013).
28
3. Methods
3.2.4 Joint Distribution Tests
When using different sampling schemes it is often important to check whether the MCMC
sampler approximates the correct posterior distribution. Joint distribution tests as pro-
posed by Geweke (2004) can be used to do this. The idea behind the joint distribution
test is to draw D sets of model parameters, θ1, . . . ,θD from the model’s prior distributions
pθ(.) and then use these parameters to generate D datasets,D1, . . . ,DD. Using the same
model and prior specifications we can then use the MCMC sampler that is being tested
to sample from each of the posterior distributions, p(θd|Dd), of the D datasets. From
each of the MCMC chains of each posterior distribution we can then take N indepen-
dent samples of the model parameters, θd,1, . . . ,θd,N . To work out whether the MCMC
samplers are sampling from the correct posterior distribution we then check whether the
samples θi,d for i ∈ {1, . . . , N} and d ∈ {1, . . . , D} follow the prior distribution used to
generate the data, p(.).
1
D
D∑
d=1
p(θ|Dd) ≈
∫
p(θ|D)p(D)dD =
∫
p(D,θ)dD = p(θ) (3.15)
If the sampled parameters follow p(.) then for a large enough D and N we can conclude
that the MCMC sampler is correctly sampling the posterior.
3.3 Bayesian Sparsity Methods
A variety of methods exist in Bayesian inference for achieving a sparse model. Like with
the Frequentist methods in Section 3.1 we can use `1 regularisation and similar methods
exist in the Bayesian paradigm, e.g. Bayesian LASSO (Park and Casella, 2008). However
`1 methods have their drawbacks as discussed below and so alternative methods have been
proposed which get round some of these issues, e.g. the spike and slab prior (George and
McCulloch, 1993, 1997; Mitchell and Beauchamp, 1988) and the binary mask model, e.g.
Murphy (2012).
Many of these Bayesian methods have been shown to give an improvement over `1
regularisation methods in terms of variable selection and prediction (Davies et al., 2014,
2016a; Mohamed et al., 2012). One of the reasons for this is the `1 regularisation term
itself, equivalent to a Laplace prior in a Bayesian context (Park and Casella, 2008). This
is computationally efficient and leads to a convex optimisation problem for penalised
maximum likelihood or Bayesian maximum a posteriori (MAP) inference. However, `1
regularisation gives an increased bias from shrinkage while not giving sufficient sparsity,
as discussed in Chapter 13 of Murphy (2012). The Bayesian methods, such as spike
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and slab priors, can improve variable selection and avoid excessive shrinkage, but lead to
a non-convex optimisation problem. These priors can also be integrated into Bayesian
hierarchical models, as can be seen in Chapters 4 and 6, and this also gives a number of
other advantages. In particular Bayesian hierarchical models allow consistent inference of
all parameters and hyper-parameters, and inference borrows strength by the systematic
sharing and combination of information; see Gelman et al. (2013a).
3.3.1 Spike and Slab Prior
Spike and slab priors have been used in a number of different contexts and have been
shown to outperform `1 methods both in terms of variable selection and out-of-sample pre-
dictive performance (Mohamed et al., 2012). They were originally proposed by Mitchell
and Beauchamp (1988) as a mixture of a Gaussian distribution and a Dirac spike, but
have also been used as a mixture of two Gaussian distributions (George and McCulloch,
1993, 1997; Ishwaran and Rao, 2005). Spike and slab priors are based on the idea that
the prior reflects whether the feature is relevant based on the values of a inferred vector
of binary indicator parameters, γ, where γ = (γ1, . . . , γJ)
> ∈ {0, 1}J . The relevance of
the jth column of X is determined by γj ∈ {0, 1}, where feature j is said to be relevant
if γj = 1. In this way we expect that wj = 0 if γj = 0, i.e. the feature is irrelevant, and
conversely it should be non-zero if the variable is relevant, wj 6= 0 if γi = 1.
The spike and slab prior of Mitchell and Beauchamp (1988) approaches this concept
by assigning a conjugate Gaussian prior where the feature, wj, is relevant, i.e. γj = 1,
and a Dirac spike at zero where it is not:
p(wj|γj, µw, σ2w) =
{
δ0(wj) if γj = 0
N(wj|µw, σ2w) if γj = 1.
(3.16)
Here we have a spike at 0 and as σ2w → ∞ the distribution, p(wj|γj = 1), approaches a
uniform distribution, a slab of constant height. In this sense where γj = 0 the variable wj
and corresponding variable Xj are effectively removed from the model as demonstrated
by the following example:
X =
x1,1 x1,2 x1,3x2,1 x2,2 x2,3
x3,1 x3,2 x3,3
 ; Xγ =
x1,1 x1,3x2,1 x2,3
x3,1 x3,3
 ;
w =
w1w2
w3
 ; wγ = [w1
w3
]
; γ =
γ1 = 1γ2 = 0
γ3 = 1
 .
(3.17)
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wj
γj y
Xj
j = 1, . . . , J
(a) Binary Mask Model
wj
γj y
Xγj ,j
j = 1, . . . , J
(b) Spike and Slab Model
Figure 3.2: Probabilistic Graphical Models (PGMs) for the (a) binary mask
and (b) spike and slab models. The grey squares refer to the data, while the white
circles refer to parameters and hyperparameters that are inferred.
The alternative spike and slab prior of George and McCulloch (1993, 1997) approxi-
mates the spike and slab prior of Mitchell and Beauchamp (1988) by replacing the Dirac
spike with a highly peaked Gaussian distribution centred around zero:
p(wj|γj, µw, σ2w1 , σ2w2) =
{
N(wj|0, σ2w1) if γj = 0
N(wj|µw, σ2w2) if γj = 1.
(3.18)
In this case the values of the spike variance parameter is usually fixed to be very small
such that σ2w1 << σ
2
w2
. The idea of fixing σ2w1 to be small is to force any wj where γj = 0
to be approximately 0, i.e. wj ≈ 0. In this thesis we have not explored this specification,
as mathematically it is inferior to the spike and slab prior of Mitchell and Beauchamp
(1988) due to the irrelevant variables only being approximately fixed to zero and the
necessity to a-priori fix the value of σ2w1 .
3.3.2 Binary Mask Model
An alternative to the spike and slab prior is the binary mask model, e.g. Jow et al.
(2014). Instead of the prior on the regression coefficients reflecting the relevance of the
variable, in the binary mask model the indicator variables, γ, ‘mask’ or hide the impact
of the non-zero coefficients, w, and explanatory variables, X, when the variable is not
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selected:
p(y|w,γ, σ2ε ,X) = N(y|XΓw, σ2εI) (3.19)
where Γ = diag(γ). This is different to the spike and slab based methods where the
variables, and their corresponding coefficients, are effectively removed from the model
via a ‘spike’ or delta prior, rather than simply masked. The difference can be seen by
comparing the directed edges associated with the γ vertex in the Probabilistic Graphical
Model (PGM) of the spike and slab model, Figure 3.2b, with the PGM of the binary
mask model given in Figure 3.2a.
3.4 Evaluation Methods
To compare the different methods and model specifications that will be used in this the-
sis, we need to introduce a variety of different methods to evaluate them. We are firstly
interested in evaluating explanatory performance, e.g the reliability of the selection of
relevant explanatory variables. In this case the distinction between in-sample and out-of-
sample prediction becomes obsolete, as the status of the variables does not change. The
explanatory methods here are sensitivity, specificity, precision, F1-score (Section 3.4.1),
Receiver Operating Characteristic (ROC) curves and Area Under the ROC curve (AU-
ROC) values (Section 3.4.2). We also wish to monitor predictive performance, where the
values change from case to case. To reduce over-optimism we therefore assess predictive
performance out-of-sample, in our case looking at out-of-sample likelihoods and Mean
Squared Errors (MSEs) of out-of-sample observations (Section 3.4.1).
3.4.1 Summary Statistics
Sensitivity, specificity, precision and F1-scores are all measures of the performance of a
binary classification, e.g. the successful inclusion or exclusion of relevant or irrelevant
explanatory variables. These are given in terms of True Positives (TP), False Positives
(FP), True Negatives (TN) and False Negatives (FN);
Sensitivity =
TP
TP + FN
(3.20)
Specificity =
TN
TN + FP
(3.21)
Precision =
TP
TP + FP
(3.22)
F1-Score =
2TP
2TP + FP + FN
(3.23)
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Figure 3.3: Example ROC Curve. A plot showing an example ROC curve, where
the perfect predictor, the actual predictor and random expectation are indicated and the
AUROC value is given by the shaded area.
where higher values imply improved performance. These summary statistics measure
explanatory performance and are used to compare different methods in their abilities to
correctly select fixed or random effects. Sensitivity and specificity are also used to create
ROC curves and the resulting AUROC values in Section 3.4.2.
Predictive performance is usually calculated out-of-sample. Here we use MSEs and
likelihoods of out-of-sample observations, yout, based on predicted observations, ypred,
taken from the inferred parameter values, θinf , from training data, yobs. In this case the
out-of-sample MSEs and mean log likelihoods are defined as follows:
MSE(yout|yobs(θinf )) =
1
||yout||
∑((
yout − ypred(θinf )
)2)
(3.24)
pˆout(yout|θinf (yobs)) =
1
||yout||
log (p(yout|θinf (yobs)) (3.25)
where ||yout|| denotes the number of out-of-sample observations.
3.4.2 ROC Curves
ROC curves are an important tool for measuring the performance of a method in variable
selection (e.g. Hanley and McNeil (1982); Section 5.7. of Murphy (2012)). ROC curves
can be constructed when an underlying gold standard is known, e.g. in a simulation
study where the relevant variables are known, and a method of ranking the importance
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of the variables is given, e.g. posterior probability of inclusion of a variable. To create
the ROC curves we use the rankings to define inclusion thresholds between each ordered
variable and plot the sensitivity, (3.20), against one minus the specificity, (3.21) for each
possible threshold. Linear interpolation is then used to complete the ROC curve. An
example ROC curve is given in Figure 3.3 and is marked as the ‘actual predictor’.
From the ROC curves AUROC values can then be calculated using numerical integra-
tion, where the area that makes up the AUROC value is shaded in Figure 3.3. AUROC
values give a measure of global performance that is not dependant on an arbitrary thresh-
old and like ROC curves can be used to compare the performance of different methods in
terms of variable selection. Random expectation gives an AUROC value of 0.5 (‘Random
expectation’ in Figure 3.3), while a value of 1 means a method offers perfect selection
(‘perfect predictor’ in Figure 3.3). The higher the AUROC value, the better the method
is said to have performed in terms of variable selection.
3.5 Model Selection Methods
We are also interested in choosing between different models and model specifications.
To choose between competing models or model specifications we can use the Widely
Applicable Information Criterion (WAIC), Watanabe (2010), or Bayesian 10-fold Cross
Validation (CV), e.g. Chapter 7 of Gelman et al. (2013a).
3.5.1 Bayesian Cross Validation
Bayesian CV methods are reliable, if computationally expensive, techniques for measuring
the out-of-sample performance of different models. CV methods work by partitioning the
data into K groups and then analysing the predictive performance of a given model on
each of the K different groups using the remainder of the data for training. In this sense
CV methods estimate out-of-sample predictive performance while still making use of all
of the available data.
Various CV methods can be used to analyse the performance of different models.
Leave-One-Out CV (LOO-CV) uses each observation as an individual group, i.e. K = N ,
with the advantage of making maximum use of the available data at every step. However
LOO-CV is computationally infeasible for many models, as it requires fitting the model
N times. As a compromise 10-fold CV is often used, where K = 10, as it only involves
fitting 10 models and this method has been used here.
To calculate the 10-fold Bayesian CV performance of a model, we apply the method
to partial data, y−k, and D−k, and use thinned samples of the model parameters, θ
ι, for
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ι ∈ {1, . . . , I}, from p(θ|y−k,D−k), to estimate the performance on the remaining data,
yk and Dk, using the likelihood. Doing this for each of the K groups gives the 10-fold
Bayesian CV performance:
pCV =
1
K
K∑
k=1
log
∫
p(yk|θ)p(θ|D−k)dθ ∝
1
K
K∑
k=1
log
1
I
I∑
ι=1
p(yk|θι). (3.26)
where θι is a sample from p(θ|D−k).
3.5.2 Widely Applicable Information Criterion
WAIC (Watanabe, 2010) and Deviance Information Criterion (DIC) (Spiegelhalter et al.,
2002) are both useful criteria for selecting the correct models in a Bayesian context. DIC
is effectively a Bayesian version of the Akaike Information Criterion (AIC), where the
posterior mean is used instead of the maximum likelihood estimate and k is replaced
with a data-based bias correction (Gelman et al., 2013b):
pDIC = 2
(
p(y|θ¯)− 1
I
I∑
ι=1
p(y|θι)
)
. (3.27)
Here the first part measures predictive performance and the second is the effective number
of parameters. DIC has been shown to work well in a number of situations, however its
performance becomes poor when the model used is singular, e.g. when spike and slab
priors are used. In this situation the posterior mean becomes a poor representation of
the posterior samples of a given parameter and the method suffers accordingly.
While DIC struggles with singular models, WAIC still remains effective for selecting
the correct model and this is why we have used WAIC in this thesis rather than DIC
(Gelman et al., 2013b). WAIC averages over the posterior distribution which is both
desirable and allows the criterion to work with singular models. Watanabe (2010) also
showed how WAIC is asymptotically equivalent to Bayesian LOO-CV. WAIC can be
computed using the thinned parameter samples, θι, from the posterior distribution of the
full dataset, p(θ|y,D), meaning the sampling process must only be carried out once for
the whole dataset:
pWAIC = −2
N∑
i=1
(
log
(
1
I
I∑
ι=1
p(yi|θι,Di)
)
− Var (log(p(yi|θι,Di)))
)
(3.28)
where Var is the sample variance.
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3.6 Discussion
In this chapter we have introduced a number of standard methods which are relevant
to the methods proposed in this thesis. We have described some classical methods,
Section 3.1, which will be used as a comparison to the methods proposed in Chapter 4.
These include standard mixed-effects, the LASSO, elastic net and mixed-effect model
versions of the LASSO and elastic net. We have also demonstrated, in Section 3.2, basic
Bayesian methods and how to infer the posterior distributions of the model parameters.
These techniques will be used in the methods proposed in Chapters 4 and 6. We have
also introduced the Bayesian sparsity methods that will be used in Chapters 4 and 6 and
discussed how they can offer an improvement over the classical methods of Section 3.1.
Section 3.4 has then specified some different evaluation methods which will be used
throughout Chapters 5 and 7. Finally in Section 3.5 we have looked at methods for
choosing between different model specifications.
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Sparse Hierarchical Bayesian Models
for Understanding Antigenic
Variability - The Methods
In this chapter we introduce the family of Sparse hierArchical Bayesian models for de-
tecting Relevant antigenic sites in virus Evolution (SABRE); the SABRE methods. The
methods can account for the experimental variability in the data and predict antigenic
variability. The SABRE methods integrate spike and slab priors into a Bayesian hier-
archical model in order to select the significant variables and identify the corresponding
sites in the viral protein which are important for the neutralisation of the virus.
The original SABRE method (Section 4.1), as published in Davies et al. (2014), is a
Bayesian hierarchical mixed effects model, based on the Frequentist mixed effects models
of Reeve et al. (2010) described in Section 3.1.1. The method aims to predict either log VN
titre or log HI assay measurements (Section 2.1) based on the fixed effects, the antigenic
residues and phylogenetic tree branches (Sections 2.1.2 and 2.1.3), and the random effects
(Section 2.1.1). To do this effectively the original SABRE method uses spike and slab
priors (Section 3.3.1) to select the relevant fixed effects and identify potential antigenic
residues. The spike and slab prior is known to outperform the Least Absolute Shrinkage
and Selection Operator (LASSO) in terms of variable selection (Mohamed et al., 2012)
and its incorporation into a Bayesian hierarchical model allows the consistent inference of
all parameters and hyper-parameters, and inference borrows strength by the systematic
sharing and combination of information; see Gelman et al. (2013a).
Section 4.2 discusses a variety of potential improvements to the original SABRE
method proposed in Davies et al. (2014), as discussed in Davies et al. (2016a). Firstly a
separate intercept parameter is introduced (Section 4.2.1) and the addition of this cre-
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ates what is known as the Semi-Conjugate SABRE method. Specifying the prior on the
intercept correctly is important as it is a biologically significant parameter which gives
the VN titre or HI assay when any two identical viruses are used as the challenge and
protective strains, i.e. when all covariates are equal to zero. Section 4.2.2 details the
Conjugate SABRE method, this gives the model increased conjugacy which introduces
additional relationships into the model and provides the opportunity to improve the
sampling scheme. Section 4.2.3 introduces the binary mask model (Section 3.3.2) in the
context of the SABRE method, allowing us to test the difference in performance between
models based on the spike and slab prior and those based on the binary mask model.
Finally Section 4.2.4 looks at different specifications of random effect priors, namely it
looks at the possibility of using the half-t prior proposed in Gelman (2006), something
that has previously been suggested in the literature.
Section 4.3 discusses posterior inference for all of the SABRE methods based on the
methods discussed in Section 3.2, providing the conditional distributions needed to sample
from the model. Section 4.3.5 discusses in detail the sampling of the latent inclusion
variables, γ, that are used in the spike and slab priors (Section 3.3.1). In particular
it looks at sampling multiple parameters via block M-H sampling, as well as exploring
the more standard method of component wise Gibbs sampling, in order to find the most
effective way of sampling γ. Finally in Section 4.3.6 we discuss the conjugate sampling
scheme (CSS) that can be used with the conjugate SABRE in order to potentially improve
the computational efficiency.
4.1 The Original SABRE Method
The original SABRE method was proposed in Davies et al. (2014) and incorporates the
spike and slab prior into a hierarchical Bayesian model. The model is shown in the
PGM in Figure 4.1 and the parameters are sampled from the posterior distribution using
MCMC based on the methods in Section 3.2, where the conditional distributions are
given in Section 4.3.1.
4.1.1 Likelihood
The likelihood for the original SABRE method is similar to the classical mixed-effects
model described in Section 3.1.1, however we include only the relevant residue and phylo-
genetic tree variables, X, and regressors, w. However instead of including all the variables,
X, and their corresponding regression coefficient, we now only include relevant variables,
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µ0,h σ20,h αw,h βw,h
µw,h σ2w,h
wj,h
βpi γj y Zk
pi Xγj ,j
σ2ε
bk,g µb,g
αpi
αε
βε
σ2b,g
αb,g
βb,g
h = 1, . . . ,H
j = 1, . . . , J
k =
1, . . . , ||b||
g = 1, . . . , G
For: j = 1, . . . , J
γj ∼ Bern(γj |pi)
pi ∼ B(pi|αpi, βpi)
y ∼ N (y|Xγwγ + Zb, σ2εI) σ2ε ∼ IG(σ2ε |αε, βε)
For: k = 1, . . . , ||b||
bk,g ∼ N (bk,g|µb,g, σ2b,g)
For: j = 1, . . . , J
wj,h ∼
{
δ0(wj,h) if γj = 0
N (wj,h|µw,h, σ2w,h) if γj = 1.
For: h = 1, . . . ,H
µw,h ∼ N (µw,h|µ0,h, σ20,h)
σ2w,h ∼ IG(σ2w,h|αw,h, βw,h)
For: g = 1, . . . , G
σ2b,g ∼ IG(σ2b,g|αb,g, βb,g)
Figure 4.1: Compact representation of the original SABRE method as a PGM.
The grey circles and squares refer to the fixed hyperparameters and data respectively,
while the white circles refer to parameters and hyperparameters that are inferred.
Xγ , and regressors, wγ :
p(y|wγ ,b, σ2ε ,Xγ ,Z) = N(y|Xγwγ + Zb, σ2εI). (4.1)
The relevance of variable j is determined by γj ∈ {0, 1}, where feature j is said to be
relevant if j = 1. This gives γ = (γ1, . . . , γJ) ∈ {0, 1}J where γ0 = 1 is fixed meaning that
there is always an intercept in the model. We then define Xγ to be the matrix of relevant
explanatory variables with
∑J
j=1 γj columns and N rows. Similarly wγ is given as the
column vector of regressors, where the inclusion of each parameter is again dependent on
γ.
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4.1.2 Noise Prior
As with the classical methods described in Section 3.1, we assume additive iid Gaussian
noise with variance σ2ε . In a Bayesian context we wish to infer σ
2
ε , so we specify the
conjugate prior:
σ2ε ∼ IG(σ2ε |αε, βε) (4.2)
where the hyper-parameters αε and βε are fixed, as indicated by the grey nodes in Fig-
ure 4.1.
4.1.3 Spike and Slab Prior
Spike and slab priors have been used in a number of different contexts and have been
shown to outperform `1 methods both in terms of variable selection and out-of-sample pre-
dictive performance (Mohamed et al., 2012). They were originally proposed by Mitchell
and Beauchamp (1988) as a mixture of a Gaussian distribution and Dirac spike, but have
also been used as a mixture of two Gaussians distributions; see Section 3.3.1.
The prior for wγ is set in the manner proposed in Mitchell and Beauchamp (1988)
such that it reflects whether a feature is relevant. In this way we expect that wj,h = 0
if γj = 0, i.e. the feature is irrelevant, and conversely it should be non-zero if the
variable is relevant, wj,h 6= 0 if γj = 1. The variables are then divided into related groups
h ∈ {1, . . . , H}, in this case two: the intercept and the covariates. A conjugate prior is
chosen when the feature is relevant:
p(wj,h|γj,h,µw,h, σ2w,h) =
{
δ0(wj,h) if γj = 0
N(wj,h|µw,h, σ2w,h) if γj = 1.
(4.3)
where δ0 is the delta function. Here we have a spike at the mean, µw,h, and as σ
2
w,h →∞
the distribution, p(wj,h|γj = 1), approaches a uniform distribution, a slab of constant
height. For this reason, these models are often known as spike and slab models.
For mathematical convenience we then define the prior distribution of wγ = (w1, . . . ,
wJ)
> as:
wγ ∼ N(wγ |mwγ ,γ ,Σwγ ) (4.4)
where mwγ ,γ = (µw,1, . . . , µw,1, µw,2, . . . , µw,H)
> and Σwγ = diag(σ
2
w) with σ
2
w = (σ
2
w,1, . . . ,
σ2w,1, σ
2
w,2, . . . , σ
2
w,H)
>. Each µw,h and σ2w,h is repeated with length ||wγ,h|| dependent on
γ.
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Through giving each group h a separate hyper-parameter σ2w,h in (4.3), we leave the
model open to penalising the groups of variables to different degrees through the priors:
σ2w,h ∼ IG(σ2w,h|αw,h, βw,h). (4.5)
By choosing the same fixed hyper-parameters, αw,h and βw,h for each h, we lose infor-
mation coupling between the different groups, although this could be regained with an
addition layer in the hierarchical model.
In addition to σ2w,h, we use the hyper-parameters µw,h to reflect the likely non-zero
means of each group h:
µw,h ∼ N(µw,h|µ0,h, σ20,h) (4.6)
where the hyper-parameters µ0,h and σ
2
0,h are fixed. This specification comes from the
expected biological values of each regression coefficients wj,h. In the FMDV and Influenza
data we are likely to observe a comparatively large intercept with negative regression co-
efficients for the variables. This is a result of amino acid changes decreasing the similarity
between virus strains and therefore reducing the measured VN titre or HI assay. Simi-
larly, traversing a significant branch of the phylogenetic tree is likely to cause differences
between the strains.
A prior must also be given for γj ∈ {2, . . . , J}, the parameters which determine the
relevance of the covariates. No prior is included for the latent indicator variable associated
with the intercept, as this is a-priori fixed to 1, γ1 = 1.
p(γ2:J |pi) =
J∏
j=2
Bern(γj|pi) (4.7)
where pi is the probability of the individual variable being relevant.
The value of pi can either be set as a fixed hyper-parameter as in Sabatti and James
(2005), where they argue that it should be determined by underlying knowledge of the
problem. Alternatively it can be given a conjugate Beta prior:
pi ∼ B(pi|αpi, βpi) (4.8)
as in this case, where the likely number of relevant variables cannot be easily specified
a priori. This is a more general model, which subsumes a fixed pi as a limiting case for
αpiβpi/((αpi + βpi)
2(αpi + βpi + 1))→ 0.
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4.1.4 Random-Effects Prior
In mixed-effects models the random effects, bk,g, are usually given group dependant Gaus-
sian priors where the group g is defined by k, i.e. bk,g is shorthand for bk,gk :
bk,g ∼ N(bk,g|µb,g, σ2b,g). (4.9)
We define this to have a fixed mean, µb,g = 0, and a common variance parameter, σ
2
b,g,
with a conjugate Inverse-Gamma prior for each random-effects group g, as shown in
Figure 4.5a:
σ2b,g ∼ IG(σ2b,g|αb,g, βb,g) (4.10)
where αb,g and βb,g are fixed hyper-parameters for each g and we define b ∼ N(b|0,Σb)
where Σb = diag(σ
2
b) with σ
2
b = (σ
2
b,1, . . . , σ
2
b,1, σ
2
b,2, . . . , σ
2
b,G)
> such that each σ2b,g is
repeated with length ||bg||.
4.2 The Alternative SABRE Methods
Various different adjustments have been applied to the original SABRE method of Davies
et al. (2014), as detailed in Davies et al. (2016a). These changes have resulted in several
different versions of the method, the semi-conjugate (SC), conjugate (C) and binary mask
conjugate (BM) SABRE methods, and these are detailed in this section.
4.2.1 The Semi-Conjugate SABRE Method
The semi-conjugate SABRE method, as proposed in Davies et al. (2016a), changes the
likelihood of the original SABRE method, (4.1) in Section 4.1.1, to accommodate a sep-
arate parameter for the biologically significant intercept parameter, w0:
p(y|w0,wγ ,b, σ2ε ,Xγ ,Z) = N(y|1w0 + Xγwγ + Zb, σ2εI). (4.11)
The intercept, w0 is especially important when it comes to modelling antigenic variability
as it is likely that the measures of antigenicity, VN titre and HI assay, will have a high
value when just the intercept has an affect. This occurs when two identical virus strains
are tested against each other and the associated variables are therefore all zero.
The change of the likelihood to (4.11) means that we also require a prior on the
42
4. The SABRE Methods - The Methods
µ0,h σ20,h αw,h βw,h
µw,h σ2w,h
wj,h
βpi γj y Zk
pi Xγj ,j
σ2ε
bk,g µb,g
αpi
αε
βε
σ2b,g
αb,g
βb,g
w0
µw0 σ2w0
h = 1, . . . ,H
j = 1, . . . , J
k =
1, . . . , ||b||
g = 1, . . . , G
For: j = 1, . . . , J
γj ∼ Bern(γj |pi)
pi ∼ B(pi|αpi, βpi)
y ∼ N (y|1w0 +Xγwγ + Zb, σ2εI) σ2ε ∼ IG(σ2ε |αε, βε) w0 ∼ N (w0|µw0 , σ2w0)
For: k = 1, . . . , ||b||
bk,g ∼ N (bk,g|µb,g, σ2b,g)
For: j = 1, . . . , J
wj,h ∼
{
δ0(wj,h) if γj = 0
N (wj,h|µw,h, σ2w,h) if γj = 1.
For: h = 1, . . . ,H
µw,h ∼ N (µw,h|µ0,h, σ20,h)
σ2w,h ∼ IG(σ2w,h|αw,h, βw,h)
For: g = 1, . . . , G
σ2b,g ∼ IG(σ2b,g|αb,g, βb,g)
Figure 4.2: Compact representation of the semi-conjugate SABRE method as a
PGM. The grey circles and squares refer to the fixed hyperparameters and data respec-
tively, while the white circles refer to parameters and hyperparameters that are inferred.
The PGM shows the addition of nodes and edges connecting w0, µw0 and σ
2
w0
into the
model, something not seen in the original SABRE method in Figure 4.1.
intercept, w0:
w0 ∼ N(w0|µw0 , σ2w0). (4.12)
We treat the intercept differently from the remaining regressors, wishing to use vague prior
settings so as not to penalise this term and effectively make the model scale invariant
(Hastie et al., 2009). The difference between the semi-conjugate SABRE method and the
original SABRE method can be seen graphically by comparing the PGMs in Figures 4.2
and 4.1, where Figure 4.2 shows the addition of nodes and edges connecting w0, µw0 and
σ2w0 into the model.
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For mathematical convenience we then define the prior distribution of w∗γ = (w0,w
>
γ )
>
as:
w∗γ ∼ N(w∗γ |mγ ,Σw∗γ ) (4.13)
where mγ = (µw0 , µw,1, . . . , µw,1, µw,2, . . . , µw,H)
> and Σw∗γ = diag(σ
2
w∗) with σ
2
w∗ =
(σ2w0 , σ
2
w,1, . . . , σ
2
w,1, σ
2
w,2, . . . , σ
2
w,H)
>. Each µw,h and σ2w,h is repeated with length ||wγ,h||
dependent on γ.
4.2.2 The Conjugate SABRE Method
The conjugate SABRE method of Davies et al. (2016a) makes the SABRE method con-
jugate rather than semi conjugate, as it is in the semi-conjugate and original SABRE
methods (Sections 4.2.1 and 4.1). The idea of conjugate Bayesian models is discussed in
detail in Chapter 3 of Gelman et al. (2013a), but in general the idea is to introduce extra
links between the parameters in the model to increase information sharing. For the con-
jugate SABRE method we add relationships between w0, wγ and µw = (µw,1, . . . , µw,H)
>
with the error variance σ2ε . Adding these additional relationship increases information
sharing and means that the error variance in terms of model fit is reflected in the distri-
bution of the regression coefficients and associated mean. In addition to this increased
information sharing, conjugate models also have a computational advantage as the sam-
pling can be improved through using collapsed Gibbs sampling, as will be described in
Section 4.3.6. The additional conjugacy of the conjugate SABRE method can be seen
by looking at its PGM in Figure 4.3 and comparing it with that of the semi-conjugate
SABRE method in Figure 4.2.
Adding the increased conjugacy requires the replacement of three of the equations
from the semi-conjugate SABRE method. We must firstly replace the distribution of the
intercept parameter, w0, from (4.12):
w0 ∼ N(w0|µw0 , σ2w0σ2ε). (4.14)
We must also adjust the spike and slab prior in the model, (4.3), so that the distribution
has increased conjugacy for the relevant variables, i.e. when γj = 1:
p(wj,h|γj, µw,h, σ2w,h, σ2ε) =
{
δ0(wj,h) if γj = 0
N(wj,h|µw,h, σ2w,hσ2ε) if γj = 1
(4.15)
which means we must also replace (4.13) with the following notationally convenient dis-
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µ0,h σ20,h αw,h βw,h
µw,h σ2w,h
wj,h
βpi γj y Zk
pi Xγj ,j
σ2ε
bk,g µb,g
αpi
αε
βε
σ2b,g
αb,g
βb,g
w0
µw0 σ2w0
h = 1, . . . ,H
j = 1, . . . , J
k =
1, . . . , ||b||
g = 1, . . . , G
For: j = 1, . . . , J
γj ∼ Bern(γj |pi)
pi ∼ B(pi|αpi, βpi)
y ∼ N (y|1w0 +Xγwγ + Zb, σ2εI) σ2ε ∼ IG(σ2ε |αε, βε) w0 ∼ N (w0|µw0 , σ2w0σ2ε)
For: k = 1, . . . , ||b||
bk,g ∼ N (bk,g|µb,g, σ2b,g)
For: j = 1, . . . , J
wj,h ∼
{
δ0(wj,h) if γj = 0
N (wj,h|µw,h, σ2w,hσ2ε) if γj = 1.
For: h = 1, . . . ,H
µw,h ∼ N (µw,h|µ0,h, σ20,hσ2ε)
σ2w,h ∼ IG(σ2w,h|αw,h, βw,h)
For: g = 1, . . . , G
σ2b,g ∼ IG(σ2b,g|αb,g, βb,g)
Figure 4.3: Compact representation of the conjugate SABRE method as a
PGM. The grey circles and squares refer to the fixed hyperparameters and data respec-
tively, while the white circles refer to parameters and hyperparameters that are inferred.
The difference between this PGM and that of the semi-conjugate SABRE method in
Figure 4.2 can be seen by noting the extra, highlighted, edges between w0, wj,h and µw,h
and the error variance σ2ε .
tribution:
w∗γ ∼ N(w∗γ |mγ , σ2εΣw∗γ ) (4.16)
Finally we must change the distribution of mean parameter of the regression coefficients
from (4.6) to the following prior distribution:
µw,h ∼ N(µw,h|µ0,h, σ20,hσ2ε). (4.17)
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µ0,h σ20,h αw,h βw,h
µw,h σ2w,h
wj,h
βpi γj y Zk
pi Xj
σ2ε
bk,g µb,g
αpi
αε
βε
σ2b,g
αb,g
βb,g
w0
µw0 σ2w0
h = 1, . . . ,H
j = 1, . . . , J
k =
1, . . . , ||b||
g = 1, . . . , G
For: j = 1, . . . , J
γj ∼ Bern(γj |pi)
pi ∼ B(pi|αpi, βpi)
y ∼ N (y|1w0 +XΓw+ Zb, σ2εI) σ2ε ∼ IG(σ2ε |αε, βε) w0 ∼ N (w0|µw0 , σ2w0σ2ε)
For: k = 1, . . . , ||b||
bk,g ∼ N (bk,g|µb,g, σ2b,g)
For: j = 1, . . . , J
wj,h ∼ N (wj,h|µw,h, σ2w,hσ2ε).
For: h = 1, . . . ,H
µw,h ∼ N (µw,h|µ0,h, σ20,hσ2ε)
σ2w,h ∼ IG(σ2w,h|αw,h, βw,h)
For: g = 1, . . . , G
σ2b,g ∼ IG(σ2b,g|αb,g, βb,g)
Figure 4.4: Compact representation of the binary mask conjugate SABRE
method as a PGM. The grey circles and squares refer to the fixed hyperparameters
and data respectively, while the white circles refer to parameters and hyperparameters
that are inferred. Compared to the PGM of the conjugate SABRE method, Figure 4.3,
the nodes here have a different structure as depicted in Figure 3.2.
4.2.3 The Binary Mask Conjugate SABRE Method
The binary mask conjugate SABRE provides an alternative to the conjugate SABRE
method by using the binary mask model (Section 3.3.2), rather than the spike and slab
prior (Section 3.3.1) (Davies et al., 2016a). In the binary mask model the indicator
variables, γ, ‘mask’ the impact of the regression coefficients rather than removing them
from the model as in a spike and slab prior based model. To get the likelihood of
the binary mask conjugate model we replace the likelihood of the conjugate and semi-
conjugate SABRE methods, (4.11), with a binary mask version:
p(y|w0,w,γ,b, σ2ε ,X,Z) = N(y|1w0 + XΓw + Zb, σ2εI) (4.18)
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where Γ = diag(γ). The differences can be seen by comparing the PGM of the binary
mask conjugate SABRE method in Figure 4.4 with that of the conjugate SABRE method
in Figure 4.3. Alternatively the difference can be seen by looking at Figure 3.2. The binary
mask conjugate SABRE method will be compared with the conjugate and semi-conjugate
SABRE methods in Section 5.3.
Despite the different model specification given in (4.18), most of the prior distributions
given in the main paper remain the same. The only prior that changes is that of wj,h,
which is now given by:
wj,h ∼ N(wj,h|µw,h, σ2w,hσ2ε) (4.19)
replacing (4.15) and resulting in the following multivariate prior for w∗ = (w0, w>)>:
w∗ ∼ N(w∗|m, σ2εΣw∗) (4.20)
where m = (µw0 , µw,1, . . . , µw,1, µw,2, . . . , µw,H)
> and Σw∗ = diag(σ2w∗) with σ
2
w∗ =
(σ2w0 , σ
2
w,1, . . . , σ
2
w,1, σ
2
w,2, . . . , σ
2
w,H)
>. Each of the components µw,h and σ2w,h is repeated
with length ||wh|| and unlike with the slab and spike prior their lengths do not depend
on γ.
4.2.4 Alternative Random Effect Priors
The final possible improvement to the SABRE methods is to try an alternative random
effects prior to that described in Section 4.1.4. One such alternative is the folded-non-
central-t prior distribution described in Gelman (2006), which gives a redundant multi-
plicative reparameterisation to the model in Figure 4.5a. This prior has several potential
advantages over the Inverse-Gamma prior. Firstly it is considered to be a prior that better
represents non-informativeness. While the posterior distribution can be sensitive to the
fixed hyper-parameter settings of an Inverse-Gamma prior, the impact is reduced when
the folded-non-central-t prior is used. In that case the posterior distribution does not
have a sharp peak at zero unlike with an vague Inverse-Gamma prior, reducing problems
with underestimating the variance. Secondly, Gelman (2006) found that the folded-non-
central-t prior results in a more realistic posterior distribution of σ2b,g when there are only
a few random effects (usually less than 8) in each group g. The author showed that the
posterior distribution reflected the marginal distribution well at its low end, but removed
its unrealistically heavy tail; see Figure 2 in Gelman (2006). Doing this ensures that σ2b,g
is not overestimated and does not lead to non-optimal shrinkage of bg. Finally the over-
parameterisation can improve sampling by reducing the dependence between parameters
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y Zk
bk,g µb,g
σ2b,g
αb,g
βb,g
k =
1, . . . , ||b||
g = 1, . . . , G
y ∼ N (y|1w0 +Xγwγ + Zb, σ2ε)
For: k = 1, . . . , ||b||
bk,g ∼ N (bk,g|µb,g, σ2b,g)
For: g = 1, . . . , G
σ2b,g ∼ IG(σ2b,g|αb,g, βb,g)
(a) Inverse-Gamma Prior
y Zk
ξ ηk,g µη,g
µξ σ2ξ σ
2
η,g
αη,g
βη,g
k =
1, . . . , ||η||
g = 1, . . . , G
y ∼ N (y|1w0 +Xγwγ + Zηξ, σ2ε) ξ ∼ N (ξ|µξ, σ2ξ )
For: k = 1, . . . , ||η||
ηk,g ∼ N (ηk,g|µη,g, σ2η,g)
For: g = 1, . . . , G
σ2η,g ∼ IG(σ2η,g|αη,g, βη,g)
(b) Half-t Prior
Figure 4.5: PGMs for the two different specifications of the hierarchical
random-effects model. (a) Classical random-effects model using Gaussian and Inverse-
Gamma priors. (b) Half-t prior specified in a hierarchical manner, as suggested by Gel-
man (2006). The grey circles and squares refer to the fixed hyperparameters and data
respectively, while the white circles refer to parameters and hyperparameters that are
inferred.
in the hierarchical model leading to improved MCMC convergence (Gelman, 2004).
The redundant multiplicative reparameterisation used for this prior specification sets
b = ηξ and is given by the following conjugate priors and shown in Figure 4.5b:
ηk,g ∼ N(ηk,g|µη,g, σ2η,g) (4.21)
ξ ∼ N(ξ|µξ, σ2ξ ) (4.22)
where µξ and σ
2
ξ are fixed for identifiability, µη,g = 0, ηk,g is shorthand for ηk,gk and each
bk,g = ξηk,g. Following Gelman (2006), we fix µξ = 0 which leads to the half-t distribution.
We then set a prior on σ2η,g:
σ2η,g ∼ IG(σ2η,g|αη,g, βη,g) (4.23)
where αη,g and βη,g are fixed hyper-parameters. In terms of standard mixed-effects mod-
els, the variance is given by σ2b,g = ξ
2σ2η,g. For convenience we define η ∼ N(η|0,Ση)
when µη,g = 0 for all g and where Ση = diag(σ
2
η) with σ
2
η = (σ
2
η,1, . . . , σ
2
η,1, σ
2
η,2, . . . , σ
2
η,G)
>
where each σ2η,g is repeated with length ||ηg||. In this thesis we implement the folded-non-
central-t prior into an alternative version of the conjugate SABRE method and compare
them in Section 5.3 (Davies et al., 2016a).
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4.3 Posterior Inference
In order to explore the posterior distributions of the different SABRE methods described
in Sections 4.1 and 4.2 we use an MCMC algorithm as introduced in Section 3.2. Hav-
ing generally chosen conjugate priors means that we can mainly use Gibbs sampling
(Section 3.2.2) to sample to majority of parameters in all of the SABRE methods.
The only exception is γ, although it is possible to use component-wise Gibbs sam-
pling with a small adaptation; see Section 4.3.5. Additionally we sample the inter-
cept and regression parameters together and define w∗γ = (w0,w
>
γ )
>, X∗γ = (1,Xγ),
mγ = (µw0 , µw,1, . . . , µw,1, µw,2, . . . , µw,H)
> and Σw∗γ = diag(σ
2
w∗) with σ
2
w∗ = (σ
2
w0
, σ2w,1,
. . . , σ2w,1, σ
2
w,2, . . . , σ
2
w,H)
>. Each µw,h and σ2w,h is repeated with length ||wγ,h|| dependent
on γ, as indicated below (4.13).
In this section we give the conditional distributions of all those parameters that are
amenable to Gibbs sampling as well as conditional distributions for γ. For readability
we do not mathematically derive these distributions in this section and instead they are
given in Appendix A.1. For convenience, we denote θ to be a vector of all parameters
and hyperparameters. The distributions required to sample the original SABRE methods
are given in Section 4.3.1, with the required changes for the alternative SABRE methods
given in Sections 4.3.2, 4.3.3 and 4.3.4. After the distributions are given, Section 4.3.5
then looks in detail at how to effectively sample γ as this is the only model parameter
that is not sampled effectively with any form of Gibbs sampling. Finally, Section 4.3.6
details the conjugate sampling strategy that can be used with the conjugate and binary
mask conjugate SABRE methods.
4.3.1 Original SABRE Method
The posterior distributions for the model parameters of the original SABRE method
which can be sampled via Gibbs sampling are given as follows, where the analytical
derivations are given in Appendix A.1.1:
wγ |θ−wγ ,D ∼ N(wγ |VwγX>γ (y− Zb)/σ2ε + VwγΣ−1wγµw,Vwγ ) (4.24)
b|θ−b,D ∼ N(b|VbZ>(y−Xγwγ)/σ2ε ,Vb) (4.25)
σ2b,g|θ−σ2b,g ,D ∼ IG(σ2b,g| ||bg||/2 + αb,g, βb,g + 12b
>
g bg) (4.26)
µw,h|θ−µw,h ,D ∼ N(µw,h|V −1µγ ,h(∑(wγ,h)/σ2w,h + µ0,h/σ20,h), Vµγ ,h) (4.27)
σ2w,h|θ−σ2w,h ,D ∼ IG(σ2w,h| ||wγ,h||/2 + αw,h, βw,h + 12
∑(wγ,h − 1µw,h)2) (4.28)
σ2ε |θ−σ2ε ,D ∼ IG(σ2ε |N/2 + αε, βε + 12∑(y−Xγwγ − Zb)2) (4.29)
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pi|θ−pi,D ∼ B(pi|αpi +∑γ, βpi + J −∑γ) (4.30)
where we sample σ2b,g, µw,h and σ
2
w,h for each g and h respectively. We also define Vwγ =
(X>γXγ/σ
2
ε+Σ
−1
w )
−1, Vb = (Z>Z/σ2ε+Σ
−1
b )
−1 and Vµγ ,h = ((||wγ,h||/σ2w,h)−1+(σ20,h)−1)−1
for notational simplicity. These distributions can be sampled in any order, with each
update using the most recent sample of the conditioned parameters; see Section 3.2.2.
Sampling γ is more difficult, as it does not naturally form a standard distribution.
Methods for achieving this are discussed in more detail in Section 4.3.5, however in order
to do this we need a conditional distribution:
p(γ|θ−γ ,D) ∝ Bern(γ|pi)
∫
N(y|Xγwγ + Zb, σ2εI)N(wγ |µw,Σw)dwγ (4.31)
∝ pi
∑
γ(1− pi)J−
∑
γN(y|Xγµw + Zb, σ2εI + XγΣwX>γ ) (4.32)
where there are J variables. Here we have used a collapsing step as in Sabatti and
James (2005), integrating out wγ through the application of standard Gaussian integrals
(Bishop, 2006) to reduce the computational requirements. The normalisation constant
is not required in (4.31) and (4.32) as it cancels out in all of the methods discussed in
Section 4.3.5.
4.3.2 Semi-Conjugate SABRE Method
To get the conditional distributions of the model parameters for the semi-conjugate
SABRE methods we begin with the conditional distributions for the original SABRE
method and replace (4.24), (4.25) and (4.29) with the following equation which have
been derived in Appendix A.1.2:
w∗γ |θ−w∗γ ,D ∼ N(w∗γ |VwγX>γ (y− Zb)/σ2ε + VwγΣ−1wγµw,Vw∗γ ) (4.33)
b|θ−b,D ∼ N(b|VbZ>(y−X∗γw∗γ)/σ2ε ,Vb) (4.34)
σ2ε |θ−σ2ε ,D ∼ IG(σ2ε |N/2 + αε, βε + 12∑(y−X∗γw∗γ − Zb)2) (4.35)
where we define Vw∗γ = (X
∗,>
γ X
∗
γ/σ
2
ε + Σ
−1
w∗)
−1 for notational simplicity.
To sample γ for the semi-conjugate SABRE method we again use collapsing steps
(Sabatti and James, 2005), however in this instance we integrate out both wγ and pi.
While it was also possible to integrate out pi in the original SABRE method, we did not
do this in Davies et al. (2014) and therefore we have not integrated pi out in Section 4.3.1
either. Integrating over wγ and pi then leaves the following conditional distribution for
γ:
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p(γ|θ−γ ,D) ∝
∫
β(pi|αpi, βpi) Bern(γ|pi)
N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ ,Σw∗γ )dpidwγ (4.36)
∝ Γ(||γ||+αpi)Γ(J−||γ||+βpi)
Γ(J+αpi+βpi)
N(y|X∗γmγ + Zb, σ2εI + X∗γΣw∗γX∗>γ ) (4.37)
which replace (4.31) and (4.32) and can be sampled using the methods from Section 4.3.5.
4.3.3 Conjugate SABRE Method
The conditional distributions of the conjugate SABRE method are similar to those of the
semi-conjugate SABRE method and their derivations can be found in Appendix A.1.3.
To sample the model parameters of the conjugate SABRE method, we use the method
for the semi-conjugate SABRE method but replace (4.33), (4.27), (4.28) and (4.35) with
the following distributions:
w∗γ |θ−w∗γ ,D ∼ N(w∗γ |Vw∗γX∗>γ (y− Zb) + Vw∗γΣ−1w∗γmγ , σ2εVw∗γ ,2) (4.38)
µw,h|θ−µw,h ,D ∼ N(µw,h|V −1µγ ,h(∑(wγ,h)/σ2w,h + µ0,h/σ20,h), σ2εVµγ ,h,2) (4.39)
σ2w,h|θ−σ2w,h ,D ∼ IG(σ2w,h| ||wγ,h||/2 + αw,h, βw,h + 12σ2ε
∑(wγ,h − 1µw,h)2) (4.40)
σ2ε |θ−σ2ε ,D ∼ IG(σ2ε |(N + ||w∗γ ||+H)/2 + αε, βε + 12Rσ2ε ) (4.41)
where we define Vw∗γ ,2 = (X
∗>
γ X
∗
γ + Σ
−1
w∗γ )
−1 and Rσ2ε = (y−X∗γw∗γ −Zb)>(y−X∗γw∗γ −
Zb) + (w∗γ −mγ)>Σ−1w∗γ (w∗γ −mγ) +
∑H
h=1(µw,h − µ0,h)2/σ20,h for notational simplicity.
To sample γ in the conjugate SABRE method we use the same method as the semi-
conjugate SABRE method but changing the distribution of w∗γ , replacing (4.13) with
(4.16):
p(γ|θ−γ ,D) ∝
∫
β(pi|αpi, βpi) Bern(γ|pi)
N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ , σ2εΣw∗γ )dpidwγ (4.42)
∝ Γ(||γ||+αpi)Γ(J−||γ||+βpi)
Γ(J+αpi+βpi)
N(y|X∗γmγ + Zb, σ2ε [I + X∗γΣw∗γX∗>γ ]). (4.43)
which replaces (4.36) and (4.37) in the sampling strategy. We can also use the CSS when
sampling the conjugate SABRE method and this is discussed in Section 4.3.6.
Finally we discuss the conditional distributions of the conjugate SABRE method when
the half-t prior is used instead of the standard Inverse-Gamma prior. In order to do this
we set b = ηξ and σ2b,g = ξ
2σ2η,g in (4.38), (4.41) and (4.43) of the sampling strategy for
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the conjugate SABRE method. We can then sample η, ξ and σ2η,g from their conditional
distributions, replacing (4.34) and (4.26):
η|θ−η,D ∼ N(η| ξσ2εVηZ
>(y−X∗γw∗γ),Vη) (4.44)
ξ|θ−ξ,D ∼ N(ξ|Vξ[µξσ2ξ +
1
σ2ε
η>Z>(y−X∗γw∗γ)], Vξ) (4.45)
σ2η,g|θ−σ2η,g ,D ∼ IG(σ2η,g|||ηg||/2 + αη,g, βη,g + 12η>g ηg) (4.46)
where Vη = (
ξ2
σ2ε
Z>Z + Σ−1η )
−1 and Vξ = ( 1σ2ξ
+ 1
σ2ε
η>Z>Zη)−1.
4.3.4 Binary Mask Conjugate SABRE Method
Changing from models that use spike and slab priors, Section 3.3.1, to a binary mask
model, Section 3.3.2, causes a number of changes to the conditional distributions. This
is a result of a change in the likelihood, (4.18), and the prior on wj,h, (4.19), and means
that only the conditional distributions of σ2b,g and pi remain the same as the conjugate
SABRE method. We give the other conditional distributions as follows:
w∗|θ−w∗ ,X∗,Z,y ∼ N(w∗|Vw∗Γ∗>X∗>(y− Zb) + Vw∗Σ−1w∗m, σ2εVw∗) (4.47)
b|θ−b,X∗,Z,y ∼ N(b|VbZ>(y−X∗Γ∗w∗)/σ2ε ,Vb) (4.48)
µw,h|θ−µw,h ,X∗,Z,y ∼ N(µw,h|V −1µ,h (∑(wh)/σ2w,h + µ0,h/σ20,h), σ2εVµ,h) (4.49)
σ2w,h|θ−σ2w,h ,X∗,Z,y ∼ IG(σ2w,h| ||wh||/2 + αw,h, βw,h + 12σ2ε
∑(wh − 1µw,h)) (4.50)
σ2ε |θ−σ2ε ,X∗,Z,y ∼ IG(σ2ε |(N + ||w∗||+H)/2 + αε, βε + 12Rσ2ε ,2) (4.51)
where we sample σ2b,g, µw,h and σ
2
w,h for each g and h respectively. We also define Vw∗ =
(Γ∗>X∗>X∗Γ + Σ−1w∗)
−1 and Rσ2ε ,2 = (y−X∗Γ∗w∗ − Zb)>(y−X∗Γ∗w∗ − Zb) + (w∗ −
m)>Σ−1w∗(w
∗ −m) + (µw − µ0)>Σ−10 (µw − µ0) for notational simplicity.
Finally, to sample γ we collapse over w and pi to give the following conditional dis-
tribution, replacing (4.42) and (4.43):
p(γ|θ−γ ,D) ∝
∫
β(pi|αpi, βpi) Bern(γ|pi)
N(y|X∗Γ∗w∗ + Zb, σ2εI)N(w∗|m, σ2εΣw∗)dpidwγ (4.52)
∝ Γ(||γ||+αpi)Γ(J−||γ||+βpi)
Γ(J+αpi+βpi)
N(y|X∗Γ∗m + Zb, σ2ε [I + X∗Γ∗Σw∗γΓ∗>X∗>]). (4.53)
4.3.5 Sampling the Latent Inclusion Variables, γ
Sampling γ is more difficult, as it does not naturally take a distribution of standard form.
However we can still get a valid conditional distribution and use a variety of techniques to
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sample from it. Multiple methods have been proposed for sampling the latent variables, γ.
Here we look at two of these in particular; the component-wise Gibbs sampling approach
and a block M-H step. In the latter we can propose changes to multiple parameters
simultaneously for a computational improvement.
A component-wise Gibbs sampler can be used to consecutively sample each γj from
γ in a random order dependent on the current state, c, of all the other γs, γc−j =
(γc1, . . . , γ
c
j−1, γ
c
j+1, . . . , γ
c
J). We can define the conditional distribution of the ith iteration
of γj to be a Bernoulli distribution with probability:
p(γj = 1|θ−γ ,γc−j,D,y) =
a
a+ b
, (4.54)
where we define a ∝ p(γj = 1,γc−j|θ−γ ,D,y) and b ∝ p(γj = 0,γc−j|θ−γ ,D,y) using the
appropriate conditional distribution of γ.
The alternative, block M-H sampling can improve mixing and convergence through
proposing sets, S, of latent indicator variables, γS, simultaneously, where γS denotes a
column vector of all the γjs where j ∈ S and γ−S its compliment. The proposals are then
accepted with the following acceptance rate:
α(γ∗S,γ
c
S|θ−γ ,Dy,γc−S) := min
{
q(γcS|piprop)p(γS = γ∗S,γc−S|θ−γ ,D,y)
q(γ∗S|piprop)p(γS = γcS,γc−S|θ−γ ,D,y)
, 1
}
(4.55)
where q(.) is a proposal density and is set to be: q(γ∗S|piprop) =
∏
j∈S Bern(γ
∗
j |piprop),
where piprop is a fixed tuning parameter. Proposed moves for independent sets of randomly
ordered inclusion parameters, γ∗S, are then accepted if α(γ
∗
S,γ
c
S| θ−γ ,D,y,γc−S) is greater
than a uniform random variable u ∼ U[0, 1], until updates have been proposed for all the
latent indicator variables.
4.3.6 Conjugate Sampling Strategy
Collapsing can lead to improved mixing and convergence, e.g. Andrieu and Doucet (1999).
We take advantage of the induced conjugacy to sample the parameters γ, w∗γ , µw =
(µw,1, . . . , µw,H)
>, σ2ε and pi as a series of collapsed distributions rather than through
Gibbs sampling:
p(γ,w∗γ ,µw, σ
2
ε , pi) (4.56)
= p(γ)p(pi|γ)p(σ2ε |pi,γ)p(µw|σ2ε , pi,γ)p(w∗γ |µw, σ2ε , pi,γ) (4.57)
= p(γ)p(pi|γ)p(σ2ε |γ)p(µw|σ2ε ,γ)p(w∗γ |µw, σ2ε ,γ) (4.58)
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where the conditionality on θ′, X, Z and y has been dropped and the simplification from
(4.57) to (4.58) follows from the conditional independence relations shown in Figure 4.3,
exploiting the fact that pi is d-separated from the remaining parameters in the argument
via γ. These distributions are achieved by collapsing over parameters as derived in
Appendix A.
4.4 Discussion
In this chapter we have proposed a family of sparse hierarchical Bayesian models for de-
tecting relevant antigenic sites in virus evolution (SABRE) should offer an improvement
over the classical mixed-effects model, the mixed-effects LASSO and the mixed-effects
elastic net. There are four reason that we should see an improvement when the meth-
ods are compared in Chapter 5. The proposed hierarchical modelling framework with
slab-and-spike prior (1) avoids the bias inherent in LASSO-type methods, (2) genuinely
and consistently achieve sparsity, (3) properly accounts for uncertainty at all levels of
inference, and (4) borrows strength from information coupling, whereby all parameters
are systematically and iteratively inferred in the context of all other parameters. In some
more detail: (1) The shrinkage effect inherent in the `1 penalty term introduces a bias by
which the regression parameters are systematically underestimated. This bias is avoided
with the slab and spike prior that we use. (2) The LASSO is known to only give sparse
solutions at the MAP (maximum a posteriori) configuration, but not when sampling
parameters from the posterior distribution. From a Bayesian perspective, the MAP is
methodologically inconsistent, as it is not guaranteed to represent the region in parameter
space with the highest probability mass. The spike-and-slab prior, which we use, avoids
this methodological inconsistency and achieves sparsity in a sound Bayesian inference
context. (3) In our hierarchical Bayesian models, all sources of uncertainty are properly
accounted for. The higher-level hyperparameters have their own distributions, which
are systematically inferred from the data. In contrast, the regularisation parameters of
the established methods are typically fixed, set e.g. by cross-validation, but without
taking their uncertainty into account (see also Chapter 5 in Gelman et al. (2013a) for
a more detailed discussion). (4) In our approach, we explicitly model all dependencies
among the variables, and inference is carried out within the context of the whole system.
This systematically borrows strength from information coupling and avoids the piecemeal
approach of established methods.
There are two fundamentally different approaches to variable selection in Bayesian
hierarchical models: the slab-and-spike prior, whereby the influence of an input variable
is controlled via the prior distribution of its associated regression parameters, and the
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binary mask model, where variables are put through a binary multiplicative filter. The
difference is depicted in Figures 4.3 and 4.4, or alternatively in Figure 3.2. Which method
is better? Standard textbooks, like Murphy (2012), describe both methods (see Chapter
13), but do not offer a comparative evaluation, and in the literature, authors rather
arbitrarily tend to opt for one method or another (see e.g. Heydari et al. (2016)). We have
proposed two version of the SABRE method in order to allow us to carry out a systematic
comparison to properly quantify the difference in terms of accuracy and computational
efficiency between the two approaches in Chapter 5. We have also provided a way of
systematically evaluated the influence of the prior, comparing a conjugate with a non-
conjugate prior, as depicted by Figures 4.3 and 4.2, and we have assessed its influence
systematically in terms of accuracy, computational efficiency, and formal model selection
preference in Chapter 5. The conjugate and binary mask conjugate also allow the use the
conjugate sampling scheme proposed in Section 4.3.6, which potentially offers improved
computational efficiency through the use of collapsed Gibbs sampling, something we test
in Chapter 5
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Chapter 5
Sparse Hierarchical Bayesian Models
for Understanding Antigenic
Variability - The Analysis
In this chapter we show how the SABRE methods introduced in Chapter 4 outperform
the alternative methods discussed in Chapter 3. We introduce the simulated and real
datasets that will be used to show this (Section 5.1) and detail the computational proce-
dures needed to produce the results (Section 5.2). The results for the simulated datasets
compare the SABRE methods, as well as the methods from Chapter 3, against each
other in terms of variable selection and out-of-sample performance. The results show
that the SABRE methods offer a clear improvement in terms of model selection over
the methods described in Chapter 3, with the SABRE methods all performing roughly
equally. Additionally Section 5.3.3 looks at using Bayesian 10-fold CV and Widely Ap-
plicable Information Criterion (WAIC) (Watanabe, 2010) to select the correct random
effect specification, quantifying the difference in performance (Davies et al., 2016b).
Finally Sections 5.4, 5.5 and 5.6 give the results for a number of real FMDV and
Influenza datasets looking at how well the various methods do in classifying variables
(based on Section 2.4) as well as discussing the biological results in terms of antigenic
residues and significant evolutionary changes in the phylogenetic trees. The results given
in these sections, as well as Appendix B, show that the SABRE methods identify a number
of known antigenic residues, as well as making novel predictions about other potentially
antigenic residues.
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5.1 Data
Detailed descriptions of the different FMDV and Influenza datasets used in this thesis
are given in Sections 2.2 and 2.3 of Chapter 2. In this section we detail the simulated
datasets that are used to test the methods described in Sections 4.1 and 4.2 against each
other and those described in Chapter 3. We also add a few extra details on the real life
datasets that are specific to this chapter of the thesis.
5.1.1 Initial Simulation Study
Davies et al. (2014) used 20 datasets in their simulation study, simulated with both fixed
and random effects. All of the datasets were given 30 variable, with 10 of the datasets
given one group of random effects and the remaining sets given two groups. Each of
the variables was then given a regression parameter. Half of each group were given small
negative regressors drawn from w1 ∼ N(−0.2, 0.01) and the other half w2 ∼ N(0, 0.0025).
Each response yi was then generated from the model with each of the perturbed regressors
w˜h,i ∼ N(wh,i, 0.007), where h ∈ {1, 2}. This was done 200 times with additive Gaussian
noise from N(0, 0.04) given to each response. Half of the data was used for training and
the remaining for testing.
5.1.2 Extended Simulation Study
In Davies et al. (2016a) we simulated 9 sets of simulated data each with 100 datasets with
100 measurements for training and 900 for testing. We varied the number of variables,
||w|| ∈ {40, 60, 80}, and the size of the error, σ2ε ∈ {0.01, 0.1, 0.3}, to test the methods
under different circumstances. Additionally we added two groups of random effects to
each dataset to represent experimental variation, both with 8 levels.
To reflect the fact that we expect many of the variables to have no influence on the
response we drew a probability pi from U(0.2, 0.4) for each dataset. With this proba-
bility, each of the variables in the dataset was then given a regressor simulated from
U(−0.4,−0.2) and zero otherwise, remembering that we expect the variables to have a
negative effect as any mutational changes will reduce the response, VN titre. Each re-
sponse yi was then generated with an intercept of 10 and with N(0, 0.02) iid additive
Gaussian noise given to each response.
57
5. The SABRE Methods - The Analysis
5.1.3 Final Simulation Study
The simulation study of Davies et al. (2016b) compared WAIC and 10-fold Bayesian CV
by generating 20 datasets each with 500 observations and 50 possible variables. The data
was generated with 10 viruses, with every virus used as both the challenge and protective
strains and for any given pair of challenge and protective strains the variables remain
identical as in the real FMDV and Influenza datasets. Possible random effects were the
protective and challenge strains and 2 generic random effects with 8 levels. The random
effects were given a variance of zero, i.e. set to be irrelevant, with probability 0.5.
5.1.4 Original SAT1 Data
The original SAT1 dataset was analysed by Reeve et al. (2010) and information about the
dataset can be found in Section 2.2.1. To analyse the dataset we log transformed the VN
titre measurements following Reeve et al. (2010). For the results given in Section 5.4.1
we used the challenge strain and antiserum as random effects. Variables related to the
phylogenetic tree were added but only to reflect where the branch lay between the chosen
challenge and protective strain, e.g. branch effects by the definitions in Section 2.1.3,
rather than any of the more complex phylogenetic effects described in Section 2.1.3.
Instead of classifying variables with correlation 1 in groups as discussed in Section 2.4,
Davies et al. (2014) instead used a strategy based on prior knowledge to exclude the less
biologically relevant variables with correlation 1.1 This resulted in the original SAT1
dataset analysed in Section 5.4.1 only containing 107 variables in total; we call this the
reduced SAT1 dataset.
Section 5.4.2 used 138 variables in total with only one of the variables that were
completely correlated included, but with the classification being based on all of the com-
pletely correlated variables as specified in Section 2.4. Multiple types of branches were
included to account for the phylogenetic tree as discussed in Section 2.1.3, rather than
just the branch effects as in Section 5.4.1. The original SAT1 results of Section 5.3.2 use
just challenge strain and antiserum as random effect groups based on the results of Reeve
et al. (2010).
5.1.5 Extended SAT1 Data
The extended SAT1 dataset is an extended version of the original SAT1 dataset (Sec-
tion 5.1.4) of Reeve et al. (2010) collected and analysed by Maree et al. (2015). We
1Davies et al. (2014) included all proven variables based on the classification in Section 2.4, then
added the branches of the phylogentic tree and finally excluded any plausible or implausible variables
which made the matrix singular; see Davies et al. (2014) for details.
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have again log transformed the data following Maree et al. (2015) and have included
multiple types of phylogentic effects; see Section 2.1.3. Random effects were included in
Section 5.4.3 to account for the challenge strain, antiserum and date of the experiment
based on the results of Maree et al. (2015); see Section 2.2.1.
5.1.6 SAT2 Data
The SAT2 dataset was originally analysed by Reeve et al. (2010) and is described in
Section 5.1.6. The VN titre measurements were again log transformed and we have
included multiple types of phylogentic effects; see Section 2.1.3. Random effects were
included in Section 5.5 to account for the challenge strain and antiserum based on the
results of Reeve et al. (2010); see Section 2.2.2.
5.1.7 H1N1 Data
Harvey et al. (2016) used a H1N1 dataset that contained 506 challenge strains and 43
protective strains. Here we have used a slightly smaller dataset in order to fully account
for the effect of the phylogentic structure. The dataset used here contains 15,693 HI
assay measurements with 43 challenge and 43 protective strains. As this full dataset is
too large to analyse using the conjugate SABRE method we have summarised the data to
just be 570 mean HI assay measurement for each combination of challenge and protective
strains. For each pair of challenge and protective strains the 279 explanatory variables,
53 surface exposed residues and 226 variables related to the phylogenetic data, remain
the same. Doing this however means we cannot use the date of the experiment as a
random effect and additionally the dataset does not contain antiserum data, meaning we
have only used the challenge strain as random effects in Section 5.6.
5.2 Computational Inference
Our code has been implemented in R (R Core Team, 2013), using the packages lme4
(Bates et al., 2013) and lmmlasso (Schelldorfer et al., 2011) for the comparison with
standard and LASSO mixed-effects models. For the mixed-effects models, as in Reeve
et al. (2010), forward inclusion was used adjusting for multiple testing using the Holm-
Bonferroni correction.
For the MCMC chains we sampled 10,000 iterations for the simulated datasets, with
varying numbers of iterations for the real data as required to get convergence. This
was determined by running 4 chains for each model and computing the PSRF (Gelman
and Rubin, 1992) from the within-chain and between-chain variances (Plummer et al.,
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2006). We take a PSRF ≤ 1.05 as a threshold for convergence and terminate the burn-in
when this is consistently satisfied for 95% of the variables. In general, the fixed hyper-
parameters, shown as grey nodes in Figures 4.1, 4.2, 4.3 and 4.4, were set to give a
vague distribution for the flexible (hyper-)parameters, shown as white nodes. The only
exception was the prior on pi, defined in (4.8), which was set to be weakly informative
such that αpi = 1 and βpi = 4, except in Section 5.3.1 where the parameters were set to
be αpi = 1 and βpi = 1. Setting the parameters to be weakly informative, αpi = 1 and
βpi = 4, corresponds to prior knowledge that only a small number of residues or branches
have a significant antigenic effect.
The following hyper-parameters are fixed to give vague distributions: αb,g = βb,g =
αη,g = βη,g = 0.001 and µb,g = µη,g = 0 for all g, αw,h = βw,h = 0.001, µ0,h = 0 and
σ20,h = 100 for all h, µξ = 0, σ
2
ξ = 100, µw0 = max(y), σ
2
w0
= 100 and αε = βε = 0.001.
The only unusual choice is µw0 = max(y) which follows from us expecting a high intercept
with the regression coefficients then having a negative effect on the response. This is a
result of strains having high reactivity with themselves, and any changes making the
strains less similar, reducing their reactivity. The only exception to this is in the original
SABRE method where intercept is treated as the only member of the first group of
fixed-effects. Here we set αw,1 = 1.501 to give a finite mean and variance for the prior
distribution of σ2w,1. Although this is not a vague prior, we have tested a number of other
values and found that this specification has little effect on the results.
To analyse the best proposal method we tested the component-wise Gibbs sampler
and several specifications of the Metropolis-Hastings sampler on the several datasets
(Section 5.4.5). For the reduced SAT1 dataset used by Davies et al. (2014) (Section 5.1.4)
we tested the component-wise Gibbs sampler and proposed the inclusion or exclusion of
variables in groups of 4, 8, 16, 32 and 64 with the block Metropolis-Hastings sampler. We
analysed convergence by monitoring the percentage of variables with a PSRF ≤ 1.1 as
in Grzegorczyk and Husmeier (2013) (Davies et al., 2014). For the full SAT1, extended
SAT1 and H1N1 dataset we again used the component-wise Gibbs sampler but proposed
the inclusion or exclusion of variables in groups of 5, 10, 15, 20 and 30 with the block
Metropolis-Hastings sampler. We analysed convergence by monitoring the percentage of
variables with a PSRF ≤ 1.05, similar to Grzegorczyk and Husmeier (2013) (Davies et al.,
2016a).
For selecting variables in the mixed-effects LASSO and elastic net we used BIC as in
Schelldorfer et al. (2011). For the SABRE methods there are a variety of techniques that
have been used in the literature to choose a cut-off. Often a cut-off of 0.5 is used and
this has been shown to be the best predictive model under strict conditions (Barbieri and
Berger, 2004). Alternatively the top Jpˆi ranked variables have been taken, where J is the
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number of variables and pˆi is the posterior mean of pi, defined in (4.7) and (4.8), i.e. the
global probability of variables being included in the model.
5.3 Results for the Simulation Studies
To summarise, we have introduced a hierarchical Bayesian modelling framework (called
SABRE) for selecting relevant antigenic sites in viral evolution. There are two funda-
mentally different approaches to variable selection: the slab and spike prior, whereby
the influence of an input variable is controlled via the prior distribution of its associated
regression parameters, and the binary mask model, where variables are put through a
binary multiplicative filter. There are also different prior distributions one can choose: a
conjugate prior, and a semi-conjugate prior. This gives us four variants of the proposed
modelling framework, including the original SABRE method which does not include an
intercept parameter:
• The original SABRE method, with slab and spike prior
• The conjugate SABRE method, with slab and spike prior
• The semi-conjugate SABRE method, with slab and spike prior
• The binary mask SABRE method.
These four variants are depicted as probabilistic graphical models in Figures 4.1, 4.3,
4.2 and 4.4. We have compared their performance with that of two established methods
from the literature: the mixed-effects model with stepwise variable selection, and the
mixed-effects LASSO. Since there are indications from the literature that the elastic net
offers an improvement over the LASSO, we have also modified the mixed-effects LASSO
model from the literature (Schelldorfer et al., 2011) by a novel mixed-effects elastic net
model. This gives us three classical methods for comparison:
• Mixed-effects model with stepwise variable selection
• Mixed-effects LASSO model
• Mixed-effects elastic net model.
We have applied and assessed the proposed methods with a three-pronged approach.
Firstly, we have tested them on a large set of synthetic benchmark data, where the
true structure of the model is known, and it is therefore straightforward to quantify the
accuracy of inference. This is discussed here in Section 5.3 and contains results Davies
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Figure 5.1: Gaussian Kernel density estimation plots of random effects vari-
ances and a comparison of posterior inclusion probabilities. Gaussian kernel
density estimation plots are shown for the sampled posterior densities of the log random
effect variance. This is given for the two groups of random effects, (a) challenge strain
and (b) antiserum, under a vague Inverse-Gamma prior (solid) and the half-t prior (dot-
ted) proposed in Gelman (2006). (c) Plot showing the comparative posterior inclusion
probability for each variable for the two models.
et al. (2014), Davies et al. (2016a) and Davies et al. (2016b) in Sections 5.3.1, 5.3.2
and 5.3.3 respectively. Secondly, we have applied the methods to real data for which
partial biological prior knowledge is known, which can be used to partially assess the
model predictions. These findings are presented in Section 5.4. Finally, in Sections 5.5
and 5.6, we present novel applications to new data, from the less well known FMDV
serotype, SAT2, and as well as from seriously reduced version of the H1N1 Influenza
dataset where it is not relevant to compare our results against those obtained from a
larger dataset. Here the purpose of our study is new hypothesis generation.
As part of the extended simulation study of Davies et al. (2016a) given in Section 5.3.2
we also tested the choice of random effects prior, comparing the Inverse-Gamma prior
(Section 4.1.4) with the half-t prior prior proposed in Gelman (2006) (Section 4.2.4). Fig-
ures 5.1a and 5.1b show posterior samples of the log variance of the two random-effects
groups from the conjugate SABRE method applied to the SAT2 dataset (Section 5.1.6)
comparing the half-t and Inverse-Gamma priors, and shows no notable differences. Simi-
larly Figure 5.1c shows that the inclusion probabilities for the two competing models are
approximately the same. Based on these findings, we only report the results obtained
with the conjugate Inverse-Gamma prior throughout this section.
5.3.1 Initial Simulation Study
Figure 5.2 shows ROC curves (Section 3.4.2) for the classical mixed-effects models, the
mixed-effects LASSO and the original SABRE method. For two random effects groups
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(a) One Random-Effect Group (b) Two Random-Effect Groups
Figure 5.2: ROC Curves for the Initial Simulation Study data described in
Section 5.1.1. ROC curves are given for the original SABRE method (black), the
mixed-effects LASSO (black dotted) and classical mixed-effects (grey) (Davies et al.,
2014). The original SABRE method is given in the figure as the ‘Novel Bayesian’ method.
The simulated data was generated with (a) one and (b) two random effect groups; see
section 5.1.1.
(Figure 5.2b), the original SABRE method, AUROC = 0.93, consistently outperforms
the mixed-effects LASSO, AUROC = 0.79, and standard mixed-effects model, AUROC
= 0.79. This is presumably a consequence of the fact that the mixed-effects LASSO
of Schelldorfer et al. (2011), is defined for a single random effect. To deal with two
random effects, we need to map the matrix of random effect combinations into a vector
of substitute single random effects, which may render the model over-complex and hence
susceptible to over-fitting. When the analysis of the simulated data in Davies et al. (2014)
was carried out, a mixed-effects LASSO with the ability to handle multiple random effects
did not exist. For data with a single random effect (Figure 5.2a), the original SABRE
method still achieves a greater AUROC value, 0.89, than the LASSO, 0.83, and standard
mixed effects model, 0.81.
In addition to the comparison of AUROC values, we also looked at the predictive
performance. For the data with 2 groups of random effects the original SABRE method
got a mean out-of-sample log-likelihood of−113.8, outperforming the mixed-effect LASSO
of Schelldorfer et al. (2011) with BIC,−160.8, and AICc, −163.3, and the standard mixed-
effect model, −127.7. Similar results were also achieved for the data with 1 random effect
group, with the models achieving a mean out-of-sample log-likelihoods of −99.9, −104.2,
−105.9 and −112.4, respectively.
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5.3.2 Extended Simulation Study
Table 5.1 compares the different methods in terms of variable selection, WAIC score
(Watanabe, 2010), predictive performance and fixed effects coefficients inference using
the simulated datasets described in Section 5.1.2. To measure variable selection we have
ranked the covariates in terms of their significance or influence. For the Bayesian meth-
ods, the ranking is defined by the marginal posterior probabilities of inclusion. For the
alternative methods, we explain the way the ranking is obtained below. Since for the sim-
ulated data the true covariates are known, this ranking can be used to produce a ROC
curve (e.g. Hanley and McNeil (1982); Section 5.7. of Murphy (2012)), where for all
possible values of the inclusion threshold, the sensitivity or recall (the relative proportion
of true positive covariates: TP/(TP+FN)) is plotted against the complementary speci-
ficity (the relative proportion of false positive covariates: FP/(FP+TN))2. By numerical
integration we obtain the AUROC value as a global measure of accuracy, where larger
values indicate a better performance, starting from AUROC = 0.5 to indicate random
expectation, to AUROC = 1 for perfect variable identification; see Section 3.4.2.
In addition to ranking the covariates to get ROC curves for the SABRE methods, we
also need to rank the alternative established methods for a comparison. For the classical
mixed-effects models this is done by removing the significance threshold and ranking the
edges by order of inclusion. For the mixed-effects LASSO and elastic net we predicted
models for a variety of different penalty parameters, λ, to create the so called LASSO path
and create a ranking based on when variables become 0. For the mixed-effects elastic
net we only show the results for α = 0.3 following Ruyssinck et al. (2014), however
the remaining results are available in Section B.1. Alternative AUROC values based on
using model selection and then ranking the variables based on the absolute values of the
regression coefficients (Aderhold et al., 2014), as well as other results, are also available
in Section B.1.
Table 5.1 also measures the accuracy of predicting out of sample observations, yout,
and the fixed effects coefficients, w in terms of MSEs. For the Bayesian methods, the
predictions are made by sampling from the model and then choosing which variables are
included based on taking the top J × pˆi variables with the highest inclusion probabilities.
The model is then sampled with just those variables set to be included and the estimates
calculated. For the mixed-effects LASSO, mixed-effects elastic net and classical mixed
effects models the regression coefficients can be taken from the chosen model. The random
effects coefficients can then be calculated using the best linear unbiased estimator and
predictions of the out of sample observations, yout, made.
2TP: true positive count, FP: false positive count, TN: true negative count, FN: false negative count
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Figure 5.3: Bar plot of AUROC values from the Simulation Study Results in
Table 5.1. The bar plots gives AUROC values for the Conjugate (C), Semi-Conjugate
(SC) and Binary Mask Conjugate (BM C) SABRE methods (black bars), the mixed-
effects (M-E) LASSO, the mixed-effects elastic net (M-E EN) with α = 0.3 (both grey
bars) and standard mixed-effects (M-E) models (white bars) applied to the simulated
data described in Section 5.1.2.
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Figure 5.4: Box plots of the difference in AUROC values for each method in
comparison to the conjugate SABRE method. The box plots give the difference in
AUROC values for each of the methods after the AUROC value of the conjugate SABRE
method has been subtracted for the appropriate dataset. Negative values indicate that the
conjugate method has outperformed the alternative method. Each box plot contains 100
datasets as described in Section 5.1.2. The alternative methods are the Semi-Conjugate
(SC) and Binary Mask Conjugate (BM C) SABRE methods, the mixed-effects (M-E)
LASSO, the mixed-effects elastic net (M-E EN) with α = 0.3 and the classical mixed-
effects models (M-E).
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In terms of variable selection, the AUROC values shown in Figure 5.3 and Table 5.1
show that all the SABRE methods outperform the alternative methods; the mixed-effects
LASSO, the mixed effects elastic net and the classical mixed effects models. This is
achieved across all datasets and is highlighted in Figure 5.4, which compares the dif-
ference in AUROC values obtained by the different methods and that of the conjugate
SABRE method.A negative score signifies a reduction in performance compared to the
conjugate SABRE method. Figure 5.4 shows that the conjugate SABRE method per-
forms significantly better than the mixed-effects LASSO, the mixed-effects elastic net and
the classical mixed-effects models in all sets of data.
The performance in terms of predicting out of sample observations and inferring fixed
effects coefficients shown in Table 5.1 again shows the SABRE methods outperforming the
alternative methods in most cases. Table 5.1 shows a huge improvement for the SABRE
methods in all cases except where both the error variance and number of variables is small.
This is especially the case with the mixed-effects LASSO and the mixed-effects elastic
net where the reliance on `1 regularisation causes a bias which affects both the inference
of the fixed effects coefficients and the variable selection, as well as subsequently the out
of sample predictions. The alternative methods do outperform the SABRE methods in
some sets of data where the number of variables is small and the error variance is low,
but this is only in 2 out of 9 sets of data. The reason for these counter intuitive results
is the model selection technique used with the SABRE methods, as in both of the sets of
data where the improvement is shown the SABRE methods achieve mean AUROC values
of 1, better than the alternative methods.3
We have also explored multiple different versions of the SABRE method, namely the
semi-conjugate (Figure 4.2), conjugate (Figure 4.3) and binary mask conjugate (Fig-
ure 4.4) SABRE methods4. As far as we are aware the quantitative comparison between
a spike and slab based method and a binary mask based one is the first of its kind. Our
results given in Table 5.1, as well as Figures 5.3 and 5.4, show a strong similarity in per-
formance between the methods. The comparison of AUROC values given in Figure 5.4
clearly shows a large overlap in both method’s variable selection performance and this is
backed up by the paired t-tests given in Tables B.4-B.6. Identifying that these methods
give similar results is important, as in practise both methods are discussed and used
throughout the literature, e.g Jow et al. (2014); Murphy (2012).
We have also compared the conjugate and semi-conjugate SABRE models, as depicted
3By choosing the J × pˆi variables with the highest marginal probability of inclusion, we have chosen
the wrong number of variables resulting in a mismatch between the inferred fixed-effects coefficients and
their true values.
4We do not have a comparison with the original SABRE method, as it does correctly specify the
biologically significant intercept parameter.
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Figure 5.5: Convergence diagnostics comparing the sampling performance of
different versions of the SABRE method. Convergence diagnostics for the conju-
gate SABRE method with the collapsed sampling scheme (CSS) (solid line), the semi-
conjugate SABRE method without CSS (crosses) and the BM conjugate SABRE method
with CSS (circles). The lines show the proportion of parameters converged (PSRF< 1.05)
versus the number of iteration of the 4 MCMC chains. The proportion is based on all of
the simulated datasets from Section 5.1.2.
in Figure 4.3 and 4.2. Overall, our results, shown in Table 5.1and Tables B.1-B.6, suggest
that the two methods perform similarly across the wide range of simulated data sets. A
paired t-test, summarised in Tables B.4-B.6, identifies two data sets (||w|| = 40, σ2ε = 0.3;
||w|| = 60, σ2ε = 0.3) where the conjugate SABRE model outperforms the semi-conjugate
SABRE model. Formal model selection based on WAIC also shows a slight, but significant
preference for the conjugate model (see Table B.6).
The final contribution of our simulation study is to test whether the use of the col-
lapsed sampling scheme in conjunction with increased conjugacy achieves an improvement
in terms of MCMC mixing and convergence. Figure 5.5 indicates that a slight improve-
ment is achieved with the conjugate SABRE model over the semi-conjugate one. However,
this difference is not statistically significant, as becomes clear when considering the con-
fidence intervals (not shown in Figure 5.5 to avoid clutter). This finding suggests that
the major bottleneck in the MCMC sampling scheme is caused by the latent variables γ
rather than the regression parameters.
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Table 5.2: Results comparing the model selection performance of WAIC com-
pared to 10-fold Bayesian CV on the simulated datasets described in Sec-
tion 5.1.3. The mean and 95% confidence intervals are given in terms of correctly
including or excluding random effect components in the simulated datasets described in
Section 5.1.3.
10-fold Bayesian CV WAIC
Sensitivity 0.91 (0.85,0.97) 0.78 (0.69,0.87)
Specificity 0.63 (0.52,0.73) 0.77 (0.68,0.86)
Predictive Accuracy 0.79 (0.70,0.88) 0.78 (0.68,0.87)
F1-Score 0.83 (0.75,0.91) 0.80 (0.71,0.88)
5.3.3 Final Simulation Study
To analyse the performance of WAIC in comparison to 10-fold Bayesian CV, Davies et al.
(2016b) looked at how accurate each method was at correctly selecting the random effect
components used to generate the datasets simulated in Section 5.1.3. Both methods were
applied to each of the 16 possible models for each dataset and selected the best model
in each case. The ability of the best models to correctly include or exclude the random
effect components that were used or not used to generate each of the datasets was then
analysed, where Table 5.2 gives the results in terms of sensitivity, specificity, predictive
accuracies and F-scores; see Section 3.4.1.
The results of Table 5.2 show that WAIC performs similarly to 10-fold Bayesian CV
in terms of correctly selecting random effect components. While 10-fold Bayesian CV
gets an increased sensitivity, WAIC has a better specificity and both perform similarly
in their predictive accuracy and F1-score. However WAIC is much more computationally
effective and to run the MCMC simulations for the WAIC took on average 87 minutes,
as opposed to 761 minutes for 10-fold Bayesian CV.
Using a spike and slab prior to include or exclude all random effect coefficients, bg,
from a particular random effect component, g, is an alternative to both WAIC and 10-
fold Bayesian CV. While WAIC and 10-fold Bayesian CV would be applied to each
combination of random effect components separately, spike and slab priors would only
require one model to be fitted. However, using spike and slab priors for selecting the
random effects will come at a large computational cost. Some of the random effect
components from the FMDV datasets contain between 30 to 50 different levels and this
would mean including or excluding 30 to 50 parameters simultaneously at each proposal
step of the MCMC sampling scheme. This is likely to lead to poor mixing as the difference
in log-likelihood for the inclusion and exclusion of a random effect component is likely to
be large. Poor mixing leads to the possibility of not sampling the optimal combination
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Figure 5.6: Bar plot showing the results for the reduced SAT1 dataset in Davies
et al. (2014). The bar plot shows proven residues (white) and implausible residues
(black) for the mixed-effects model results of Reeve et al. (2010), the mixed-effects LASSO
using AICc and BIC (Schelldorfer et al., 2011) and the original SABRE method (given
here ‘novel Bayesian’).
of fixed and random effects, as the proposals will struggle to move between different
combinations of random effect components. Therefore in order to ensure the optimal
selection of fixed and random effects is found it would be necessary to sample the model
for a large number of iterations. Due to the computational inefficiency of this inter-
model approach, we have used an intra-model approach and run MCMC simulations for
a relatively small number of models in parallel to compute WAIC and 10-fold Bayesian
CV scores for each plausible candidate model separately.
5.4 Results for the SAT1 Datasets
Both SAT1 datasets have been analysed using classical mixed-effects models. Originally
Reeve et al. (2010) analysed the original SAT1 dataset (Section 5.1.4) and Maree et al.
(2015) investigated an extended version of this dataset (Section 5.1.5). We have used
our method on each of these datasets in order to identify a number of candidate residues
which could be considered important for understanding antigenic variability. Knowledge
of which residues are antigenically important is partially incomplete. Therefore, for val-
idation purposes, residues were assigned to three different groups, proven, plausible and
implausible, based on how likely they are to be antigenic based on experimental results;
see Section 2.4.
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Figure 5.7: Proportion of categorised SAT1 variables included based on differ-
ent cut-off values for posterior inclusion probability. The graph shows the propor-
tion of the experimentally proven (thick solid line), plausible (solid line) and implausible
(dashed line) variables based on a cut-off value for the posterior inclusion probability.
The variables were classified into groups based on the method outlined in Section 2.4.
Cut-offs are marked at 0.5 posterior inclusion probability (vertical dashed line) and the
posterior inclusion probability equivalent to the top Jpˆi variables with the highest poste-
rior inclusion probabilities (vertical dotted line).
5.4.1 Reduced SAT1 Dataset
The reduced SAT1 dataset described in Section 5.1.4 was analysed in Davies et al. (2014)
with the original SABRE method. With respect to the evaluation of the prediction, we
need to point out that the original SABRE method is the only one that could be applied
in a fully automatic manner. The forward-variable selection technique used in Reeve
et al. (2010) drew on biological prior knowledge to design an effective variable selection
schedule, and the optimisation algorithm for the mixed-effects LASSO, as implemented in
the software of Schelldorfer et al. (2011), failed due to ill-conditioned (i.e. quasi-singular)
matrices.
To cope with the latter problem, we applied the mixed-effects LASSO as follows: in
the first instance, we included all proven residues (as informed by Section 2.4.1). We
then included any branches of the phylogenetic tree that did not prevent the matrix
inversion as explanatory variables. The plausible and implausible residues were then
added, before being iteratively excluded until the matrix inversion no longer ran into
numerical problems. We need to point out that this strategy uses prior knowledge that
would usually not be available and is not required for the proposed Bayesian method.
However for a fair comparison, we used this reduced set of 107 variable for all methods.
For performance evaluation, we have concentrated on the prediction of the relevant
residues, which indicate areas of the virus protein that are targeted by the immune system,
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Figure 5.8: Phylogenetic tree indicating significant branches in the evolution-
ary history of the SAT1 serotype based on the original SAT1 dataset in Sec-
tion 5.1.4. Phylogenetic trees were created using BEAST v1.7.2 and FigTree v1.4.2 from
aligned nucleotide sequence data with date of isolation. Marked on the tree are protective
strains (*) and topotype defining branches (dashed vertical line). Branches inferred by
the conjugate SABRE method are highlighted (black). Symbols indicate whether this
was inferred to be a change in virus antigenicity (†), virus reactivity (‡) or virus im-
munogenicity (§). Where a highlighted branch has no symbol, an associated change in
antigenicity or reactivity could not be discriminated between. The cut-off for significance
was taken to be the Jpˆi variables with the highest marginal inclusion probability, where
the branches chosen are given in Table B.8.
where mutations potentially allow the virus to escape the host immune response. For
evaluation we used the classification scheme described in Section 2.4.1. The predictions
are shown in Figure 5.6. It can be seen that the original SABRE method finds no
implausible variables, while also showing an increased number of proven variables.
5.4.2 Original SAT1 Dataset
The analysis of the original SAT1 dataset with the conjugate SABRE method in Davies
et al. (2016a) has resulted in the identification of 29 residues or branches of importance
based on taking the top Jpˆi variables with the highest marginal posterior inclusion prob-
abilities. 9 of the selected residues and 2 of the branches are classified as proven, at the
expense of only 1 implausible variable. A full list of selected variables can be found in
Table B.7. The proportion of the differently classified variables at different cut-off points
is shown in Figure 5.7a. The proven residues include several that have been validated
using MAbs in the SAT1 serotype (Grazioli et al., 2006), as well as others from the VP2
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B-C loop, VP1 G-H loop and VP1 C-terminus (the end of the VP1 protein) and we have
focused on these proven residues in our analysis. The classifications of the variables are
taken from Section 2.4.
The residues that have been experimentally validated in the SAT1 serotype are VP3
71 and VP3 77 in the VP3 B-C loop and VP1 144 and VP1 149 in the VP1 G-H loop
(Grazioli et al., 2006). Additionally in the VP1 G-H loop, an antigenic loop in every
FMDV serotype (Bolwell et al., 1989; Crowther et al., 1993b; Grazioli et al., 2013, 2006;
Kitson et al., 1990; Lea et al., 1994) known to distract the host immune systems, the
conjugate SABRE method has also identified VP1 143 and VP1 150. These residues are
next to the experimentally validated residues in the protein alignment and confirm that
the VP1 G-H loop is a highly antigenic part of the SAT1 serotype.
In addition to the residues in the VP3 B-C and VP1 G-H loops, the conjugate SABRE
method has additionally selected VP2 74 in the VP2 B-C loop, as well as VP1 216 and
VP1 219 in the VP1 C-terminus. The VP2 B-C loop is antigenic in all serotypes and
contains the highly antigenic VP2 72 residue, which has been experimentally validated in
all of the FMDV serotypes except SAT2 (Aktas and Samuel, 2000; Crowther et al., 1993a;
Grazioli et al., 2013, 2006; Kitson et al., 1990; Lea et al., 1994; Saiz et al., 1991). The
VP1 C-terminus has been proven to be antigenic in all but the Asia1 serotype, although
it is almost certainly antigenic there also (Aktas and Samuel, 2000; Baxt et al., 1989;
Grazioli et al., 2006; Mateu, 1995).
Figure 5.8 shows the model predictions for the antigenically significant branches based
on using just the branch variables from the original SAT1 dataset. Here we have identified
all of the branches known to divide topotypes (Reeve et al., 2010), as well as a number of
other branches. Several of the branches, including two topotype defining branches, have
been specifically identified as reactivity, immunogenic or antigenic changes, an improve-
ment over previously used models.
5.4.3 Extended SAT1 Dataset
The analysis of the extended SAT1 dataset (Section 5.1.5) with the conjugate SABRE
method in Davies et al. (2016a) resulted in selecting 76 variables, which included 24
proven residues, 4 important branches in the evolutionary history and only 2 implausible
residues. A full list of the selected variables can again be found in Table B.9 and the
proportion of proven, plausible and implausible residues selected at different cut-offs is
shown in Figure 5.7b here. The improved results over Section 5.4.2 show the advantage
of getting a larger dataset through testing an increased number of strains under a variety
of different experimental conditions.
The conjugate SABRE method has identified 11 residues in the highly variable VP1
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Figure 5.9: Phylogenetic trees indicating significant branches in the evolution-
ary history of the SAT1 serotype. Phylogenetic trees were created using BEAST
v1.7.2 and FigTree v1.4.2 from aligned nucleotide sequence data with date of isolation.
Marked on the tree are protective strains (*) and topotype defining branches (dashed ver-
tical line). Branches inferred by the conjugate SABRE method are highlighted (black).
Symbols indicate whether this was inferred to be a change in virus antigenicity (†), virus
reactivity (‡) or virus immunogenicity (§). Where a highlighted branch has no symbol,
an associated change in antigenicity or reactivity could not be discriminated between.
The cut-off for significance was taken to be 0.5 highest marginal inclusion probability,
where the branches chosen are given in Table B.10.
G-H loop (VP1 142, VP1 143, VP1 144, VP1 147, VP1 148, VP1 149, VP1 150, VP1
155, VP1 156, VP1 163 and VP1 164). Finding this many significant residues in this
highly antigenic region while keeping the number of implausible residues low shows that
the model is working effectively.
Additionally, like with the original SAT1 dataset in Section 5.4.2, the conjugate
SABRE method has selected VP2 74 from the VP2 B-C loop. However in addition
it has also selected VP2 72 which is antigenic in all FMDV serotypes and VP2 79 which
has been experimentally validated in the A, O, Asia1 and SAT2 serotypes (Grazioli et al.,
2013, 2006; Mateu, 1995). The conjugate SABRE model also again selects several residues
from the VP1 C-terminus; VP1 209, VP1 211 and VP1 218.
The final proven residues are from the VP3 B-B knob or have been experimentally
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validated specifically in the SAT1 serotype (Grazioli et al., 2006). In the VP3 B-B knob
the conjugate SABRE method has identified VP3 58 (serotypes A, O, C and Asia1) and
VP3 61 (serotype A) (Grazioli et al., 2006; Lea et al., 1994; Mateu, 1995). From those
residues which have specifically been validated in the SAT1 serotype, again VP3 71 and
VP3 77 from the VP3 B-C loop have been selected. However for the extended SAT1
dataset, the conjugate SABRE method has also selected VP3 138, which was also found
in Reeve et al. (2010), from VP3 E-F loop.
As well as finding some branches in our overall model (including 4 topotype defining
branches identified as representing significant evolutionary changes a priori), we have
also compiled a model based only on branches to help us understand the evolutionary
history of the serotype. The results of this model are given in Figure 5.9, where the
seven branches known to define topotypes are indicated by the vertical line. In order to
produce more interpretable results, where larger groups of strains are not separated by a
significant evolutionary change (selected branch), we have used a cut-off of 0.5. The full
results using a Jpˆi cut-off are given in Figure B.1. The results given in Figure 5.9 show
that we have been able to identify all but one of the topotype defining branches, while
the other is found when the Jpˆi cut-off is used. We have also been able to specify whether
the evolutionary changes have affected virus antigenicity, immunogenicity or reactivity,
helping us to further understand the underlying biological processes.
5.4.4 Comparison with Previous Work
To compare the results of the SABRE method against the mixed-effects models used
in Reeve et al. (2010) and Maree et al. (2015), we examine which categories (proven,
plausible or implausible) the various residues selected fall into. Note that to do this we
ignore any branch terms that do not directly correspond to a residue term. The full
results for variables selected can be found in Tables B.7 and B.9. For comparison, the
results of Maree et al. (2015) are given in Table B.13, as the results of the equivalent
study are not given in the original paper.
For the original SAT1 dataset, Reeve et al. (2010) selected 0 proven, 0 plausible and
0 implausible residues using the method described in Section 3.1.1 (i.e. when the Holm-
Bonferroni correction was used). These results compare to 1 proven, 1 plausible and
0 implausible residues when the conjugate SABRE method was used and selecting any
residue variables with a marginal posterior inclusion probability of greater than or equal
to 0.5.5 We have also looked at how well the methods do before selecting an implausible
variable or before a p-value of greater than 0.05 (before the Holm-Bonferroni correction
5The power can be further improved (12 proven and 9 plausible residues) by inferring the selection
threshold and selecting the top Jpˆi variables, at the expense of the selection of 1 implausible residue.
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Figure 5.10: Convergence diagnostics for the reduced SAT1 dataset used in
Davies et al. (2014) and described in Section 5.1.4. The lines show the proportion
of parameters that have converged (PSRF ≤ 1.1) when using component-wise Gibbs sam-
pling (black) and Metropolis-Hastings sampling proposing 4 (grey), 8 (black dashed), 16
(grey dashed), 32 (black thick) and 64 (grey thick) inclusion parameters simultaneously.
was used) was reached (in Reeve et al. (2010) the variable selection process was stopped
as soon as a 0.05 p-value was reached). In this situation again the conjugate SABRE
method offers an improvement, selecting 5 proven, 5 plausible and 0 implausible residues
compared to 1, 1 and 0 respectively for the standard-mixed effects models. The difference
in these results shows an advantage for the conjugate SABRE method over the standard
mixed-effects models.
In the extended SAT1 dataset, Maree et al. (2015) used the method of Reeve et al.
(2010) to select 5 proven, 0 plausible and 0 implausible residues, or 8, 1 and 0, respec-
tively, if the method continued until selecting the first implausible residue. The conjugate
SABRE method selected 11 proven, 3 plausible and 0 implausible residues when taking
any variables with marginal posterior inclusion probabilities of greater than or equal to
0.5, or 15, 4 and 0, respectively, before selecting the first implausible residue.6 It can
again be seen that the power of the proposed conjugate SABRE method has improved
over the method of Reeve et al. (2010).
5.4.5 Sampling of Latent Indicators
Figures 5.10 and 5.11 compare component-wise Gibbs sampling against block Metropolis-
Hastings sampling (both described in Section 4.3.5) in terms of speed of convergence. To
6The power can be further improved (24 proven and 15 plausible residues) by inferring the selection
threshold and selecting the top Jpˆi variables, at the expense of the selection of 2 implausible residues.
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Figure 5.11: Convergence diagnostics for the original and extended SAT1
datasets described in Section 5.1. The lines show the proportion of parameters
that have converged (PSRF < 1.05) versus the average CPU time (second) when using
component-wise Gibbs sampling (crosses) and Metropolis-Hastings sampling proposing 5
(solid), 10 (dashed), 15 (dotted), 20 (thick solid) and 30 (thick dotted) inclusion param-
eters simultaneously.
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do this we ran 4 chains for the component-wise Gibbs sampler and each of the variations
of the Metropolis-Hastings sampler, monitoring the PSRFs for each parameter in the
different methods. Figures 5.10 and 5.11 show the proportion of parameters with PSRFs
< 1.1 (Figure 5.10) or PSRFs < 1.05 (Figure 5.11) in each case compared with the CPU
time taken to get that number of samples. The higher the proportion of parameters with
PSRFs lower than the required value (1.1 or 1.05), the better the method is said to have
performed (Grzegorczyk and Husmeier, 2013).
Figure 5.10 compares convergence speed of different methods of proposing γ on the
reduced SAT1 dataset used in Davies et al. (2014); see Section 5.1.4. The results, based
on monitoring whether the PSRFs were less than 1.1, show that proposing a larger
proportion of 8 (7.5%) or 16 (15%) binary selection hyperparameters, γ, simultaneously
in a block Metropolis-Hastings scheme achieves faster convergence than component-wise
Gibbs sampling, despite the higher rejection probability (recall that Gibbs sampling has
an acceptance probability of 1). This suggests that component-wise Gibbs sampling
should not always be the default choice.
The results from Figure 5.11 support the advantage of a block Metropolis-Hastings
sampler over a component-wise Gibbs sampler as shown in Figure 5.10, where following
Davies et al. (2016a) convergence was determined by monitoring the percentage of vari-
ables with a PSRF ≤ 1.05. In all of the datasets the block Metropolis-Hastings samplers
have outperformed the component-wise Gibbs sampler, with the exception of when more
than 40 or 50 variables were sampled at a time (not shown in the diagrams for clarity).
This shows that even sampling a reasonably large number of variables simultaneously,
where the acceptance rate is likely to be low, can still yield a notable improvement. The
results7 in Figures 5.10 and 5.11 suggest that as a rule of thumb, sampling about 10 of
the variables at a time will lead to effective sampling with the quickest convergence
5.5 Results for the SAT2 Dataset
For the SAT2 dataset, very little knowledge is available on how mutational changes affect
antigenic variability, and no significant variables have been found in previous in silico
work (Reeve et al., 2010). We have therefore applied our conjugate SABRE method as
a tool for new hypothesis generation; see Table B.11 for the full results. For partial
validation of our results, we exploit the fact that previous work by Grazioli et al. (2006)
and Crowther et al. (1993b) has found evidence for antigenicity of the following three
7The best performing samplers in Figure 5.11 are as follows: Metropolis-Hastings samplers with 10
(7.2%) or 15 (10.9%) variables at a time for the original SAT1 dataset, with 10 (4.5%) or 15 (6.8%)
variables at a time for the extended SAT1 dataset and 5 (1.8%) and 10 (3.6%) variables at a time for
the H1N1 dataset.
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Figure 5.12: Phylogenetic tree indicating significant branches in the evolution-
ary history of the SAT2 serotype based on the SAT2 dataset in Section 5.1.6.
The phylogenetic tree was created using BEAST v1.7.2 and FigTree v1.4.2 from aligned
nucleotide sequence data with date of isolation. Marked on the tree are protective strains
(*). Branches associated with a change in virus phenotype are highlighted (black). Sym-
bols indicate whether this was inferred to be a change in virus antigenicity (†), virus
reactivity (none-identified) or virus immunogenicity (§). Where a highlighted branch has
no symbol, an associated change in antigenicity or reactivity could not be discriminated
between. The cut-off for significance was taken to be the Jpˆi variables with the highest
marginal inclusion probability, where the branches chosen are given in Table B.12.
areas: VP1 140-169 (part of the VP1 G-H loop), VP1 200-224 (VP1 C terminus) and
VP2 70-82 (VP2 B-C loop).
Firstly in the VP2 B-C loop, the SABRE method has identified 5 residues that are
antigenic; VP2 71, VP2 72, VP2 78, VP2 79 and VP2 80 (Grazioli et al., 2013, 2006;
Kitson et al., 1990; Lea et al., 1994; Saiz et al., 1991). Of these VP2 78 has been
experimentally identified using MAbs (Grazioli et al., 2006). Additionally VP2 72 is
known to be antigenic in all other serotypes and these results suggest it is also antigenic
in the SAT2 serotype (Grazioli et al., 2013, 2006; Mateu, 1995).
The second region in which antigenically significant residues have been found is in
the VP1 G-H loop. The VP1 G-H loop is known to be a highly variable distracter site
designed to confuse the host immune system (Crowther et al., 1993b) and is antigenic in
all of the FMDV serotypes. In this loop, the conjugate SABRE method has specifically
identified VP1 144 and VP1 166, where it is notable that VP1 166 lies directly between
several residues that have been experimentally validated in the SAT2 serotype using
MAbs (Crowther et al., 1993b).
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The final known antigenic region that has been identified by the conjugate SABRE
method is part of the VP1 C-terminus, the end of the VP1 protein. In the VP1 C-
terminus we have identified VP1 207, VP1 208, VP1 209, VP1 210 and VP1 211 which
are part of a region known to be antigenic in all FMDV serotypes except Asia1 (Aktas
and Samuel, 2000; Grazioli et al., 2006; Lea et al., 1994; Saiz et al., 1991). With the
conjugate SABRE method identifying all these neighbouring residues, it suggests that
this section of the protein is a highly antigenic part of the SAT2 serotype.
Figure 5.12 gives the phylogentic tree for the SAT2 serotype with the predicted sig-
nificant evolutionary changes. Unlike the SAT1 serotype, there is no prior knowledge of
which residues and branches are antigenically relevant and we therefore apply our method
to generate genuinely new hypotheses. The results presented give our best prediction for
the significant branches and show a couple of potentially interesting groupings which
could represent functional groups for the SAT2 serotype.
5.6 Results for the H1N1 Dataset
The analysis of the H1N1 dataset described in Section 5.1.7 selected 62 variables including
11 proven residues, 3 plausible residues and 5 implausible residues. A full list of the
selected variables can again be found in Table B.14. Of the proven residues, one was
identified on the RBS, position 187 (on the H1 common alignment) from the Sb antigenic
site, and 4 others nearby; positions 130, 153, 189 and 190. Of those nearby, two occurred
close together on the Sb antigenic site (189 and 190) and another on the Sa antigenic site
(153). The other proven residue close to the RBS (130) is not part of an antigenic site
but is known to be the location of a major antigenic change (Harvey et al., 2016).
The other proven residues selected come from two of the other antigenic sites; Ca and
Cb. Positions 69, 72 and 74 are all found on Cb antigenic site, while positions 139, 141
and 142 are found on the Ca antigenic site. Additionally two of the plausible residues are
also found nearby the Ca antigenic site. The remaining plausible residue (252) is part of
the head domain and therefore considered plausible. The implausible residues selected
cannot easily be explained but those selected may be partially a result of reducing the
dataset (see Section 2.3.1). The one implausible residue that can be explained however is
position 43 which by chance has a strong correlation with a known antigenic site (Harvey
et al., 2016) rationalising its selection.
We have not constructed a separate estimate of the antigenicity of the branches of the
H1N1 like we did for the FMDV datasets. We have not done this due to the phylogenetic
tree of the H1N1 serotype being large and difficult to interpret. Additionally the H1N1
serotype is subject to rapid antigenic drift (Harvey et al., 2016) and therefore any inference
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would have less relevance. Finally we have not done a comparison with the results of
Harvey et al. (2016) as they used a much larger dataset with more challenge strains and
so any comparison would not be relevant.
5.7 Discussion
We have addressed the problem of identifying the residues within the SAT1 and SAT2
serotypes of FMDV and Influenza A (H1N1) that are responsible for changes in antigenic
variability. This allows us to identify which residues must remain the same in order for
two strains to cross react and for one strain to potentially be used as an effective vaccine
against another. Identifying such residues can reduce the number of strains that must be
tested as a vaccine, potentially reducing the time and cost associated with the selection
procedure.
We have tested the family of SABRE methods introduced in Chapter 4 and shown how
they offer improvement over the classical mixed-effects model, the mixed-effects LASSO
and the mixed-effects elastic net as a result of the differences discussed in Section 5.7;
see Section 5.3. We have additionally examined to fundamentally different approaches to
variable selection in Bayesian hierarchical models: the slab-and-spike prior and the binary
mask model; see Section 3.3. Our results given in Table 5.1 and displayed in Figures 5.3
and 5.4 show that the difference between these methods is negligible. We have also
evaluated the difference between using a conjugate and semi-conjugate prior, as depicted
by Figures 4.3 and 4.2. The differences in accuracy are negligible (see e.g. Figure 5.4).
The conjugate model has slightly better computational efficiency (Figure 5.5), but this
difference is not significant; this finding indicates that the bottleneck in the computational
procedure is the sampling of the latent variables rather than the regression parameters.
The conjugate model shows a slight but significant improvement over the non-conjugate
model in the model selection scores based on WAIC, as seen from Tables 5.1 and B.6,
but this has little immediate impact on the variable selection. Overall, our findings
demonstrate a remarkable robustness of the proposed hierarchical modelling framework
with respect to minor model modifications, which boosts our confidence in the predictions
and in the variable ranking.
Further to this we have investigated the sampling of latent inclusion variables. We
have shown that by proposing multiple variables simultaneously through Metropolis-
Hastings sampling it is possible to give a significant computational improvement over the
conventional component-wise Gibbs sampler (Figures 5.10 and 5.11). We have shown this
improvement in a number of different datasets and have offered a general rule of thumb
that proposing 10 variables at a time will lead to good mixing within MCMC chains for
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a variety of different datasets.
Through the use of this new model with the improved sampling techniques we have
been able to identify an increased number of known antigenic sites in the SAT1 serotype
of FMDV (Grazioli et al., 2006) compared to Reeve et al. (2010) and Maree et al. (2015),
while incurring no (for the default selection threshold 0.5) or only a very small number (for
the inferred selection threshold Jpˆi) implausible residues. Very little biological knowledge
exists about the SAT2 serotype, and a previous in silico application has failed to make
any predictions at all (Reeve et al., 2010). To our knowledge, our study is the first time
that specific new hypotheses about genetic-antigenic associations have been made with an
in silico model based on the currently available data. Additionally we have provided an
insight into the evolutionary history of the SAT serotypes (Figures 5.8, 5.9 and 5.12) and
have provided a novel way of interpreting the biological effects of these virus mutations.
Finally we have identified a number of significant antigenic sites in the H1N1 Influenza
virus based on a reduced dataset and provided new hypotheses for this virus.
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Chapter 6
A Sparse Hierarchical Bayesian
Latent Variable Model for
Understanding Antigenic Variability
- The Methods
While the SABRE method offers consistent parameter inference and improved variable
selection leading novel biological predictions, it does not fully take into account the data
generation process. The structure of the data, discussed in Section 2.1, is a result of
the same pair of challenge and protective strains being used to create multiple VN titre
or HI assay measurements. As a result, the genetic and evolutionary data described
in Sections 2.1.2 and 2.1.3 will be the same for any two measurements where the same
challenge and protective strains are used. Modelling this structure more accurately is
important and doing so should lead to more accurate biological results than those achieved
by both the alternative methods in Chapter 3 and SABRE methods in Chapters 4 and 5.
In the work described in the current chapter, we describe an extended version of the
conjugate SABRE method, the extended SABRE (eSABRE) method, which can properly
account for the structure of the data while still retaining the attractive properties of
the SABRE methods discussed and tested in Chapters 4 and 5. The eSABRE method
introduces a latent variable structure into the mixed-effects model likelihood previously
used in the SABRE methods in order to properly account for the data structure described
in Chapter 2. In Section 6.1.1 we introduce the likelihood for the eSABRE method, with
the remainder of the Section 6.1 defining the prior distributions of the model. In general
the prior distributions for the eSABRE method follow those of the conjugate SABRE
method (Section 4.2.2), but with adjustments and additions to fit in with the new latent
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variable likelihood described in Section 6.1.1.
As a result of using similar prior distributions to the conjugate SABRE method, the
posterior inference of the eSABRE method in Section 6.2 roughly follows that of the
conjugate SABRE method and we have used the conjugate sampling scheme proposed in
Section 4.3.6. The differences in the posterior inference does however indicate one impor-
tant advantage of the eSABRE method; its increased computational efficiency for larger
datasets. As a result of the improved likelihood of the eSABRE method in Section 6.1.1,
the sampling of the latent indicators, γ, become less computationally onerous. This is
massively advantageous as the sampling of γ was identified as the computational bottle-
neck of the SABRE methods in Chapter 4. The reduction in computational complexity
comes from reducing the complexity of calculating the conditional distribution of γ by
making it dependant on the inferred mean VN titre or HI assay for each pair of challenge
and protective strains, rather than all of the individual VN titre and HI assay measure-
ments. There are less pairs of challenge and protective strains then there are VN titre
and HI assay measurements in all of the FMDV and Influenza datasets. This reduction
in computational complexity is possible as a result of the latent variable structure of the
likelihood introduced in Section 6.1.1 and explained further in Section 6.2.
Finally, in addition to proposing the eSABRE method, the current chapter also looks
at methods for selecting random effects factors as we did previously in Chapters 4 and 5.
As the latent variable likelihood for the eSABRE methods is specified as the product
of two distributions, it is possible that alternative model selection techniques may offer
an improvement over those proposed in Section 3.5 and tested in Chapter 5. Here we
introduce a variation of the Widely Applicable Information Criterion (WAIC) (Watanabe,
2010), block integrated WAIC (biWAIC) based on integrated WAIC (iWAIC) as proposed
in Li et al. (2015). biWAIC takes into account the specific structure of the model and
integrates over the latent variables. We have described how this converges to a particular
form of Cross Validation (CV) and in Chapter 7 we use a simulation study to compare it
to Bayesian 10-fold integrated CV (iCV) and non-integrated WAIC (nWAIC), a method
which naively applies WAIC to the part of the latent variable likelihood containing the
response, y.
6.1 The eSABRE Method
The eSABRE method is based on the conjugate SABRE method from Section 4.2.2 in
Chapter 4 (Davies et al., 2016a) but with a likelihood that better takes into account the
data structure described in Chapter 2. The change in the structure is given in Section 6.1.1
and the remaining sections define the prior distributions of the eSABRE method, keeping
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to those used for the conjugate SABRE method as close as possible. Finally, the model
is shown as a PGM in Figure 6.1 and the parameters are sampled from the posterior
distribution using MCMC based on the methods described in Section 3.2.
6.1.1 Latent Variable Based Likelihood
The conjugate SABRE method described in Chapter 4 used the following likelihood, also
given in (4.11), similar to classical mixed-effects models (Davies et al., 2016a):
y ∼ N(y|1w0 + Xγwγ + Zb, σ2εI). (6.1)
In (6.1), the response, log HI assay or log VN titre, is given by y = (y1, . . . , yN)
>. The
random-effects design matrix, Z, is set to be a the matrix of indicators with N rows and
||b|| columns, where ||.|| indicates the length of the vector and b is a column vector of
random-effect coefficients. The explanatory variables, X, are given as a matrix of J + 1
columns and N rows and contain indicators of mutational changes at different residues
or information on the phylogenetic structure where the first column is a column full of
ones for the intercept. Of the explanatory variables, X, only the relevant variables, Xγ ,
are included in (6.1) dependant on γ = (γ1, . . . , γJ)
> ∈ {0, 1}J . The relevance of the
jth column of X is determined by γj ∈ {0, 1}, where feature j is said to be relevant if
γj = 1. Similarly wγ is given as the column vector of regressors, where the inclusion of
each parameter is dependent on γ.
While (6.1) gives a general model which can be used in a variety of different contexts,
it does not completely account for the structure of the data used to model antigenic
variability described in Chapter 2. The structure from the experiments means that any
observations from the same challenge and protective strains will have the same explana-
tory variables. However it is worth noting that a given pair of viruses will give different
explanatory variables if the strains used as challenge and protective strains are switched.
As a result of this structure, we can introduce latent variables, µy, into the model, where
each µy,p represents the inferred underlying HI assay measurement of any given pair of
challenge and protective strains, p.
The introduction of the latent variables, µy, into the models results in the following
distribution for y:
y ∼ N(y|Mµy + Zb, σ2yI) (6.2)
where M is a design matrix which ensures that each y has the underlying inferred VN
titre or HI assay measurement, µy,p, for its given pair of challenge and protective strains,
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µw σ2w
wj
βpi γj y Zk
pi Xγj ,j
σ2ε
bk,g µb,g
αpi
αε
βε
σ2b,g
αb,g
βb,g
w0
µw0 σ2w0
µy,p
Mp
σ2y
αy βy
j = 1, . . . , J
k =
1, . . . , ||b||
g = 1, . . . , G
p = 1, . . . , P
For: j = 1, . . . , J
γj ∼ Bern(γj |pi)
pi ∼ B(pi|αpi, βpi)
y ∼ N (y|Mµy + Zb, σ2yI) µy ∼ N (µy|1w0 +Xγwγ , σ2εI) σ2ε ∼ IG(σ2ε |αε, βε) w0 ∼ N (w0|µw0 , σ2w0σ2ε)
σ2y ∼ N (σ2y |αy, βy)
For: k = 1, . . . , ||b||
bk,g ∼ N (bk,g|µb,g, σ2b,g)
For: j = 1, . . . , J
wj ∼
{
δ0(wj) if γj = 0
N (wj|µw, σ2wσ2ε) if γj = 1.
µw,h ∼ N (µw|µ0, σ20σ2ε)
σ2w,h ∼ IG(σ2w|αw, β2w)
For: g = 1, . . . , G
σ2b,g ∼ IG(σ2b,g|αb,g, β2b,g)
Figure 6.1: Compact representation of the eSABRE method as a PGM. The
grey circles and squares refer to the fixed hyperparameters and data respectively, while
the white circles refer to parameters and hyperparameters that are inferred. The main
differences with the conjugate SABRE method given in Figure 4.3 can be seen by noting
the addition of the latent variables, µy,p , between wj and y, the addition of nodes and
edges connecting σ2y, αy and βy, and the edges connecting σ
2
ε and w0 to µy,p rather than
y.
p. The random effects factors are added into this part of the likelihood as some of these
factors, e.g. the date of the experiment, affect measurements at the individual level, i.e.
they are different for each y; see Section 2.1.1 for details on the random effects factors.
We then wish to infer the values of the VN titre or HI assay measurements of the pairs
of challenge and protective strains, µy, based on the differences in the protein structure
and evolutionary history of the virus described in Sections 2.1.2 and 2.1.3:
µy ∼ N(µy|1w0 + Xγwγ , σ2εI). (6.3)
As with the SABRE methods in Chapter 4, we only wish to use the relevant explanatory
variables, Xγ , and corresponding regression coefficients, wγ . We also include an intercept
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parameter, w0 as we expect high underlying HI assay measurements when the two virus
strains used are the same, i.e. the explanatory variables are equal to zero. The full model
is given graphically in Figure 6.1.
The eSABRE method’s latent variable likelihood, given in (6.2) and (6.3), has two
major advantages over the likelihood of the conjugate SABRE method, given in (6.1).
Firstly it allows us to better attribute the error to the correct part of the model. In the
VN titre and HI assay measurements some of the error comes from variability within the
experiments, e.g. getting multiple different results for the same pair of challenge and
protective strains once the experimental conditions have been taken into account, and
this is modelled by σ2y. Other errors will come from the model fit, e.g. our model not
completely replicating the true underlying biological process, and this is given by σ2ε .
Attributing the error better means our model matches better with the data collection
process and should result in more accurate results.
The second advantage of the eSABRE is massively improved computational perfor-
mance. For example to analyse the H1N1 dataset would take the SABRE method weeks
or months to sample the required number of iterations to achieve convergence and a rea-
sonable sample size after burn-in, the eSABRE method is able to achieve the result in
less than a day. The improvement is a result of reducing the computation required to
calculate the posterior distribution of γ. In essence, through the introduction of latent
variables the eSABRE method reduces the posterior distribution of γ to a multivariate
Gaussian distribution of dimension ||µy||, ||µy|| = 570 in the H1N1 dataset, as opposed
to dimension ||y||, ||y|| = 15, 693 in the H1N1 dataset, in the SABRE method. This is a
result of the d-separation of y and γ via µy in Figure 6.1. Similar results are also likely
for the H3N2 dataset, although the times required would be much larger.
6.1.2 Noise and Intercept Priors
Unlike the SABRE methods in Chapter 4, the eSABRE method contains two types of
error rather than one to better reflect the error coming from the data collection process.
The first part of the error is given by σ2y in (6.2). This error term represents the variation
seen in the measurements collected from the same pair of challenge and protective strains:
σ2y ∼ IG(σ2y|αy, βy) (6.4)
where the hyper-parameters αy and βy are fixed, as indicated by the grey nodes in Fig-
ure 6.1. As with the SABRE methods in Chapter 4 we have used conjugate priors where
possible, so we can use Gibbs sampling to sample as many parameters as possible.
The other error comes from the second part of the likelihood, (6.2), and is given by
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σ2ε :
σ2ε ∼ IG(σ2ε |αε, βε) (6.5)
where the hyper-parameters αε and βε are fixed. This represents the error between the
inferred underlying HI assay or VN titre measurements for each pair of challenge and
protective strains and what can be explained by the fixed effects, w∗γ . σ
2
ε is also included
in the distributions for w0, wγ and µw (defined in (6.6) and Section 6.1.3) following the
conjugate SABRE method described in Section 4.2.2. The advantage of this information
sharing is that the error variance in terms of model fit is reflected in the distribution of
the regression coefficients and a potential computational advantage can also be obtained
through collapsed Gibbs sampling; see Davies et al. (2016a).
Additionally we also require a prior on our intercept:
w0 ∼ N(w0|µw0 , σ2w0σ2ε). (6.6)
As discussed in Section 4.2.1, we treat the intercept differently from the remaining re-
gressors, wishing to use vague prior settings so as not to penalise this term and effectively
make the model scale invariant (Hastie et al., 2009).
6.1.3 Spike and Slab Priors
As with the conjugate SABRE method, we use spike and slab priors as proposed by
Mitchell and Beauchamp (1988) and described in Section 3.3.1. Again the idea of the
spike and slab prior is that the prior reflects whether the feature is relevant based on the
values of γ. In this way we expect that wj = 0 if γj = 0, i.e. the feature is irrelevant,
and conversely it should be non-zero if the variable is relevant, wj 6= 0 if γj = 1. With
the eSABRE method the effects of the spike and slab prior are seen on the estimate of
µy rather than y itself as in the SABRE methods, with µy then affecting the estimate of
y. This can be seen by comparing Figures 4.3 and 6.1. Following the conjugate SABRE
method, we again add σ2ε into the distribution for further conjugacy:
wj ∼
{
δ0(wj) if γj = 0
N(wj|µw, σ2wσ2ε) if γj = 1
(6.7)
for j ∈ 1, . . . , J and where δ0 is the delta function. The prior for the variance of the
parameter is then given by:
σ2w ∼ IG(σ2w|αw, βw). (6.8)
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where αw and βw are fixed; see Figure 6.1.
As with the conjugate SABRE method, we again assign a flexible parameter for the
mean of the regression coefficients, wγ :
µw ∼ N(µw|µ0, σ20σ2ε) (6.9)
where the hyper-parameters µ0 and σ
2
0 are fixed and σ
2
ε is again included in the variance for
further conjugacy. The need for a flexible vale of µw is due to our biological understanding
of the problem, with the model likely to have a high intercept, w0, and only negative
regression coefficients; see Section 2.1.
The final part of the spike and slab prior is to define the prior for the latent binary
indicators, γ. For this we assign Bernoulli prior for each γj with probability pi, with the
probability pi itself given a prior following a conjugate Beta distribution:
p(γ|pi) =
J∏
j=1
Bern(γj|pi) (6.10)
pi ∼ B(pi|αpi, βpi) (6.11)
where αpi and βpi are fixed, as indicated by the grey nodes in Figure 6.1.
6.1.4 Random-Effects Priors
For the random effects priors we use the same priors as with the conjugate SABRE
method. We do not consider the folded-non-central-t prior distribution described in
Gelman (2006) and tested here in Section 5.3 (Davies et al., 2016a). The results of
Figure 5.1 showed that the prior did not offer any advantage in the context of the SABRE
methods and therefore we have not used it here.
As with mixed-effects models and the SABRE methods we give the random effects
coefficients, bk,g, group dependant Gaussian priors where the group is defined by k, i.e.
bk,g is shorthand for bk,gk :
bk,g ∼ N(bk,g|µb,g, σ2b,g). (6.12)
where we again fix µb,g = 0 with the group dependant variance parameter, σ
2
b,g, given a
conjugate Inverse-Gamma prior:
σ2b,g ∼ IG(σ2b,g|αb,g, βb,g) (6.13)
where αb,g and βb,g are fixed hyper-parameters for each g. Again, as in Section 4.1.4,
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we define b ∼ N(b|0,Σb) where Σb = diag(σ2b) with σ2b = (σ2b,1, . . . , σ2b,1, σ2b,2, . . . , σ2b,G)>
such that each σ2b,g is repeated with length ||bg||.
6.2 Posterior Inference
To explore the posterior distribution of the eSABRE method we have used an MCMC
algorithm; see Section 3.2. As with the SABRE methods in Chapter 4, we have chosen
conjugate priors where possible meaning that we can use Gibbs sampling for most of the
model parameters; see Section 3.2.2. The distributions needed for sampling are given
here and are derived in Section A.2, where we again use a slight abuse of notation and
denote θ′ as all other parameters that are not on the left of the conditioning bar. The
only parameter that we cannot use Gibbs sampling with is γ and this is discussed in
Section 6.2.1.
µy|θ−µy ,X∗γ ,Z,y ∼ N(µy|Vy(M>(y− Zb)/σ2y + X∗γw∗γ/σ2ε),Vy) (6.14)
w∗γ |θ−w∗γ ,X∗γ ,Z,y ∼ N(w∗γ |Vw∗γX∗>γ µy + Vw∗γΣ−1w∗γmγ , σ2εVw∗γ ) (6.15)
b|θ−b,X∗γ ,Z,y ∼ N(b| 1σ2yVbZ
>(y−Mµy),Vb) (6.16)
µw|θ−µw ,X∗γ ,Z,y ∼ N(µw|Vµw(1wγ/σ2w + µ0/σ20), σ2εVµw) (6.17)
σ2y|θ−σ2y ,X∗γ ,Z,y ∼ IG(σ2y| ||y||/2 + αy, 12(y−Mµy − Zb)>(y−Mµy − Zb)) (6.18)
σ2w|θ−σ2w ,X∗γ ,Z,y ∼ IG(σ2w| ||wγ ||/2 + αw, 12σ2ε (wγ − Iµw)
>(wγ − Iµw)) (6.19)
σ2b,g|θ−σ2b,g ,X∗γ ,Z,y ∼ IG(σ2b,g| ||bg||/2 + αb,g, βb,g + 12b
>
g bg) (6.20)
σ2ε |θ−σ2ε ,X∗γ ,Z,y ∼ IG(σ2ε |(||µy||+ ||w∗γ ||+ 1)/2 + αε, βε + 12Rσ2ε ) (6.21)
pi|θ−pi,X∗γ ,Z,y ∼ β(pi| αpi + ||γ||, βpi + J − ||γ|). (6.22)
where we sample σ2b,g for each g. We also define Vy = (1/σ
2
εI + M
>M/σ2y)
−1, Vw∗γ =
(X∗>γ X
∗
γ + Σ
−1
w∗γ )
−1, Vb = ( 1σ2yZ
>Z + Σ−1b )
−1, Vµw = (1/σ
2
0 + ||wγ ||/σ2w)−1 and Rσ2ε =
(µy−X∗γw∗γ)>(µy−X∗γw∗γ) + (w∗γ −mγ)>Σ−1w∗γ (w∗γ −mγ) + (µw−µ0)>(µw−µ0)/σ20 for
notational simplicity.
Following Davies et al. (2016a) we have again used collapsing in an attempt to improve
mixing and convergence, e.g. Andrieu and Doucet (1999). As in Section 4.3.6 this is
achieved through a series of collapsed distributions for γ, w∗γ , µw, σ
2
ε and pi:
p(γ,w∗γ , µw, σ
2
ε , pi) = p(γ)p(pi|γ)p(σ2ε |pi,γ)p(µw|σ2ε , pi,γ)p(w∗γ |µw, σ2ε , pi,γ) (6.23)
= p(γ)p(pi|γ)p(σ2ε |γ)p(µw|σ2ε ,γ)p(w∗γ |µw, σ2ε ,γ) (6.24)
where the conditionality on θ′, X, Z and y has been dropped and the simplification from
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(6.23) to (6.24) follows from the conditional independence relations shown in Figure 6.1,
exploiting the fact that pi is d-separated from the remaining parameters in the argument
via γ. These distributions are achieved by collapsing over parameters as derived in
Section A.2.
6.2.1 Sampling the Latent Indicators
In the SABRE methods of Chapter 4, sampling γ is both difficult, as a result of it
not naturally taking a distribution of standard form, and computationally expensive.
However a conditional distribution can still be obtained and Davies et al. (2016a) used
collapsing methods following Sabatti and James (2005), as described in Section 4.3.5, to
achieve faster mixing and convergence as follows:
p(γ|θ−γ ,X∗γ ,Z,y) ∝
∫
p(γ|θ−γ ,X∗γ ,Z,y)dµwdw∗γdpidσ2ε (6.25)
where using the likelihood for the conjugate SABRE method given in (6.1) and the priors
described in Sections 4.1 and 4.2.
However with the likelihood for the conjugate SABRE method given in (6.1), as well
as the likelihoods for the other SABRE methods, the computational cost of computing
(6.25) becomes dependant inverting a ||y|| × ||y|| matrix. For the FMDV datasets this is
not problematic, as ||y|| is relatively small. However with the H1N1 and H3N2 datasets,
where ||y|| = 15, 693 and ||y|| = 7, 315 respectively, calculating any distribution where a
||y|| × ||y|| matrix inversion is repeatedly required becomes infeasible.
It is at this point that the latent variable likelihood given in (6.2) and (6.3) shows
its huge computational advantage over the SABRE methods discussed in Chapter 4;
see Table 7.1 for an example of the computational savings. As in the conjugate SABRE
method, (6.25), we use collapsing methods and integrate over µw, w
∗
γ , pi and σ
2
ε . However
while in the SABRE method this gives a computational dependence on ||y||, ||y|| =
15, 693 for the H1N1 dataset, for the eSABRE method we get a computational dependence
on ||µy||:
p(γ|θ−γ ,X∗γ ,µy) ∝
∫
p(γ|θ−γ ,X∗γ ,µy)dµwdw∗γdpidσ2ε . (6.26)
The dependency on µy rather than y is a result of (6.2) not containing γ and γ therefore
does not need to be included in (6.26). The dependence on ||µy|| rather than ||y|| is where
the main computational cost reduction occurs, as in the H1N1 dataset ||µy|| = 570 is
much smaller ||y||making the computational cost of computing (6.26) far less than (6.25).
Further collapsing is possible within the sampling step for γ in the eSABRE method, i.e.
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collapsing over µy. However despite the potentially improved sampling available per
iteration by doing this, the increased computational cost of calculating (6.26) at each
step would far outweigh any gains that would be made.
Based on the results of Section 5.4.5 taken from Davies et al. (2014) and Davies et al.
(2016a) we have chosen to sample γ via a block Metropolis-Hastings step. In those studies
it was found that block Metropolis-Hastings sampling was the method that offered the
quickest convergence of the parameters based on CPU time. The only difference here is
that we have a posterior distribution of dimension ||µy|| rather than ||y||
6.3 Selection of Random Effect Components
There are various methods that can be used to select the random effects that should be
used within the model, here we look at Bayesian integrated CV (iCV), e.g. Vehtari and
Ojanen (2012), and several variations of WAIC (Watanabe, 2010).
6.3.1 Integrated Cross Validation
Bayesian CV methods are reliable, if computationally expensive, techniques for measuring
the out-of-sample performance of different models. Bayesian iCV is a special version of
CV which works well in latent variable models. Bayesian iCV integrates over the latent
variables, in this case µy, to give the following utility function for k-fold Bayesian iCV:
piCV =
1
K
K∑
k=1
log
1
I
I∑
ι=1
p(yk|θι) (6.27)
where the distribution p(yk|θι) comes from integrating over µy in the distribution given
by the product of (6.2) and (6.3). The parameter samples, θι, are taken from the eSABRE
method applied to y−k, X−k, Z−k and M−k.
6.3.2 Block Integrated WAIC
WAIC, as proposed in Watanabe (2010) and defined here in Section 3.5.2, is a natural
method for selecting the correct model when the underlying model is singular, i.e mod-
els with a non-identifiable parameterisation, such as the SABRE method. WAIC has
been proven to be asymptotically equivalent to Bayesian leave-one-out CV (LOO-CV) in
Watanabe (2010) and is computed as follows from posterior samples θι for ι ∈ {1, . . . , I}:
pWAIC = −2
N∑
i=1
(
log
(
1
I
I∑
ι=1
p(yi|θι,Xγ,i,Zi)
)
− Var (log(p(yi|θι,Xγ,i,Zi)))
)
. (6.28)
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where Var is the sample variance. WAIC can be used for a wide variety of problems,
however it is only justifiable for problems where the observed data are independently
distributed with a population distribution, e.g. the SABRE method where the joint
likelihood is given by (6.1).
To make WAIC more applicable to latent variable models such as the eSABRE
method, Li et al. (2015) introduced two alternative versions of WAIC; non-integrated
WAIC (nWAIC) and integrated WAIC (iWAIC). nWAIC applies WAIC to the predictive
density of the observed variables, y = (y1, . . . , yN), conditional on the model parameters,
θ, and the potentially correlated latent variables, ψ = (ψ1, . . . , ψN):
pnWAIC = −2
N∑
i=1
(
log
(
1
I
I∑
ι=1
p(yi|θι, ψιi ,Zi)
)
− Var (log(p(yi|θι, ψιi ,Zi)))
)
(6.29)
where θι and ψιi are sampled via MCMC and Var is the sample variance. In the proposed
eSABRE method, taking just the likelihood for yi from (6.2) would be the distribution
corresponding to p(yi|θι, ψιi ,Zi) and would seem unlikely to completely satisfy the inde-
pendence assumptions of WAIC based methods.
nWAIC also does not fully account for the mismatch in the model fit of the latent
variables, i.e. how well the latent variables are predicted by the fixed effects. Li et al.
(2015) therefore proposed iWAIC:
piWAIC = −2
N∑
i=1
(
log
(
1
I
I∑
ι=1
p(yi|θι,Xγ,i,Zi,ψι-i)
)
− Var (log(p(yi|θι,Xγ,i,Zi,ψι-i)))
)
(6.30)
where Var is the sample variance and the distribution used is given by p(yi|θι,Xγ,i,Z,ψι-i)
=
∫
p(yi|θι,ψι-i, ψi,Z)p(ψi|θι,Xγ)dψi, the marginal likelihood based on taking both parts
of the likelihood of the latent variable model and integrating over the latent variable ψi
corresponding to yi.
The proposed version of iWAIC does not however work with the eSABRE method.
This is a result of each observation, yi, not having its own corresponding latent variable,
ψi. Instead any two observations, y1 and y2, from the same pair of challenge and protective
strains, p, will have the same latent variable, i.e. ψ1 = ψ2 = µy,p. Under this model,
i.e. where ρ(ψ1, ψ2) = 1, it is mathematically intractable to integrate over ψ1 = µy,p
without integrating over ψ2 = µy,p, something which is required in order to calculate
p(yi|θι,Xγ,i,Zi,ψ-i) as needed for (6.30). We must therefore either use nWAIC given by
(6.29) or find an alternative.
In this current work we proposed biWAIC for latent variable models with latent
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variables that are either completely correlated or have no correlation. While WAIC,
nWAIC and iWAIC rely on using independent distributions for each yi, biWAIC instead
uses a distribution for independent groups of observations yp, given by yp : yi where
pi = p. Given this notation we can then compute biWAIC as follows:
pbiWAIC = −2
P∑
p=1
(
log
(
1
I
I∑
ι=1
p(yp|θι,Xγ,p,Zp)
)
− Var (log(p(yp|θι,Xγ,p,Zp))))
(6.31)
where Var is the sample variance and the distribution used is given by p(yp|θι,Xγ,p,Z) =∫
p(yp|θι, µy,p,Z) p(µy,p|θι,Xγ,p)dµy,p where the two distributions that are part of the
marginalisation are taken from (6.2) and (6.3).
As well as being applicable to the eSABRE method and particular specifications of
latent variable models, biWAIC also has some useful asymptotic properties. Previously
Watanabe (2010) has shown that WAIC is asymptotically equivalent to Bayesian LOO-
CV. While biWAIC is not asymptotically equivalent to LOO-CV, based on the same
concept it is asymptotically equivalent to Bayesian leave-one-group-out CV (LOGO-CV).
We define LOGO-CV as the cross validation method where observations are divided into
P independent groups based on the latent structure, as opposed to n groups of single
observations for LOO-CV or k groups for k-fold CV.
6.4 Discussion
In this chapter we have introduced the eSABRE method and discussed how it can of-
fer improved performance over the SABRE methods discussed in Chapter 4 and 5. In
Section 6.1 we have described how the model can take into account the data generation
process to improve modelling and variable selection performance, and have specified the
change in likelihood needed to achieve this; Section 6.1.1. In Section 6.2 we have then
described how the change in likelihood given in Section 6.1.1 can potentially lead to
significantly improved computational efficiency and given the conditional distributions.
Finally in Section 6.3 we have discussed methods for selecting the random effect compo-
nents in the eSABRE method and have proposed an alternative criterion, biWAIC, which
may better take into account the latent variable structure of the eSABRE method and
other similar methods.
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Chapter 7
A Sparse Hierarchical Bayesian
Latent Variable Model for
Understanding Antigenic Variability
- The Analysis
In this chapter we test the effectiveness of the eSABRE method proposed in Chapter 6,
as well as a newly proposed information criterion; block integrated WAIC (biWAIC).
We firstly introduce the data in Section 7.1 where we describe the simulated datasets
we have used to demonstrate the improvements offered by the eSABRE method over the
conjugate SABRE method (Section 4.2.2). We additionally describe the real life Influenza
datasets that the eSABRE method has been applied to, before Section 7.2 describes the
computational inference.
Section 7.3 looks at the results of the simulation studies. The results show the im-
provement offered by the eSABRE method over the conjugate SABRE method when the
simulated data is generated from a more biologically realistic model. The results from Ta-
ble 7.1 show that the eSABRE method is robust to increases in the error related to model
fit (see Section 6.1.1) and outperforms the conjugate SABRE method across all datasets.
Table 7.1 additionally demonstrates the computational efficiency of the eSABRE method
compared to the SABRE method when the number of observations increases, something
which is important when it comes to applying the model to the real life Influenza datasets.
Table 7.2 also shows how that the eSABRE method gives improved variable selection over
the conjugate SABRE method when more realistic simulation studies are used. Finally,
Table 7.3, Figure 7.2 and Figure 7.3 compare the performance of non-integrated WAIC
(nWAIC), biWAIC and 10-fold Bayesian integrated CV (iCV) in terms of correctly se-
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lecting random effect factors. The results show that all three of the methods perform
similarly, with the biWAIC offering an alternative threshold for the inclusion of random
effect factors as a result of fully accounting for the latent variable likelihood.
Section 7.4 compares the performance of the eSABRE method against the conjugate
SABRE method in terms of correctly identifying antigenic residues from the H1N1 In-
fluenza serotype. The results firstly demonstrate how it is possible to apply the eSABRE
method to the full H1N1 dataset, whereas for computational feasibility the conjugate
SABRE method had to be applied to a reduced H1N1 dataset in Chapter 5. While the
results show similar amounts of proven antigenic residues based on the classifications in
Section 2.4.3, the eSABRE method reduces the number of implausible residues selected.
In the H3N2 dataset our results identify a large number of antigenic residues from three
of the five known antigenic regions. Additionally we propose other plausible residues that
appear to be antigenic and may require further experimental investigation.
7.1 Data
Detailed descriptions of the H1N1 and H3N2 Influenza datasets are given in Section 2.3
of Chapter 2. In this section we describe the simulated datasets that are used to test
the effectiveness of the eSABRE and conjugate SABRE methods described in Section 6.1
and Chapter 4, and add a few details on the real life datasets that are specific to this
chapter of the thesis.
7.1.1 Non-FMDV Simulated Data
To initially test the eSABRE and conjugate SABRE methods we generated 3 datasets
with a reasonably small number of variables. These 3 datasets (Simulated Dataset 1
(SD1), SD2 and SD3) are based on the same structure as the H1N1 and FMDV datasets
with a varied number of random effect factors based on Section 2.1.1. In each of the
datasets 2000 observations were simulated from 55 pairs of challenge and protective
strains (10 viruses which are designated as both challenge and protective strains) with
50 possible fixed effects and 4 possible random effect components (including the chal-
lenge and protective strains). The random effects coefficients are generated from a zero
mean Gaussian distribution with each component having a fixed variance drawn from
U(0.2, 0.5). Fixed effects, wj, were given non-zero effects generated from a uniform dis-
tribution, U(−0.4,−0.2), with probability pi ∼ U(0.2, 0.4). σ2y and σ2ε were both set to
be 0.033, 0.1 and 0.3 respectively for the three simulated datasets.
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7.1.2 FMDV Simulated Data
To make the simulation studies more realistic we wanted to make simulated datasets based
on the H1N1 and H3N2 Influenza datasets described in Sections 2.3. However using the
conjugate SABRE method to analyse datasets of this size is computational prohibitive.
Therefore instead we have created 20 simulated datasets based on the extended SAT1
FMDV dataset used in Maree et al. (2015) and Davies et al. (2016a); Section 2.2.1. These
datasets were created to be the same size as the FMDV datasets using the maximum a-
posteriori parameter estimates of the eSABRE method applied to the FMDV dataset,
but with varied error in the underlying model, σ2ε ∈ {0.02, 0.2, 0.5}, and different mean
regression parameters, µw ∈ {−0.1,−0.3,−0.5}, so as to highlight the differences in per-
formance of the two models under different circumstances. Following Maree et al. (2015)
we used 3 random effect components; the challenge strain, the date of the experiment
and the antiserum.
7.1.3 Simulated Data for Model Selection
Finally, to compare nWAIC, biWAIC and 10-fold Bayesian iCV, we have generated 9 sets
of 20 datasets with up to 4 random effects; the challenge strain, the protective strain
and two generic random effect factors. The datasets were generated with 50 possible
fixed effects and up to 4 random effect factors included with probability 0.5. Of the 9
sets of datasets, 3 contain 10 virus strains, where each virus strain has been used as a
protective and challenge strain, meaning there are 55 pairs of challenge and protective
strains. Following the same set up, 3 of the sets of datasets include 30 virus strains (465
pairs) and the other 3 have 45 virus strains (1035 pairs). Within each of these sets of 3
datasets, the model error, σ2ε , was varied to be either 0.1, 0.3 or 0.5.
7.1.4 Influenza Data
Both of H1N1 and H3N2 are described in Section 2.3 and we have used the full datasets
described here. In each case we have used biWAIC to choose the random effect factors
that are included in the models analysed in Sections 7.4 and 7.5.
7.2 Computational Inference
To test model convergence for both the simulated and real datasets we ran 4 chains for
each model and then computed the PSRF (Gelman and Rubin, 1992) from the within-
chain and between-chain variances. We took the threshold of convergence to be a PSRF
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Table 7.1: Table of AUROC values and CPU time for the eSABRE and the con-
jugate SABRE methods applied to the non-FMDV based simulated datasets.
The table gives the AUROC values and CPU times per 1,000 iterations (seconds) for the
eSABRE and conjugate SABRE methods, where the results for the conjugate SABRE
method are given in brackets. The result come from when the methods were applied to
the non-FMDV simulated datasets (SD1, SD2 and SD3) described in Section 7.1.1 with
varied numbers of observations.
Obs.
AUROC Values CPU Time Per 1,000 Iterations
SD1 SD2 SD3 SD1 SD2 SD3
500 0.98 (0.90) 0.90 (0.77) 0.82 (0.64) 25 (497) 25 (867) 47 (444)
1000 0.98 (0.83) 0.91 (0.70) 0.82 (0.59) 29 (6,931) 26 (5,623) 36 (5,546)
2000 0.98 (0.75) 0.92 (0.61) 0.83 (0.58) 32 (35,231) 25 (32,243) 43 (20,904)
≤ 1.1 and terminated the burn-in phase when this was satisfied for 95% of the variables.
The fixed hyperparameters were set the same for both the eSABRE and conjugate SABRE
methods such that αb = βb = (0.001, . . . , 0.001), αw = βw = αy = βy = αε = βε = 0.001,
µ0 = 0, σ
2
0 = 100, w0 = max(y), αpi = 1 and βpi = 4 following Davies et al. (2016a).
7.3 Results for the Simulation Studies
Table 7.1 gives the AUROC values for the eSABRE and conjugate SABRE (Section 4.2.2)
methods applied to the non-FMDV simulated datasets from Section 7.1.1; SD1, SD2,
SD3. For each combination of dataset and number of observations, the eSABRE method
offers an improvement in terms of global variable selection performance over the SABRE
method. This improvement is a result of the latent variable structure of the eSABRE
method which better reflects the data generation process, where the difference in the
methods can be seen by comparing the PGMs in Figures 4.3 and 6.1. Table 7.1 also
shows the effect of deviating from this data collection process. For the SD1 dataset where
both of the error variances in the data generation process are small, σ2y = σ
2
ε = 0.033,
the conjugate SABRE method gives similar results to the eSABRE method. However
as the error variances get larger, e.g. SD2 and SD3, the eSABRE method offers a much
clearer improvement over the SABRE method. This is a result of the conjugate SABRE
and eSABRE methods becoming identical models as σ2ε → 0. Given the large variance in
HI assay measurement for any given pair of challenge and protective strains in the H1N1
and H3N2 datasets, this improvement is vital.
Another notable result from Table 7.1 is the reduction in performance in terms of
AUROC values of the conjugate SABRE method (Section 4.2.2) as the number of obser-
vations increases. This is an unexpected result as we would expect more data to provide
more information to the model, resulting in a better selection of variables in the models
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Figure 7.1: Box plots showing the effect of non-iid Gaussian noise on a model
assuming iid Gaussian noise. The box plots show the probability of an irrelevant
variable being included in a model for data with iid Gaussian noise (white) against the
probabilities for a model with noise based on FMDV and Influenza Data (grey).
and higher AUROC values. The reason for this strange result is a consequence of the
mismatch between the data generation process where errors come in two forms, σ2ε and
σ2y , and the model which only directly accounts for the error in y coming from σ
2
y.
To demonstrate that the strange reduction in performance of the conjugate SABRE
method is a result of the mismatch between the data and the model we have completed
a small simulation study with linear models. We have generated groups of datasets
with 500, 1,000 and 2,000 observations generated from a linear model with each group
containing 2000 datasets. For each of these groups, half the datasets have observations
generated with iid noise, e.g. just σ2y , and the other half with correlated errors based on
the structure of the FMDV and Influenza data, e.g. both σ2y and σ
2
ε . Additionally each
of the datasets contains two variables, one relevant, xr, and one irrelevant, xir. We have
then calculate the marginal likelihood of each of the four possible models, where we have
fixed σ2w and marginalised out σ
2
y and w, to give the probability of the irrelevant variable
being included in the final model, M, as follows:
P(xir ∈M) = p(y|xir) + p(y|xir,xr)
p(y|.) + p(y|xir,xr) + p(y|xr) + p(y|xir,xr) . (7.1)
Figure 7.1 gives box plots of the probability of the irrelevant variable, xir, being
included in the final model for each of the datasets from our small simulation study. The
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Table 7.2: Table of AUROC values for the eSABRE and the conjugate SABRE
methods when applied to the FMDV based simulated datasets. The table gives
AUROC values for the eSABRE and conjugate SABRE methods, where the results for
the conjugate SABRE method are given in brackets, when applied to the FMDV based
simulated datasets described in Section 7.1.2.
σ2ε
0.02 0.2 0.5
µw
-0.1 0.67 (0.69) 0.67 (0.60) 0.63 (0.57)
-0.3 0.72 (0.71) 0.70 (0.61) 0.67 (0.58)
-0.5 0.75 (0.72) 0.74 (0.64) 0.73 (0.57)
box plots show the affect on the probabilities caused by the different types of noise and
varied amounts of observations. Figure 7.1 shows that as the number of observations
increases the chance of the irrelevant variable being included decreases for the iid noise,
as would be expected. However for the non-iid noise based on the FMDV and Influenza
datasets, the results show an increase in the probability of the irrelevant variable being
included as the number of observations increases, indicating that the noise mismatch is
what causes the strange results in Table 7.1.
Finally, Table 7.1 shows the improvement the eSABRE method offers over the con-
jugate SABRE method in terms of computational efficiency. Table 7.1 shows how the
SABRE method becomes vastly more computationally expensive as the number of ob-
servations increases, while the require CPU hardly changes for the eSABRE method if
the number of pairs of challenge and protective strains remains the same. This improve-
ment in terms of computational efficiency explains why it is viable to use the eSABRE
method on the H1N1 dataset for example, where ||y|| = 15, 693 and P = 570, but not the
conjugate SABRE method or any of the other SABRE methods described in Chapter 4.
Table 7.2 shows the effectiveness of the eSABRE method on larger more realistic
datasets (Section 7.1.2) based on the real life FMDV data from Reeve et al. (2010). Like
Table 7.1, the results of Table 7.2 again show the eSABRE method clearly outperforming
the conjugate SABRE method across all of the simulated datasets from Section 7.1.2.
The results show that as the model error in the simulated data increases, the conjugate
SABRE seriously drops off in performance while the eSABRE method remains reasonably
consistent. Like with the results of Table 7.1, the difference in performance is again caused
by the mismatch between the conjugate SABRE and the underlying generation process
which the eSABRE method matches more closely.
To compare the methods described in Section 6.3, nWAIC, biWAIC and Bayesian
10-fold iCV, we have compared their performance in terms of correctly selecting random
effect factors on the datasets from Section 7.1.3. The results are given in Table 7.3 and
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Table 7.3: Table of results looking at the random effects factor selection per-
formance of the methods described in Section 6.3. The table gives results in terms
of the successful selection or exclusion of random effects factors when using the methods
described in Section 6.3, nWAIC, biWAIC and Bayesian 10-fold iCV, on parameter sam-
ples from the eSABRE method applied to the simulated data from Section 7.1.3. The
results given are sensitivity, specificity and F-scores and are displayed in an alternative
manner in Figures 7.2 and 7.3.
P σ2ε nWAIC biWAIC Bayesian 10-fold iCV
Sensitivity
55 0.1 0.90 0.97 0.92
55 0.3 0.92 0.90 0.89
55 0.5 0.78 0.71 0.93
465 0.1 0.97 0.94 0.85
465 0.3 0.86 0.84 0.86
465 0.5 0.95 0.90 0.86
1035 0.1 0.93 0.71 0.98
1035 0.3 0.91 0.79 0.87
1035 0.5 0.90 0.66 0.74
Specificity
55 0.1 0.68 0.56 0.15
55 0.3 0.70 0.60 0.41
55 0.5 0.59 0.54 0.26
465 0.1 0.45 0.60 0.66
465 0.3 0.49 0.63 0.63
465 0.5 0.37 0.56 0.53
1035 0.1 0.32 0.60 0.47
1035 0.3 0.33 0.52 0.33
1035 0.5 0.39 0.55 0.29
F-Score
55 0.1 0.80 0.80 0.65
55 0.3 0.88 0.84 0.79
55 0.5 0.72 0.66 0.70
465 0.1 0.70 0.75 0.73
465 0.3 0.70 0.74 0.75
465 0.5 0.73 0.76 0.72
1035 0.1 0.73 0.69 0.80
1035 0.3 0.77 0.74 0.75
1035 0.5 0.60 0.54 0.60
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Figure 7.2: Bar plot of F1-Scores given in Table 7.3. The bar plot compares the
F1-scores for nWAIC (white), biWAIC (grey) and Bayesian 10-fold iCV (black) in terms
of correctly selecting random effect components for the dataset described in Section 7.1.3.
The figure takes the results from Table 7.3.
are displayed visually in Figures 7.2 and 7.3.
The results in Table 7.3 show that all of the methods, nWAIC, biWAIC and Bayesian
10-fold iCV, perform similarly in terms of overall selection accuracy. The similarly is
best demonstrated by looking at the F1-scores, which offer a more general assessment of
performance than looking at specificity and sensitivity individually. The F1-scores from
Table 7.3 can also be seen in Figure 7.2 where the results are shown as box plots. With
the results from Table 7.3 and Figure 7.2 suggesting that the information criteria, nWAIC
and biWAIC, give similar selection performance to Bayesian 10-fold iCV, it is reasonable
to use one of the criteria on the Influenza dataset in Section 7.4 and 7.5, where Bayesian
10-fold iCV will be computationally onerous.
While suggesting that the methods perform similarly overall, Table 7.3 also indicates
that the methods operate with different thresholds, meaning that on average some meth-
ods include more random effect factors than others. This can be seen by looking at the
sensitivities and specificities of nWAIC, biWAIC and Bayesian 10-fold iCV in Table 7.3
or alternatively by looking at Figure 7.3. Figure 7.3 plots the sensitivities achieved by
the different methods on each set of datasets against the 1 minus specificities and shows
that the biWAIC method operates at a higher threshold for inclusion, meaning that it
selects less random effect factors in the model on average. This can be seen by noting
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Figure 7.3: Plot of sensitivities and 1 minus specificities for the results given in
Table 7.3. The plot compares nWAIC (circles), biWAIC (crosses) and Bayesian 10-fold
iCV (triangles) in terms of correctly selecting random effect components for the dataset
described in Section 7.1.3. The figure takes the results from Table 7.3 and plots the
sensitivities against the 1 minus specificities, i.e. as single point from a ROC curve.
the lower sensitivities and higher specificities in Figure 7.3 or Table 7.3.
The reason for the difference between nWAIC and biWAIC in terms of the average
number of random effect factors included is a result of the distribution from which they
measure the sample means and variances needed to calculate the criterion. nWAIC,
(6.29), takes its sample means and variances based on only the distribution of y, (6.2),
the distribution which contains the random effects specification. biWAIC, (6.31), however
takes its sample means and variances from the marginalised distribution of y where µy
has been integrated out as detailed in Section 6.3.2. As a result, like Bayesian 10-fold
iCV, biWAIC takes into account both the model fit of y and µy.
Taking into account both distributions of the latent variable likelihood, (6.2) and (6.3),
better assesses the fit of the model and prevents the overfitting of the first distribution
of the latent variable likelihood, (6.2). The results for nWAIC show that not accounting
for (6.3) as well as (6.2) leads to unrealistically high sensitivities and low specificities.
It is interesting however that we do not see a similar threshold with Bayesian 10-fold
iCV which also takes into account both parts of the latent variable likelihood. This is a
consequence of the different thresholds given by criteria based on WAIC and those based
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on CV. We observed this in Table 5.2 when we compared WAIC and Bayesian CV.
7.4 Results for the H1N1 Dataset
We have applied the eSABRE method to the H1N1 dataset using the 8 possible combi-
nations of random effect components. The biWAIC score was then calculated for each
of the models, Section 6.3, with the model with the best biWAIC score containing the
challenge strain and the date of the experiment as random effect components. biWAIC
was chosen to select the best model based on feasibility, it is far more computational
efficient than 10-fold Bayesian iCV, and the results from Table 7.3. Full results for the
variables selected by the eSABRE method are given in Table B.15, and in Table B.14 for
those selected by the conjugate SABRE method based on the reduced dataset described
in Section 5.1.7.
Having selected the model with the best selection of random effects, we have then
compared the results in terms of variable selection to those achieved by the SABRE
method on a reduced H1N1 dataset in Section 5.6. We do no compare our results with
those of Harvey et al. (2016) as those results were achieved on a larger dataset, see
Section 2.3.1, using a non-automated version of mixed-effects. Using the eSABRE method
we have selected 5 proven, 1 plausible and 1 implausible based on choosing a marginal
inclusion probability of 0.5, or 10 proven, 5 plausible and 2 implausible based on taking
the pˆiJ variable with the highest marginal inclusion probabilities. These results compare
to 5 proven, 1 plausible and 2 implausible or 11, 2 and 3 for the conjugate SABRE method
based on the same criteria. The results show the methods performing reasonably similarly,
however the eSABRE offers an improvement in terms of not selecting as many implausible
residues. The classification of these results is based on our biological knowledge of the
H1N1 serotype from Section 2.4.
Of the 10 proven residues, we have identified one residue on the Residual Binding Site
(RBS) as in Section 5.6 when using the conjugate SABRE method, residue 187 on the
H1 common alignment. Residue 187 is part of the the Sb antigenic site and we have also
identified two other nearby residues (189 and 190) on the same antigenic site. The other
proven residues come from the Ca (141, 142 and 170), Cb (69, 72 and 74) and Sa (130)
antigenic sites which also contain 4 of the plausible residues predicted to be antigenic
by the eSABRE method. These should potentially be investigated experimentally to
determine whether they are indeed antigenic residues. The final plausible residue is
related to a mutation resulting in one of the tested viruses and its potential antigenicity
can be attributed to 4 different residues, 3 of which are proven and one of which is
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implausible8, and it is possible that some of these residues may be antigenic.
7.5 Results for the H3N2 Dataset
As with the H1N1 dataset in Section 7.4, we have applied the eSABRE method and
biWAIC to the H3N2 dataset from Section 2.3.2 with 8 different combinations of random
effect components. biWAIC has indicated that the best possible model is the one that
contains all of the possible random effects factors; the challenge strain, the protective
strain and the date of the experiment. The full results for the eSABRE method applied
to the H3N2 dataset described in Section 2.3.2 are given in Table B.16. We do not
compare our results with those of Harvey (2016), as while they have used classical mixed-
effects models, they used a piecemeal approach which required manual intervention to
guide the selection procedure. The eSABRE method can be applied in a fully automatic
manner.
The results of our analysis of the H3N2 dataset from Section 2.3.2 using the eSABRE
method and biWAIC has resulted in the selection of 10 proven, 3 plausible and 2 implau-
sible residues, given here by their common alignments; see (Harvey et al., 2016). We have
ruled out one implausible residue based on the information given in Section 2.4.4. Of the
proven residues, we have identified 8 in the highly variable antigenic site B (155, 158,
159, 164, 189, 183, 193,197), and among these are residues known to part of the residual
binding site (Harvey, 2016). In addition we have also identified 2 other residues in the
C and E antigenic regions, 276 and 262 respectively. Of the plausible sites, one gives an
antigenic effect that could be explained by either a branch, an implausible residue or a
proven residue. While we have no specific evidence, it is highly likely that this antigenic
effect is a result of the the proven residue on the antigenic site E (75). The other two
plausible residues (279 and 212) come from areas close to the C and D antigenic sites,
with 212 next to a proven antigenic residue in the alignment and potentially worthy of
further investigation.
7.6 Discussion
In this chapter we have tested and analysed the eSABRE method proposed in Chapter 6.
We have tested it against the conjugate SABRE method proposed in Chapter 4 and
shown how it offers improved performance on a variety of different simulated datasets;
Tables 7.1 and 7.2. The results in Table 7.1 also demonstrate the computational improve-
ment offered by the eSABRE methods, as discussed in Chapter 6, and give examples as
8We classify this variable as plausible based on line 4 of Table 2.1
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to where the biggest computational improvements can be seen. In addition to testing
the eSABRE method, we have also looked at the best way of selecting random effects
coefficients. Table 7.3 and Figure 7.2 show that biWAIC, as proposed in Chapter 6,
performs equally well in terms of selecting the correct random effect factors as two more
established methods. Figure 7.3 then demonstrates how the biWAIC criterion properly
accounts for the entire latent variable distribution resulting in a more realistic number of
random effects factors being included.
Sections 7.4 and 7.5 demonstrate how the eSABRE method, together with biWAIC,
can be effectively applied to large real life Influenza datasets. In Section 7.4 we show
how the improvement in computational efficiency demonstrated in Table 7.1 allows us
to make use of the full H1N1 dataset rather than a reduced version as was required
for the conjugate SABRE method in Chapter 5. The results from using the full H1N1
dataset and properly accounting for the error in the data collection process through the
eSABRE method show an improvement in the selection of antigenic variables in the
H1N1 datasets. Finally Section 7.5 applies the eSABRE method and biWAIC to the
H3N2 dataset, identifying a number of proven and plausible antigenic residues, at the
expense of a small number of implausible residues.
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Chapter 8
Conclusions and Further Work
The aim of this thesis has been to create models that can address the problems caused
by antigenic variability. Based on this objective we have created models, Section 8.1,
which can use biological measure of antigenic variability to link genetic and phyloge-
netic changes to significant antigenic changes. We have proposed a family of models,
the SABRE methods, to this end, Section 8.1.1, and demonstrated the improved perfor-
mance they offer over the standard methods used. We have then extended this method
and proposed a new model, the eSABRE method, which gives an improvement in re-
sults, Section 8.1.2, and can provide accurate biological prediction on large datasets; see
Section 8.2. The following sections summarise the work that has been completed in this
thesis and Section 8.3 gives proposals for further work in the area.
8.1 Methodological Advances
In general, the methodological work from this thesis can be broken down into two parts;
the SABRE methods and the eSABRE method. The work related to the SABRE methods
in Section 8.1.1 is taken from Chapters 4 and 5, but this section also includes methods
proposed in Davies et al. (2016a) which were detailed in Chapter 3. The eSABRE method
was proposed and evaluated in Chapters 6 and 7, and is summarised here in Section 8.1.2.
8.1.1 The SABRE Methods
In Section 4.1 we introduced the original SABRE method, Figure 4.1, as proposed in
Davies et al. (2014). The SABRE method is a Bayesian hierarchical mixed-effects model
which can simultaneously account for the experimental effects of the data collection pro-
cess, and select the residues and evolutionary changes that affect the measured antigenic
variability. To select variables the SABRE method uses spike and slab priors, which have
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been shown to give improved variable selection over methods based on `1 regularisation
(Mohamed et al., 2012). We have demonstrated this improvement here through both
simulated and real life studies, Chapter 5, and have given a detailed explanation of the
reasons for this improvement in Section 4.4. To summarise, the improvement is a result of
(1) avoiding the bias inherent in `1 regularisation based methods, (2) the method giving
genuine and consistent sparsity, (3) properly accounting for uncertainty, and (4) through
borrowing strength from information coupling through the hierarchical structure seen in
Figure 4.1.
In the remainder of Chapter 4, we have investigated potential changes to the original
SABRE method that might lead to improved variable selection and sampling. We have
proposed three additional versions of the SABRE method; the semi-conjugate SABRE
method (Section 4.2.1), the conjugate SABRE method (Section 4.2.2) and the binary
mask conjugate SABRE method (Section 4.2.3). In Chapter 5 we have compared these
methods against each other and a number of alternative methods including the addi-
tional methods proposed in Davies et al. (2016a) and described in Chapter 3. The new
alternative methods extend the previously proposed mixed-effects LASSO (Schelldorfer
et al., 2011) to allow the specification of multiple random effects factors and propose the
alternative mixed-effects elastic net.
The semi-conjugate SABRE method given in Figure 4.2, improves the original SABRE
method by properly modelling the biologically significant intercept parameter. The in-
tercept is important as it gives the VN titre or HI assay measurement when a virus is
used as both the challenge and protective strain. The conjugate SABRE method given in
Figure 4.3 then increases the conjugacy of the semi-conjugate SABRE method by adding
additional edges between the error variance, σ2ε , and some of the parameters associated
with the regression coefficients, w∗γ and µw,h. The conjugate SABRE method also allows
for the possibility of improving the sampling scheme through collapsing; Section 4.3.6.
We have compared the semi-conjugate and conjugate SABRE methods in terms of accu-
racy, computational efficiency, and formal model selection preference in Table 5.1. The
results show that the differences in accuracy are negligible, Figure 5.4. Similarly there is
no significant difference in terms of computational efficiency, Figure 5.5, indicating that
the sampling of the latent indicator variables, γ, is the computational bottleneck of the
SABRE methods. In terms of model selection, WAIC showed a significant difference in
favour of the conjugate SABRE method, Table 5.1, but this has little impact on the
variable selection accuracy. Overall the similarity of the results supports the robustness
of the SABRE methods and its reliability in making predictions.
Chapter 5 also tested the difference between a model based on the binary mask model
and one using spike and slab priors; see Figure 3.2 in Section 3.3. While both meth-
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ods are discussed and used in the literature (Murphy, 2012), our work represents the
first quantification of the difference in performance between the two methods. We have
proposed the binary mask conjugate SABRE method, Figure 4.4, and tested it against
the conjugate SABRE method, Figure 4.3. Our systematic comparison quantifies the
differences between these methods in terms of accuracy and computational efficiency,
and found the differences to be negligible. Quantifying this result is important, as both
approaches have been used as variable selection methods in the literature, with authors
tending to arbitrarily chose one method or the other, e.g. Davies et al. (2014), Heydari
et al. (2016).
The work in Chapters 4 and 5 also looks at the computational bottleneck of the
SABRE methods, the sampling of γ. We have investigated the possibility of sampling
γ through a block Metropolis-Hastings sampler rather than the more commonly used
component-wise Gibbs sampler; Section 4.3.5. Our results in Section 5.4.5 show the com-
putational improvement offered by the block Metropolis-Hastings sampler. The results,
shown in Figures 5.10 and 5.11, indicate that sampling around 10 latent indicators at
time offers the most computational efficient sampling scheme.
Finally, we have demonstrated the conjugate SABRE method on real life FMDV
and Influenza datasets from Chapter 2. Our results find a number of known antigenic
residues and significant evolutionary changes, discussed in Section 8.1.2, and show that
the SABRE methods are accurate in silico methods that can be used to identify antigenic
residues and provide an effective way of modelling antigenic variability.
8.1.2 The Extended SABRE Method
In Chapter 6 we proposed the eSABRE method given in Figure 6.1. The eSABRE method
replaces the likelihood of the conjugate SABRE, (6.1), with one based on a latent variable
model, (6.2) and (6.3), which better accounts for the data generation process described
in Chapter 2. The eSABRE method takes into account the fact that for any given pair of
challenge and protective strains the fixed effects will remain the same and modelling this
properly leads to an improvement in terms of model accuracy by fulling account for the
error inherent in the data collection process. The method also has the advantage that
γ is d-separated from y via µy in Figure 6.1, offering an improvement in computational
efficiency in the sampling of γ; see Section 6.2.1.
In addition to the eSABRE method, we have also looked at different ways of selecting
the random effect factors in the eSABRE method. We have considered Bayesian 10-fold
integrated CV (iCV), a CV based method that integrates over the latent variables, µy,
to fully account for both parts of the latent variable likelihood, (6.2) and (6.3). We have
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compared this against the previously proposed non-integrated WAIC (nWAIC) (Li et al.,
2015), which naively applies WAIC to the part of the latent variable likelihood containing
the observations, (6.2). In addition we proposed our own criterion, block integrated WAIC
(biWAIC), based on integrated WAIC of Li et al. (2015), which integrates over the latent
variables, µy, to give a criterion which fully accounts for both distributions of the latent
variable likelihood of the eSABRE method.
In Chapter 7 we have tested the eSABRE method against the SABRE method and
biWAIC against nWAIC and Bayesian 10-fold iCV. The results of the simulation stud-
ies in Section 7.3 show that the eSABRE method outperforms the conjugate SABRE
method both in terms of variable efficiency and variable selection accuracy. Table 7.3
and Figure 7.2 additionally showed that biWAIC, nWAIC and Bayesian 10-fold iCV all
performed similarly in terms of correctly selecting random effect factors in the models and
in Figure 7.3 we have demonstrated the effect of accounting for the fit of the full latent
variable model in biWAIC. Finally we have demonstrated how the eSABRE method and
biWAIC can be applied to the Influenza datasets from Section 2.3 to provide relevant bi-
ological results in a situation where, due to the size of the datasets, applying the SABRE
methods of Chapter 4 would be computationally infeasible.
8.2 Biological Advances
In terms of direct biological improvements, in Section 2.1.3 we have proposed new methods
for understanding how evolutionary changes effect antigenicity. Previous methods, e.g.
Reeve et al. (2010) and Davies et al. (2014), included the branches of the phylogenetic
trees to account for any changes in the measured VN titre or HI assay that could not
be explained by the mutational changes. However where a particular branch separates
two virus strains which have been used as both challenge and protective strains, we
can include additional variables in the model and give a biological understanding of the
potential reasons for their inclusion. To summarise, we can include branch variables to
explain the effect amino acid substitutions at a particular phylogenetic branch have on the
challenge and protective strains carrying those amino acid substitutions, see Section 2.1.3
for further details, with branches also included to explain general antigenic effects not
described by the mutational changes. We have demonstrated this approach on the FMDV
datasets and have made predictions of the antigenically significant evolutionary changes
in both the SAT1 and SAT2 serotypes; Figures 5.8, 5.9 and 5.12. In the SAT1 serotype,
where prior knowledge of these changes is available, we have identified a number of
topotype defining branches and the biological effect they are having; Figures 5.8 and 5.9.
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The improved variable selection and modelling accuracy of the methods proposed in
Chapters 4 and 6 has resulted in more biological accurate predictions of the antigenic
residues and in the datasets for the FMDV serotypes we have identified a number of known
and potential antigenic residues. In the SAT1 serotype, using the extended SAT1 dataset,
we have been able to demonstrate the improved ability of the conjugate SABRE to select
antigenic residues over the previous work using mixed-effects models. We were able to
identify significantly more known antigenic residues than Maree et al. (2015), as well
as make a number of predictions of other residues that are potentially antigenic. In the
SAT2 serotype we made the first in silico prediction of potentially antigenic residues, with
Reeve et al. (2010) unable to identify any significant residues. Within these prediction we
were able to identify a number of potentially antigenic regions in need of further biological
experimentation.
In the Influenza datasets we were able to demonstrate the effectiveness of the eSABRE
method at properly accounting for the error inherent in the data collection process and
make use of the full H1N1 and H3N2 datasets from Section 2.3 through the computational
improvement the method offers. Our results on the H1N1 dataset show that we have
identified a number of known antigenic residues from the residual binding site and each
of the four known antigenic regions for that serotype. In the H3N2 dataset we have
again identified a large number of proven variables at the cost of only a small number of
implausible ones. We have identified residues from the residual binding site, as well as
from three of the main antigenic regions. We have also proposed additional residues as
antigenic in nearby areas of the virus shell.
8.3 Further Work
The models created and tested in this thesis give an accurate way of predicting antigenic
variability in order to identify antigenic residues and have been shown to work effectively
in both the FMDV and Influenza datasets. However increased accuracy and biological
understanding can be gained by creating extended models which can better approximate
the complex biological problem that we are modelling. From the biological viewpoint, it
would be valuable to extend the models to better account for four aspects of the biological
process associated with antigenic variability; (1) make better use of the genetic code of
the virus strains, (2) link the effects of the residues to their location on the virus shell,
(3) account better for the uncertainty in the phylogenetic trees, and (4) link the effects
of the evolution and residues together in more realistic manner. Additionally, from the
statistic methodology perspective, (5) it would be useful to improve the sampling of the
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latent binary variables, γ, in order to gain faster parameter convergence in any models
which could extend the eSABRE method.
At present our datasets, described in Chapter 3, consist only of indicators of muta-
tional changes that occur without any regard to the type of mutation; see Section 2.1.2.
This is addressed in Maree et al. (2015), (1), where the variables included indicate the
change in the genetic code. Adding this information into the models will allow us to
differentiate between different antigenic changes and enable us to better understand the
biological processes involved.
Including more information relating to the genetic code will lead to more information,
and therefore more variables, relating to the mutations being included in the models. It
may therefore be necessary to add additional information sharing between the latent
indicator variables, γ, to avoid selecting variables whose correlation with changes in
antigenicity are only through random chance, (2). Latent Gaussian processes can be used
to model this, where inference can be achieved in a variety of ways, e.g. Filippone et al.
(2013). The use of latent Gaussian processes would allow us to introduce correlations
between mutations of the same type or mutations occurring in similar location on the
surface of the virus shell. This can potentially allow us to identify which types of mutation
are important, and give us the ability to identify complete antigenic regions rather than
just individual residues.
We can also improve our model by better accounting for the uncertainty of the phy-
logenetic tree, (3). In this thesis we used single phylogentic trees taken from the original
publication of the FMDV and Influenza datasets (Harvey et al., 2016; Maree et al., 2015;
Reeve et al., 2010). In these papers, multiple trees were tested based on different biolog-
ical models with the best one selected using Bayes factors; see Section 2.3.2 in Harvey
(2016) for details. While choosing the best phylogenetic tree via Bayes factors may give
a good estimate of the true evolution of the serotypes, it does not account for the un-
certainty in this choice. Sampling different trees within our models provides one way of
accounting for this uncertainty, however this is likely to be computationally infeasible
and an approach based on model averaging may be more feasible.
While the eSABRE method (Chapter 6) better models the biological processes of
antigenic variation then the SABRE methods (Chapter 4), the eSABRE does not fully
account for the changes causing antigenic differences. Both the eSABRE and SABRE
methods treat the residues and evolutionary changes as equally likely to cause changes in
antigenicity, however this is an approximation of how the changes in antigenicity occur,
(4). In fact, the mutational changes are what is used to create the phylogenetic trees
in the first places, with the trees designed to best explain the genetic differences in
the residues. Therefore a more realistic model should see the mutational changes at the
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residues explaining the antigenic effects of the phylogenetic branch terms, with the branch
terms in turn explaining the the mean VN titre or HI assay measurement of each pair of
challenge and protective strains, µy. This would in essence require another layer in the
likelihood, with the likelihood being given in the form p(y|µy)p(µy|φ)p(φ|w), where φ
represents the phylogenetic branch terms and w the residue terms.
To implement any of the biological changes suggested above in the eSABRE method
would likely require an improvement in the sampling strategy to make the changes fea-
sible, (5). In this thesis we have identified that the sampling of the latent indicator
variables, γ, is the computational bottleneck of both the SABRE and eSABRE meth-
ods and so we would need to design an improved proposal method beyond the block
Metropolis-Hastings samplers tested in Section 4.3.5. For continuous variables, meth-
ods such as the Delayed Rejection Adaptive Metropolis (DRAM) algorithm of Haario
et al. (2006) have been proposed to take into account the posterior correlations between
the variables in the proposal scheme via a multivariate Gaussian distribution inferred
from the accepted parameter vector. Finding a similar method to this for binary vari-
ables would be useful for achieving faster parameter convergence in the more complex,
computationally onerous models proposed above.
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Appendix A
Posterior Distributions
In this appendix we derive the conditional distributions from Section 4.3 and 6.2 needed
to sample the parameters of the SABRE and eSABRE methods.
A.1 SABRE Methods
The conditional distribution derived here are laid out in a similar way to Section 4.3. In
Section A.1.1 we give the conditional distributions needed to sample the parameters of the
original SABRE method, with only the subsequent changes needed to adjust these distri-
butions given for the semi-conjugate, conjugate and binary mask conjugate methods in
Sections A.1.2, A.1.3 and A.1.4 respectively. Finally the conditional distributions needed
for the collapsing scheme described in Section 4.3.6 are given for both the conjugate and
binary mask conjugate SABRE method in Section A.1.5.
A.1.1 Original SABRE Method
Using standard results for conditional Gaussian distributions, e.g. Bishop (2006), and
Figure 4.1, we can calculate the conditional distributions of wγ , b and µw,h for the
original SABRE method, where we define θ to be a vector of all the parameters and
hyperparameters:
p(wγ |θ−wγ ,Xγ ,Z,y) ∝ N(y|Xγwγ + Zb, σ2εI)N(wγ |mwγ ,γ ,Σwγ ) (A.1)
∝ N(wγ |VwγX>γ (y− Zb)/σ2ε + VwγΣ−1wγµw,Vwγ ) (A.2)
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where we define Vwγ = (X
>
γXγ/σ
2
ε + Σ
−1
w )
−1,
p(b|θ−b,Xγ ,Z,y) ∝ N(y|Xγwγ + Zb, σ2εI)N(b|0,Σb) (A.3)
∝ N(b|VbZ>(y−Xγwγ)/σ2ε ,Vb) (A.4)
where we define Vb = (Z
>Z/σ2ε + Σ
−1
b )
−1, and
p(µw,h|θ−µw,h ,Xγ ,Z,y) ∝ N(wγ,h|1µw,h, σ2εσ2wγ ,hI)N(µw,h|µ0,h, σ2εσ20,h) (A.5)
∝ N(µw,h|Vµγ ,h(∑(wγ,h)/σ2w,h + µ0,h/σ20,h), σ2εVµγ ,h) (A.6)
where Vµγ ,h = ((||wγ,h||/σ2w,h)−1 + (σ20,h)−1)−1.
We can then calculate the conditional distributions of the variance parameters:
p(σ2w,h|θ−σ2w,h ,Xγ ,Z,y) ∝ N(wγ,h|1µw,h, σ2εσ2w,hI)IG(σ2w,h|αw,h, βw,h) (A.7)
∝ IG(σ2w,h| ||wγ,h||/2 + αw,h, βw,h + 12σ2ε
∑(wγ,h − 1µγ,h)2) (A.8)
where we sample for each h separately,
p(σ2b,g|θ−σ2b,g ,Xγ ,Z,y) ∝ N(bg|0, σ2b,gI)IG(σ2b,g|αb,g, βb,g) (A.9)
∝ IG(σ2b,g| ||bg||/2 + αb,g, βb,g + 12b>g bg) (A.10)
where we sample for each g separately, and
p(σ2ε |θ−σ2ε ,Xγ ,Z,y) ∼ N(y|Xγwγ + Zb, σ2εI)IG(σ2ε |αε, βε) (A.11)
∝ IG(σ2ε |N/2 + αε, βε + 12∑(y−Xγwγ − Zb)2) (A.12)
.
We can then get the conditional distribution of pi as follows:
p(pi|θ−pi,Xγ ,Z,y) ∝
{
J∏
j=1
Bern(γj|pi)
}
B(pi|αpi, βpi) (A.13)
∝ B(pi|αpi +∑γ, βpi + J −∑γ) (A.14)
and finally, via the application of standard Gaussian integrals, we have the distribution
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for γ as derived in Section 4.3.1:
p(γ|θ−γ ,Xγ ,Z,y) ∝ Bern(γ|pi)
∫
N(y|Xγwγ + Zb, σ2εI)N(wγ |µw,Σw)dwγ (A.15)
∝ pi
∑
γ(1− pi)J−
∑
γN(y|Xγµw + Zb, σ2εI + XγΣwX>γ ). (A.16)
.
A.1.2 Semi-Conjugate SABRE Method
The differences between the original SABRE method and the semi-conjugate SABRE
method can be seen by comparing Figures 4.1 and 4.2 in Chapter 4. To get the conditional
distributions for the semi-conjugate SABRE method we start with those given for the
original SABRE method in Section A.1.1 and replace (A.2), (A.4), (A.12) and (A.16)
with the distributions given below:
p(w∗γ |θ−w∗γ ,X∗γ ,Z,y) ∝ N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ ,Σw∗γ ) (A.17)
∝ N(w∗γ |VwγX>γ (y− Zb)/σ2ε + VwγΣ−1wγµw,Vw∗γ ) (A.18)
where we define Vw∗γ = (X
∗,>
γ X
∗
γ/σ
2
ε + Σ
−1
w∗)
−1,
p(b|θ−b,X∗γ ,Z,y) ∝ N(y|X∗γw∗γ + Zb, σ2εI)N(b|0,Σb) (A.19)
∝ N(b|VbZ>(y−X∗γw∗γ)/σ2ε ,Vb) (A.20)
where we again define Vb = (Z
>Z/σ2ε + Σ
−1
b )
−1,
p(σ2ε |θ−σ2ε ,X∗γ ,Z,y) ∝ N(y|X∗γw∗γ + Zb, σ2εI)IG(σ2ε |αε, βε) (A.21)
∝ IG(σ2ε |N/2 + αε, βε + 12∑(y−X∗γw∗γ − Zb)2), (A.22)
and finally the conditional distribution for γ original derived in Section 4.3.2
p(γ|θ−γ ,X∗γ ,Z,y) ∝
∫
β(pi|αpi, βpi) Bern(γ|pi)
N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ ,Σw∗γ )dpidwγ (A.23)
∝ Γ(||γ||+αpi)Γ(J−||γ||+βpi)
Γ(J+αpi+βpi)
N(y|X∗γmγ + Zb, σ2εI + X∗γΣw∗γX∗>γ ). (A.24)
117
A.1.3 Conjugate SABRE Method
The differences between the semi-conjugate SABRE method and the conjugate SABRE
method can be seen by comparing Figures 4.2 and 4.3 in Chapter 4. To get the conditional
distributions for the conjugate SABRE method we start with those used for the semi-
conjugate SABRE method in Sections A.1.1 and A.1.2. We then replace (A.18), (A.6),
(A.8), (A.22) and (A.24) with the following conditional distributions:
p(w∗γ |θ−w∗γ ,X∗γ ,Z,y) ∝ N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ , σ2εΣw∗γ ) (A.25)
∝ N(w∗γ |Vw∗γX∗>γ (y− Zb) + Vw∗γΣ−1w∗γmγ , σ2εVw∗γ ) (A.26)
where Vw∗γ = (X
∗>
γ X
∗
γ + Σ
−1
w∗γ )
−1,
p(µw,h|θ−µw,h ,X∗γ ,Z,y) ∝ N(wγ,h|1µw,h, σ2εσ2wγ ,hI)N(µw,h|µ0,h, σ2εσ20,h) (A.27)
∝ N(µw,h|Vµγ ,h(∑(wγ,h)/σ2w,h + µ0,h/σ20,h), σ2εVµγ ,h) (A.28)
where Vµγ ,h = ((||wγ,h||/σ2w,h)−1 + (σ20,h)−1)−1, and
p(σ2w,h|θ−σ2w,h ,X∗γ ,Z,y) ∝ N(wγ,h|1µw,h, σ2εσ2w,hI)IG(σ2w,h|αw,h, βw,h) (A.29)
∝ IG(σ2w,h| ||wγ,h||/2 + αw,h, βw,h + 12σ2ε
∑(wγ,h − 1µγ,h)2)
(A.30)
where we sample for each h separately.
We can then find the distribution for σ2ε , defining µ0 = (µ0,1, . . . , µ0,H)
> and Σ0 =
diag(σ20,1, . . . , σ
2
0,H):
p(σ2ε |θ−σ2ε ,X∗γ ,Z,y) ∝ N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ , σ2εΣw∗γ )
×N(µw|µ0, σ2εΣ0)IG(σ2ε |αε, βε) (A.31)
∝ IG(σ2ε |(N + ||w∗γ ||+H)/2 + αε, βε + 12Rσ2ε ). (A.32)
where H is the number of groups of regressors and
Rσ2ε = (y−X∗γw∗γ − Zb)>(y−X∗γw∗γ − Zb)
+ (w∗γ −mγ)>Σ−1w∗γ (w∗γ −mγ) + (µw − µ0)>Σ−10 (µw − µ0) (A.33)
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In order to improve mixing and convergence, Davies et al. (2014) used a collapsing step
over w∗γ when sampling γ, via the application of standard Gaussian integrals, e.g. Bishop
(2006), following Sabatti and James (2005). Doing this should result in an improvement
in computational efficiency and we have therefore also integrated over pi here via an
application of Beta-Bernoulli models:
p(γ|θ−γ ,X∗γ ,Z,y) ∝
∫
p(γ, pi,w∗γ |θ′,X∗γ ,Z,y)dw∗γdpi (A.34)
∝
∫
p(γ|pi)p(pi)p(y|w∗γ ,X∗γ ,Z,y)p(w∗γ)dw∗γdpi (A.35)
∝
∫
N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ , σ2εΣw∗γ ){
J∏
j=1
Bern(γj|pi)
}
B(pi|αpi, βpi)dw∗γdpi (A.36)
∝ Γ(||γ||+ αpi)Γ(J − ||γ||+ βpi)
Γ(J + αpi + βpi)
∫
N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ , σ2εΣw∗γ )dwγ
(A.37)
∝ Γ(||γ||+ αpi)Γ(J − ||γ||+ βpi)
Γ(J + αpi + βpi)
N(y|X∗γmγ + Zb, σ2ε [I + X∗γΣw∗γX∗>γ ]). (A.38)
In addition to the conditional distributions for the standard conjugate SABRE method,
we also need to calculate the conditional distributions for the half-t random-effect priors
as follows:
p(η|θ−η,X∗γ ,Z,y) ∝ N(y|X∗γw∗γ + Zηξ, σ2εI)N(η|0,Ση) (A.39)
∝ N(η| ξ
σ2ε
VηZ
>(y−X∗γw∗γ),Vη) (A.40)
where Vη = (
ξ2
σ2ε
Z>Z + Σ−1η )
−1.
p(ξ|θ−ξ,X∗γ ,Z,y) ∝ N(y|X∗γw∗γ + Zηξ, σ2εI)N(ξ|µξ, σ2ξ ) (A.41)
∝ N(ξ|Vξ[µξσ2ξ +
1
σ2ε
η>Z>(y−X∗γw∗γ)], Vξ) (A.42)
where Vξ = (
1
σ2ξ
+ 1
σ2ε
η>Z>Zη)−1.
p(σ2η,g|θ−σ2η,g ,X∗γ ,Z,y) ∝ N(ηg|0, σ2η,gI)IG(σ2η,g|αη,g, βη,g) (A.43)
∝ IG(σ2η,g|||ηg||/2 + αη,g, βη,g + 12η>g ηg) (A.44)
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where we sample for each g separately. These distributions replace (A.20) and (A.10) in
the sampling scheme of the conjugate SABRE method described above, and we addition-
ally set b = ηξ and σ2b,g = ξ
2σ2η,g in the other conditional distributions.
A.1.4 Binary Mask Conjugate SABRE Method
The differences between the conjugate SABRE method and the binary mask conjugate
SABRE method can be seen by comparing Figures 4.3 and 4.4 in Chapter 4. While
the models are reasonably similar the conditional distributions are not with only the
distributions for σ2b,g and pi remaining the same; (A.10) and (A.14). Here we give the
remaining distributions required for the binary mask conjugate SABRE method:
p(w∗|θ−w∗ ,X∗,Z,y) ∝ N(y|1w0 + XΓw + Zb, σ2εI)N(w∗|m, σ2εΣw∗) (A.45)
∝ N(w∗|Vw∗Γ∗>X∗>(y− Zb) + Vw∗Σ−1w∗m, σ2εVw∗) (A.46)
where we define Vw∗ = (Γ
∗>X∗>X∗Γ + Σ−1w∗)
−1,
p(b|θ−b,X∗,Z,y) ∝ N(y|1w0 + XΓw + Zb, σ2εI)N(b|0,Σb) (A.47)
∝ N(b| 1
σ2ε
VbZ
>(y−X∗Γ∗w∗),Vb) (A.48)
where we define Vb = (
1
σ2ε
Z>Z + Σ−1b )
−1,
p(µw,h|θ−µw,h ,X∗,Z,y) ∝ N(wh|1µw,h, σ2εσ2wγ ,hI)N(µw,h|µ0,h, σ2εσ20,h) (A.49)
∝ N(µw,h|V −1µ,h (∑(wh)/σ2w,h + µ0,h/σ20,h), σ2εVµ,h) (A.50)
where we define Vµ,h = ((||wh||/σ2w,h)−1 + (σ20,h)−1)−1 and sample separately for each h,
p(σ2w,h|θ−σ2w,h ,X∗,Z,y) ∝ N(wh|1µw,h, σ2εσ2wγ ,hI)IG(σ2w,h|αw,h, βw,h) (A.51)
∝ IG(σ2w,h| ||wh||/2 + αw,h, βw,h + 12σ2ε (wh − 1µw,h)
>(wh − 1µw,h)) (A.52)
where we again sample separately for each h, and
p(σ2ε |θ−σ2ε ,X∗,Z,y) ∝ N(y|1w0 + XΓw + Zb, σ2εI)N(w∗|m, σ2εΣw∗)
N(µw|µ0, σ2εΣ0)IG(σ2ε |αε, βε) (A.53)
∝ IG(σ2ε |(N + ||w∗||+H)/2 + αε, βε + 12Rσ2ε ) (A.54)
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where Rσ2ε = (y−X∗Γ∗w∗−Zb)>(y−X∗Γ∗w∗−Zb)+(w∗−m)>Σ−1w∗(w∗ −m)+(µw−
µ0)
>Σ−10 (µw − µ0).
Finally the distribution of γ is given by
p(γ|θ−γ ,X∗,Z,y) ∝
∫
β(pi|αpi, βpi) Bern(γ|pi)
N(y|X∗Γ∗w∗ + Zb, σ2εI)N(w∗|m, σ2εΣw∗)dpidwγ (A.55)
∝ Γ(||γ||+αpi)Γ(J−||γ||+βpi)
Γ(J+αpi+βpi)
N(y|X∗Γ∗m + Zb, σ2ε [I + X∗Γ∗Σw∗γΓ∗>X∗>]) (A.56)
as originally defined in Section 4.3.4.
A.1.5 Conjugate Sampling Scheme
In the conjugate and binary mask conjugate model we can make use of the conjugate
sampling strategy proposed in Section 4.3.6. In the conjugate sampling scheme, the
conditional distribution of γ is found by integrating over both σ2ε and µwas well as those
parameters marginalised Section A.1.3 and A.1.4; w∗γ and pi. This collapsing is possible
due to the conjugate prior specification of w∗γ and µw in both methods; see Figures 4.3
and 4.4. This step is not feasible in either the original SABRE method or the semi-
conjugate SABRE method.
The distribution of γ for the conjugate SABRE method is given as follows:
p(γ|θ−γ ,X∗γ ,Z,y) ∝
∫
p(γ, pi, σ2ε ,w
∗
γ ,µw|θ′,X∗γ ,Z,y)dµwdw∗γdpidσ2ε (A.57)
∝
∫
p(γ|pi)p(pi)p(y|w∗γ , σ2ε ,X∗γ ,Z,y)p(w∗γ |µw, σ2ε)p(µw)p(σ2ε)dµwdw∗γdpidσ2ε (A.58)
∝ Cpi
∫
N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ , σ2εΣw∗γ )N(µw|µ0, σ2εΣ0)
IG(σ2ε |αε, βε)dµwdw∗γdσ2ε (A.59)
∝ Cpi
∫
N(y|X∗γw∗γ + Zb, σ2εI)N(w∗γ |mγ,0, σ2ε [Σw∗γ + Vγ,0])
IG(σ2ε |αε, βε)dw∗γdσ2ε (A.60)
∝ Cpi
∫
N(y|X∗γmγ,0 + Zb, σ2ε [I + X∗γ [Σw∗γ + Vγ,0]X∗,>γ ])IG(σ2ε |αε, βε)dσ2ε (A.61)
∝ Cpi|Σγ |−
1
2 [βε +
1
2
(y−X∗γmγ,0 − Zb)>Σ−1γ (y−X∗γmγ,0 − Zb)]−(N/2+αε) (A.62)
where Cpi =
Γ(||γ||+αpi)Γ(J−||γ||+βpi)
Γ(J+αpi+βpi)
, Σγ = [I + X
∗
γ [Σw∗γ + Vγ,0]X
∗>
γ ], mγ,0 = (µw0 , µ0,1, . . . ,
µ0,1, µ0,2, . . . , µ0,H)
> with each µ0,h repeated with length ||wγ,h|| dependent on γ, and
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Vγ,0 is a block diagonal matrix of (0, σ
2
0,1, σ
2
0,2, . . . , σ
2
0,H) where the square blocks have
length 1, ||wγ,1||, . . . , ||wγ,H || respectively.
We can use the Woodbury identity and the extended Sylvester’s determinant theorem
to speed up the computations and give the following conditional posterior distribution:
log p(γ|θ−γ ,X∗γ ,Z,y) ∝ log Γ(||γ||+ αpi) + log Γ(J − ||γ||+ βpi)
− log Γ(J + αpi + βpi)− 12 log |Σw∗γ + Vγ,0| − 12 log |[Σw∗γ + Vγ,0]−1 + X∗>γ X∗γ |
− (N
2
+ αε) log(βε +
1
2
(y−X∗γmγ,0 − Zb)>
[I−X∗γ([Σw∗γ + Vγ,0]−1 + X∗γX∗>γ )−1X∗>γ )](y−X∗γmγ,0 − Zb)). (A.63)
This was also done with the conditional distribution of γ for the original and semi-
conjugate SABRE methods in Sections A.1.1 and A.1.2.
In addition to the conditional distribution of γ we must also derive distributions for
σ2ε and µw. We do not need to derive conditional distributions for wγ and pi as they are
identical to those given in (A.26) and (A.14).
p(σ2ε |γ,θ−σ2ε ,X∗γ ,Z,y) ∝ N(y|X∗γmγ,0 + Zb, σ2εΣγ)IG(σ2ε |αε, βε) (A.64)
∝ IG(σ2ε |||y||/2 + αε, βε + 12(y−X∗γmγ,0 − Zb)>Σ−1γ (y−X∗γmγ,0 − Zb)) (A.65)
where the first distribution is taken from the derivation of the conditional distribution of
γ.
p(µw|σ2ε ,γ,θ−µw ,X∗γ ,Z,y)
∝ N(y|1µw0 + XγMγ,µµw + Zb, σ2ε [I + X∗γΣw∗γX∗>γ ])N(µw|µ0, σ2εΣ0) (A.66)
∝ N(µw|Vµγ,w [Σ−10 µ0 + M>γ,µX>γ [I + X∗γΣw∗γX∗>γ ]−1(y− 1µw0 − Zb)], σ2εVµγ,w)
(A.67)
where the first distribution is again taken from the derivation of the conditional distri-
bution of γ and Vµγ,w = [Σ
−1
0 + M
>
γ,µX
>
γ [I + X
∗
γΣw∗γX
∗>
γ ]
−1XγMγ,µ]−1. Mµ, required
for (A.72), is a matrix of indicators where each element mµ,j,h is 1 for any wj,h in group
h and 0 otherwise, where Mγ,µ only includes the relevant elements dependent on γ. For
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example:
Mµ =

1 0
1 0
0 1
0 1
0 1
 ; Mγ,µ =
1 00 1
0 1
 ; w =

w1,1
w2,1
w3,2
w4,2
w5,2
 ; wγ =
w1,1w3,2
w5,2
 ; γ =

γ1 = 1
γ2 = 0
γ3 = 1
γ4 = 0
γ5 = 1
 . (A.68)
We can calculate the log conditional distribution of γ for the binary mask conjugate
SABRE method the same way we did for the conjugate SABRE method:
log p(γ|θ−γ ,X∗,Z,y) ∝ log
∫
p(γ|pi)p(pi)p(y|w∗,γ,b, σ2ε ,X∗γ ,Z,y)p(w∗|µw, σ2ε)
p(µw|σ2ε)p(σ2ε)dµwdw∗γdpidσ2ε (A.69)
∝ log Γ(||γ||+ αpi) + log Γ(J − ||γ||+ βpi)
− log Γ(J + αpi + βpi)− 12 log |Σw∗ + V0| − 12 log |[Σw∗ + V0]−1 + Γ∗>X∗>XΓ∗|
− (N
2
+ αε) log(βε +
1
2
(y−X∗Γ∗m0 − Zb)>
[I−X∗Γ∗>([Σw∗ + V0]−1 + X∗Γ∗Γ∗>X∗>)−1Γ∗>X∗](y−X∗Γ∗m0 − Zb)). (A.70)
where m0 = (µw0 , µ0,1, . . . , µ0,1, µ0,2, . . . , µ0,H)
> with each µ0,h repeated with length ||wh||
not dependant on γ and V0 is a block diagonal matrix of (0, σ
2
0,1, σ
2
0,2, . . . , σ
2
0,H) where
the square blocks have length 1, ||w1||, . . . ||wH || respectively.
Finally we can calculate the collapsing steps for the conditional distributions of σ2ε
and µw:
p(σ2ε |γ−σ2ε ,θ−σ2ε ,X∗,Z,y)
∝ IG(σ2ε |||y||/2 + αε, βε + 12(y−X∗Γ∗m0 − Zb)>Σ−1γ (y−X∗Γ∗m0 − Zb)) (A.71)
p(µw|σ2ε ,γ,θ−µw ,X∗,Z,y) ∝
N(µw|Vµw [Σ−10 µ0 + M>µΓ>X>[I + X∗Γ∗Σw∗γΓ∗>X∗>]−1(y− 1µw0 − Zb)], σ2εVµw)
(A.72)
where Vµw = [Σ
−1
0 + M
>
µXΓ
>[I + X∗Γ∗Σw∗γΓ
∗>X∗>]−1XγMµ]−1.
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A.2 eSABRE Method
The conditional distributions for the eSABRE method in Chapter 6 can again be found
by using some of the basic results from standard textbooks, e.g. Murphy (2012), where we
define X∗γ = (1,Xγ), mγ = (µw0 , µw,1, . . . , µw,1, µw,2, . . . , µw,H)
> and Σw∗γ = diag(σ
2
w∗)
with σ2w∗ = (σ
2
w0
, σ2w,1, . . . , σ
2
w,1, σ
2
w,2, . . . , σ
2
w,H)
>.
Using standard results for conditional Gaussian distributions and Figure 6.1, we can
calculate the conditional distributions for µy, w
∗
γ , b and µw , where we define θ to be a
vector of all the parameters and hyperparameters::
p(µy|θ−µy ,X∗γ ,M,Z,y) ∝ N(y|Mµy + Zb, σ2yI)N(µy|1w0 + Xγwγ , σ2εI) (A.73)
∝ N(µy|Vy(M>(y− Zb)/σ2y + X∗γw∗γ/σ2ε),Vy) (A.74)
where Vy = (1/σ
2
εI + M
>M/σ2y)
−1.
p(w∗γ |θ−w∗γ ,X∗γ ,M,Z,y) ∝ N(µy|X∗γw∗γ , σ2εI)N(w∗γ |mγ , σ2εΣw∗γ ) (A.75)
∝ N(w∗γ |Vw∗γX∗>γ µy + Vw∗γΣ−1w∗γmγ , σ2εVw∗γ ) (A.76)
where Vw∗γ = (X
∗>
γ X
∗
γ + Σ
−1
w∗γ )
−1.
p(b|θ−b,X∗γ ,M,Z,y) ∝ N(y|Mµy + Zb, σ2yI)N(b|0,Σb) (A.77)
∝ N(b| 1
σ2y
VbZ
>(y−Mµy),Vb) (A.78)
where Vb = (
1
σ2y
Z>Z + Σ−1b )
−1.
p(µw|θ−µw ,X∗γ ,M,Z,y) ∝ N(wγ |1µw, σ2εσ2wI)N(µw|µ0, σ20σ2ε) (A.79)
∝ N(µw|Vµw(1wγ/σ2w + µ0/σ20), σ2εVµw) (A.80)
where Vµw = (1/σ
2
0 + ||wγ ||/σ2w)−1.
We can then calculate the conditional distributions of the variance parameters:
p(σ2y|θσ2y ,X∗γ ,M,Z,y) ∝ N(y|Mµy + Zb, σ2yI)IG(σ2y|αy, βy) (A.81)
∝ IG(σ2y| ||y||/2 + αy, 12(y−Mµy − Zb)>(y−Mµy − Zb)) (A.82)
124
p(σ2w|θ−σ2w ,X∗γ ,M,Z,y) ∝ N(wγ |Iµw, σ2εσ2wI)IG(σ2w|αw, βw) (A.83)
∝ IG(σ2w| ||wγ ||/2 + αw, 12σ2ε (wγ − Iµw)
>(wγ − Iµw)) (A.84)
p(σ2b,g|θ−σ2b,g ,X∗γ ,M,Z,y) ∝ N(bg|0, σ2b,gI)IG(σ2b,g|αb,g, βb,g) (A.85)
∝ IG(σ2b,g| ||bg||/2 + αb,g, βb,g + 12b>g bg) (A.86)
where we sample for each g separately.
p(σ2ε |θ−σ2ε ,X∗γ ,M,Z,y)
∝ N(µy|X∗γw∗γ , σ2εI)N(w∗γ |mγ , σ2εΣw∗γ )N(µw|µ0, σ2εσ20)IG(σ2ε |αε, βε) (A.87)
∝ IG(σ2ε |(||µy||+ ||w∗γ ||+ 1)/2 + αε, βε + 12Rσ2ε ). (A.88)
where we give Rσ2ε as:
Rσ2ε = (µy −X∗γw∗γ)>(µy −X∗γw∗γ)
+ (w∗γ −mγ)>Σ−1w∗γ (w∗γ −mγ) + (µw − µ0)>(µw − µ0)/σ20 (A.89)
Finally we calculate the distribution for pi:
p(pi|θ−pi,X∗γ ,M,Z,y) ∝
{
J∏
j=1
Bern(γj|pi)
}
B(pi|αpi, βpi) (A.90)
∝ β(pi| αpi + ||γ||, βpi + J − ||γ|). (A.91)
A.2.1 Sampling γ
In order to sample γ we use collapsing methods as detailed in Section 6.2. Following the
method proposed in Davies et al. (2016a) we integrate over µw, w
∗
γ , pi, and σ
2
ε , however
in the case of the eSABRE method are left with a conditional distribution that includes
µy but not y, leading to the increased computational efficiency discussed and tested in
Chapters 6 and 7:
p(γ|θ−γ ,X∗γ ,M,Z,y) ∝
∫
p(γ, pi, σ2ε ,w
∗
γ , µw|θ′,X∗γ ,Z,y)dµwdw∗γdpidσ2ε (A.92)
∝
∫
p(γ|pi)p(pi)p(µy|w∗γ , σ2ε ,X∗γ)p(w∗γ |µw, σ2ε)p(µw)p(σ2ε)dµwdw∗γdpidσ2ε (A.93)
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∝ Cpi
∫
N(µy|X∗γw∗γ , σ2εI)N(w∗γ |mγ , σ2εΣw∗γ )N(µw|µ0, σ2εσ20)
IG(σ2ε |αε, βε)dµwdw∗γdσ2ε (A.94)
∝ Cpi
∫
N(µy|X∗γw∗γ , σ2εI)N(w∗γ |mγ,0, σ2ε [Σw∗γ + Vγ,0])
IG(σ2ε |αε, βε)dw∗γdσ2ε (A.95)
∝ Cpi
∫
N(µy|Xγmγ,0, σ2ε [I + Xγ [Σw∗γ + Vγ,0]X>γ ])IG(σ2ε |αε, βε)dσ2ε (A.96)
∝ Cpi|Σγ |−
1
2 [βε +
1
2
(µy −X∗γmγ,0)>Σ−1γ (µy −X∗γmγ,0)]−(N/2+αε) (A.97)
where Cpi =
Γ(||γ||+αpi)Γ(J−||γ||+βpi)
Γ(J+αpi+βpi)
, Σγ = [I+X
∗
γ [Σw∗γ+Vγ,0]X
∗>
γ ], mγ,0 = (µw0 , µ0, . . . , µ0)
>
with µ0 repeated with length ||wγ || dependent on γ, and Vγ,0 is a block diagonal matrix
of (0, σ20) where the square blocks have length 1 and ||wγ || respectively.
We can again use the Woodbury identity and the extended Sylvester’s determinant
theorem to speed up the computations and give the following conditional posterior dis-
tribution:
log p(γ|θ−γ ,X∗γ ,M,Z,y) ∝ log Γ(||γ||+ αpi) + log Γ(J − ||γ||+ βpi)
− log Γ(J + αpi + βpi)− 12 log |Σw∗γ + Vγ,0| − 12 log |[Σw∗γ + Vγ,0]−1 + X∗>γ X∗γ |
− (N
2
+ αε) log(βε +
1
2
(µy −X∗γmγ,0)>
[I−X∗γ([Σw∗γ + Vγ,0]−1 + X∗γX∗>γ )−1X∗>γ )](µy −X∗γmγ,0)). (A.98)
A.2.2 Collapsing Within Conditional Distributions
In order to sample the eSABRE method via the collapsing scheme suggested in Section 6.2
we must derive the collapsed conditional distributions for σ2ε and µw. The conditional
distribution of γ is derived in Section A.2.1, while (A.75) and (A.90) in Section A.2 give
the distributions for pi and w∗γ . The conditional distribution for σ
2
ε can then be derived
as follows:
p(σ2ε |γ,θ−σ2ε ,X∗γ ,M,Z,y) ∝ N(µy|X∗γmγ,0, σ2εΣγ)IG(σ2ε |αε, βε) (A.99)
∝ IG(σ2ε |||µy||/2 + αε, βε + 12(µy −X∗γmγ,0)>Σ−1γ (µy −X∗γmγ,0)) (A.100)
where the first distribution is taken from results in Section A.2.1 and the definitions of
mγ,0 and Σγ are given in Section A.2.1. Finally we can give the conditional distribution
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of µw as follows:
p(µw|σ2ε ,γ,θ−µwX∗γ ,M,Z,y)
∝
∫
N(µy|X∗γw∗γ , σ2εI)N(w∗γ |mγ , σ2εΣw∗γ )N(µw|µ0, σ2εσ20)dw∗γ (A.101)
∝ N(µy|1µw0 + Xγ1µw, σ2ε [I + X∗γΣw∗γX∗,>γ ])N(µw|µ0, σ20) (A.102)
∝ N(µw|Vµw [µ0/σ20 + 1>X>γ [I + X∗γΣw∗γX∗,>γ ]−1(µy − 1µw0)], σ2εVµw) (A.103)
where Vµγ,w = [1/σ
2
0 + 1
>X>γ [I + X
∗
γΣw∗γX
∗>
γ ]
−1Xγ1]−1.
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Appendix B
Further Results
In this appendix we give extended results for the simulation studies in Chapter 5. We also
give complete lists of results for the FMDV and Influenza datasets we have analysed in
Chapters 5 and 7, these results include the common alignments of the individual residues
and branches that were selected (Davies et al., 2016a).
B.1 Extended Simulation Study Results
The tables given in this section relate to the work completed in Section 5.3 of Chapter 5.
The tables are adapted from Davies et al. (2016a) and contain result for for different
values of α for the elastic net and alternative measures of performance to those discussed
in Section 5.3. For completeness and comparability, many of the related results from
Section 5.3 are also given here.
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Table B.1: Table of Extended Simulation Study Results - Part 1. The table gives
results for the Conjugate, Semi-Conjugate and BM Conjugates SABRE methods, the
mixed-effects LASSO, the mixed-effects elastic net with α ∈ {0.2, 0.3, 0.4, 0.5, 0.6, 0.8} and
the classical mixed-effects models applied to the simulated data described in Section 5.1.2.
The table gives the mean AUROC value based on ordering the variables (OV) and model
selection (MS).
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Table B.2: Table of Extended Simulation Study Results - Part 2. The table gives
results for the Conjugate, Semi-Conjugate and BM Conjugates SABRE methods, the
mixed-effects LASSO, the mixed-effects elastic net with α ∈ {0.2, 0.3, 0.4, 0.5, 0.6, 0.8} and
the classical mixed-effects models applied to the simulated data described in Section 5.1.2.
The table gives the MSEs of the out-of-sample observations, yout, and the MSEs of the
fixed effects coefficients, w.
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Table B.3: Table of Extended Simulation Study Results - Part 3. The table gives
results for the Conjugate, Semi-Conjugate and BM Conjugates SABRE methods, the
mixed-effects LASSO, the mixed-effects elastic net with α ∈ {0.2, 0.3, 0.4, 0.5, 0.6, 0.8} and
the classical mixed-effects models applied to the simulated data described in Section 5.1.2.
The table gives the MSEs of the random effects coefficients, b, and the mean WAIC scores
for each method.
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Table B.4: Table of P-Values for the Simulation Study Results - Part 1. The
table gives the results for paired t-tests where the Conjugate SABRE is compared against
each of the other methods; the Semi-Conjugate and BM Conjugates SABRE methods,
the mixed-effects LASSO, the mixed-effects elastic net with α ∈ {0.2, 0.3, 0.4, 0.5, 0.6, 0.8}
and classical mixed-effects models. The table gives the p-values for comparing the mean
AUROC value based on ordering the variables (OV) and model selection (MS).
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Table B.5: Table of P-Values for the Simulation Study Results - Part 2. The
table gives the results for paired t-tests where the Conjugate SABRE is compared against
each of the other methods; the Semi-Conjugate and BM Conjugates SABRE methods,
the mixed-effects LASSO, the mixed-effects elastic net with α ∈ {0.2, 0.3, 0.4, 0.5, 0.6, 0.8}
and classical mixed-effects models. The table gives the p-values for comparing the MSEs
of the out-of-sample observations, yout and the MSEs of the fixed effects coefficients, w
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Table B.6: Table of P-Values for the Simulation Study Results - Part 3. The
table gives the results for paired t-tests where the Conjugate SABRE is compared against
each of the other methods; the Semi-Conjugate and BM Conjugates SABRE methods,
the mixed-effects LASSO, the mixed-effects elastic net with α ∈ {0.2, 0.3, 0.4, 0.5, 0.6, 0.8}
and classical mixed-effects models. The table gives the p-values for comparing the MSEs
of the random effects coefficients, b, and the mean WAIC scores with the conjugate
SABRE for each method.
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B.2 Foot-and-Mouth Disease Virus Data
This section gives a complete list of results for all the real datasets discussed in the
main paper. Tables B.7, B.9 and B.11 give full lists of results for the original SAT1,
extended SAT1 and SAT2 datasets based on taking the top Jpˆi variables from the model.
Tables B.8, B.10 and B.12 give similar results for when only the branch variables are used.
Finally Figure B.1 gives the complete phylogenetic tree for the extended SAT1 dataset
when the Jpˆi variables with the highest predicted marginal probability of inclusion are
used, as opposed to any variables with greater than 0.5 predicted marginal inclusion
probability as shown in Figure 8b of the main paper.
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Figure B.1: Phylogenetic tree indicating significant branches in the evolution-
ary history of the SAT1 serotype at a low threshold. The phylogenetic tree was
created using BEAST v1.7.2 and FigTree v1.4.2 from aligned nucleotide sequence data
with date of isolation. Marked on the tree are protective strains (*) and topotype defining
branches (dashed vertical line). Branches inferred by the SABRE method are highlighted
(black). Symbols indicate whether this was inferred to be a change in virus antigenicity
(†), virus reactivity (‡) or virus immunogenicity (§). Where a highlighted branch has
no symbol, an associated change in antigenicity or reactivity could not be discriminated
between. The cut-off for significance was taken to be the Jpˆi variables with the highest
probability of inclusion given in Table B.10.
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Table B.7: Selected variables using the original SAT1 data with challenge strain
and antiserum used as random effects factors. The table gives a list of the variables
selected using the conjugate SABRE method with a cut-off of Jpˆi. Additionally the cut-
off at 0.5 is marked by a horizontal line. Residues are given by their protein sequence
alignment (Reeve et al., 2010), where for instance VP3 138 is position 138 on the VP3
protein. Branches are given as to indicate: a reactivity effect associated with the challenge
strain (react), an immunogenic effect of the protein strain (immun), an antigenic effect
(anti) or an unknown effect which is either a reactivity or antigenic effect (bran). More
details on the types of branches can be found in Section 2.1.3 and the labelled phylogenetic
tree for this dataset is given in Figure 2.2.
Variable Inclusion Prob. Plausibility Complete Correlations
VP2 74 0.87 Proven -
VP3 74 0.51 Plausible -
bran 1A 0.50 Plausible -
VP1 143 0.49 Proven -
VP1 189 0.48 Plausible -
bran 2A 0.46 Proven VP3 177; VP2 82; VP1 201;
VP2 131; VP2 187; VP3 141
VP1 47 0.45 Plausible -
bran 0014 0.45 Plausible -
VP3 193 0.43 Plausible -
VP1 150 0.43 Proven -
VP1 62 0.41 Proven bran 1C
VP3 67 0.38 Plausible -
VP3 9 0.38 Implausible -
VP2 198 0.37 Plausible -
VP3 199 0.35 Plausible bran 0002
VP1 149 0.35 Proven -
react 3A 0.34 Plausible -
anti 0013 0.32 Plausible -
VP1 219 0.31 Proven -
VP3 72 0.31 Proven -
VP3 77 0.31 Proven -
VP2 79 0.30 Proven VP2 81; bran 0007
VP3 176 0.30 Plausible -
bran 2C 0.29 Plausible -
VP3 171 0.29 Plausible -
bran 1F 0.29 Plausible -
bran 0011 0.28 Plausible -
VP1 144 0.28 Proven -
VP1 216 0.28 Proven -
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Table B.8: Selected variables using the original SAT1 branch data with chal-
lenge strain and antiserum used as random effects factors. The table gives a
list of the variables selected using the conjugate SABRE method with a cut-off of Jpˆi.
Branches are given as to indicate: a reactivity effect associated with the challenge strain
(react), an immunogenic effect of the protein strain (immun), an antigenic effect (anti)
or an unknown effect which is either a reactivity or antigenic effect (bran). More details
on the types of branches can be found in Section 2.1.3. The labelled phylogenetic tree
for this dataset is given in Figure 2.2 here and the inferred phylogenetic tree in Figure 8a
of the main paper.
Variable Inclusion Prob. Complete Correlations
anti 0013 1 -
anti 0010 0.99 -
anti 0004 0.92 -
bran 2A 0.82 -
bran 0014 0.80 -
anti 1B 0.75 -
bran 1C 0.72 -
bran 1A 0.70 -
anti 4A 0.68 -
bran 0012 0.64 -
bran 0020 0.59 -
bran 0002 0.57 -
bran 1F 0.50 -
bran 0001 0.48 -
bran 0006 0.44 -
bran 0007 0.43 -
bran 3C 0.43 -
bran 0019 0.39 -
138
Table B.9: Selected variables using the extended SAT1 data with challenge
strain, date and antiserum used as random effects factors. The table gives a
list of the variables selected using the conjugate SABRE method with a cut-off of Jpˆi.
Additionally the cut-off at 0.5 is marked by a horizontal line Residues are given by their
protein sequence alignment (Reeve et al., 2010), where for instance VP3 138 is position
138 on the VP3 protein. Branches are given as to indicate: a reactivity effect associated
with the challenge strain (react), an immunogenic effect of the protein strain (immun),
an antigenic effect (anti) or an unknown effect which is either a reactivity or antigenic
effect (bran). More details on the types of branches can be found in Section 2.1.3 and
the labelled phylogenetic tree for this dataset is given in Figure 2.3.
Variable Inclusion Prob. Plausibility Complete Correlations
VP1 149 1 Proven -
VP2 72 0.99 Proven -
VP3 138 0.97 Proven -
VP1 209 0.81 Proven -
anti 0031 0.69 Plausible -
VP3 171 0.68 Plausible -
VP3 72 0.66 Proven -
VP1 144 0.65 Proven -
VP1 147 0.63 Proven -
react 4A 0.58 Proven -
VP2 198 0.57 Plausible -
VP1 116 0.54 Plausible -
VP2 74 0.53 Proven -
VP3 77 0.53 Proven -
bran 1G 0.53 Plausible -
immun 0018 0.52 Proven immun 1H, 2D, 3C, 4B,
5A, 6A, 7A
VP1 148 0.51 Proven -
VP1 163 0.51 Proven -
VP3 223 0.51 Plausible -
VP2 79 0.49 Proven -
VP1 211 0.46 Proven -
bran 0016 0.45 Plausible -
VP1 150 0.45 Proven -
VP1 207 0.45 Proven -
immun 8A 0.45 Proven -
VP1 86 0.44 Implausible -
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Table B.9 Selected variables using the extended SAT1 data
Variable Inclusion Prob. Plausibility Complete Correlations
bran 2A 0.44 Proven VP3 177; VP2 82; VP1 201;
VP2 131; VP2 187; VP3 141
VP2 95 0.43 Plausible -
react 1C 0.43 Plausible -
bran 1A 0.43 Plausible -
VP3 67 0.43 Plausible -
anti 0029 0.43 Plausible -
immun 9A 0.42 Plausible -
VP1 218 0.41 Proven -
react 6A 0.41 Plausible -
bran 2F 0.41 Plausible -
VP1 142 0.41 Proven -
bran 1J 0.41 Plausible -
VP3 58 0.4 Proven -
bran 3B 0.4 Plausible -
react 1K 0.4 Plausible -
anti 2G 0.4 Plausible -
react 0007 0.4 Plausible -
VP3 61 0.4 Proven -
bran 2B 0.39 Plausible -
VP1 156 0.39 Proven bran 0017
anti 1K 0.39 Plausible -
bran 0002 0.38 Plausible -
bran 0030 0.38 Plausible -
VP1 143 0.38 Proven -
bran 0038 0.38 Plausible -
bran 0024 0.38 Plausible -
bran 0027 0.38 Plausible -
VP3 199 0.38 Plausible -
anti 3E 0.38 Plausible -
VP1 45 0.38 Plausible -
VP3 182 0.38 Plausible -
bran 0006 0.38 Plausible -
VP3 76 0.38 Plausible -
140
Table B.9 Selected variables using the extended SAT1 data
Variable Inclusion Prob. Plausibility Complete Correlations
bran 3D 0.38 Plausible -
bran 0001 0.37 Plausible -
VP1 42 0.37 Plausible bran 0013
VP3 69 0.37 Plausible -
VP1 155 0.37 Proven -
react 5A 0.37 Plausible -
react 3A 0.36 Plausible -
VP3 134 0.36 Plausible -
VP1 164 0.36 Proven -
VP3 178 0.36 Plausible VP2 194, bran 0009
anti 0007 0.36 Plausible -
VP2 192 0.36 Plausible bran 0026
bran 2C 0.36 Plausible -
bran 1D 0.36 Plausible -
react 7A 0.36 Plausible -
VP3 16 0.35 Implausible bran 0010
bran 0023 0.35 Plausible -
Table B.10: Selected variables using the extended SAT1 branch data using
challenge strain and antiserum as random effects factors. The table gives a
list of the variables selected using the conjugate SABRE method with a cut-off of Jpˆi.
Additionally the cut-off at 0.5 is marked by a horizontal line. Branches are given as to
indicate: a reactivity effect associated with the challenge strain (react), an immunogenic
effect of the protein strain (immun), an antigenic effect (anti) or an unknown effect which
is either a reactivity or antigenic effect (bran). More details on the types of branches
can be found in Section 2.1.3. The labelled phylogenetic tree for this dataset is given in
Figure 2.3 here. The inferred phylogenetic tree for a Jpˆi cut-off is given in Figure B.1
here and for the 0.5 cut-off in Figure 5.9.
Variable Inclusion Prob. Plausibility
anti 0007 1 -
anti 0029 1 -
anti 0031 1 -
anti 8A 1 -
bran 1G 0.91 -
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Table B.10 Selected variables using the extended SAT1 branch data
Variable Inclusion Prob. Plausibility
anti 0018 0.85 -
anti 0004 0.80 -
bran 0016 0.73 -
anti 1B 0.71 -
react 4A 0.70 -
bran 2A 0.70 -
bran 0030 0.69 -
bran 1A 0.68 -
bran 0024 0.66 -
bran 0038 0.63 -
anti 6B 0.62 -
immun 0018 0.61 immun 1H, 2D, 3C, 4B,
5A, 6A, 7A
bran 0039 0.61 -
anti 2G 0.58 -
bran 1J 0.56 -
anti 3E 0.54 -
bran 0006 0.54 -
bran 0013 0.53 -
bran 0042 0.52 -
bran 0027 0.51 -
react 6A 0.50 -
bran 0002 0.50 -
react 1C 0.49 -
bran 3D 0.49 -
react 1K 0.48 -
bran 0035 0.48 -
bran 0017 0.48 -
bran 1M 0.47 -
bran 0023 0.46 -
bran 0001 0.45 -
anti 10A 0.43 -
bran 0021 0.41 -
bran 0008 0.40 -
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Table B.10 Selected variables using the extended SAT1 branch data
Variable Inclusion Prob. Plausibility
bran 2F 0.40 -
immun 8A 0.39 -
bran 3B 0.39 -
react 3C 0.39 -
bran 0041 0.39 -
bran 0003 0.39 -
bran 2B 0.38 -
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Table B.11: Selected variables using the SAT2 data using challenge strain and
antiserum as random effects factors. The table gives a list of the variables selected
using the conjugate SABRE method with a cut-off of Jpˆi. Residues are given by their
protein sequence alignment (Reeve et al., 2010), where for instance VP3 138 is position
138 on the VP3 protein. Branches are given as to indicate: a reactivity effect associated
with the challenge strain (react), an immunogenic effect of the protein strain (immun),
an antigenic effect (anti) or an unknown effect which is either a reactivity or antigenic
effect (bran). More details on the types of branches can be found in Section 2.1.3 and
the labelled phylogenetic tree for this dataset is given in Figure 2.4.
Variable Inclusion Prob. Complete Correlations
VP1 88 0.91 -
VP1 48 0.77 VP1 66, anti 0013
VP2 71 0.73 VP2 72, VP1 180,
VP1 208, anti 0003
VP1 103 0.65 -
VP1 210 0.60 -
VP1 166 0.41 -
VP2 101 0.39 -
VP1 209 0.38 -
immun 0003 0.36 immun 1A, 2A, 3A, 4A, 5A
VP2 134 0.36 -
VP3 69 0.35 -
immun 6A 0.35 immun 7A
VP1 102 0.34 -
VP3 199 0.33 -
VP2 132 0.33 -
VP2 193 0.32 -
VP1 178 0.29 -
VP1 211 0.29 -
VP1 144 0.28 -
VP1 54 0.28 -
react 8A 0.27 -
VP2 80 0.26 VP1 189
VP1 207 0.26 -
VP1 47 0.26 -
VP1 60 0.26 -
VP3 68 0.26 VP2 78, VP1 101,
VP2 140, bran 0022
VP3 88 0.26 -
VP2 85 0.26 VP2 195, bran 0005
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Table B.12: Selected variables using the SAT2 branch data using challenge
strain and antiserum as random effects factors. The table gives a list of the
variables selected using the conjugate SABRE method with a cut-off of Jpˆi. Branches
are given as to indicate: a reactivity effect associated with the challenge strain (react),
an immunogenic effect of the protein strain (immun), an antigenic effect (anti) or an
unknown effect which is either a reactivity or antigenic effect (bran). More details on the
types of branches can be found in Section 2.1.3. The labelled phylogenetic tree for this
dataset is given in Figure 2.4 here and the inferred phylogenetic tree in Figure 5.12.
Variable Inclusion Prob. Complete Correlations
anti 0003 1 -
anti 0013 1 -
anti 1G 0.98 -
anti 0016 0.91 -
bran 0015 0.46 -
bran 0018 0.46 -
immun 0003 0.45 immun 1A, 2A, 3A, 4A, 5A
bran 1B 0.43 -
bran 1H 0.35 -
immun 6A 0.34 immun 7A
bran 0022 0.34 -
bran 0009 0.34 -
bran 0014 0.32 -
bran 0005 0.31 -
immun 0020 0.3 immun 1G
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Table B.13: Antigenic SAT1 Residues Selected by Maree et al. (2015). The
table gives the results of Maree et al. (2015) that are equivalent to those reported in this
paper. Due to Maree et al. (2015) having a different overall aim to this current paper,
these results were not directly reported in their paper. The horizontal line indicates the
cut-off based on the Holm-Bonferroni correction and the results are reported up until
the first implausible residue is selected. Residues are given by their protein sequence
alignment (Reeve et al., 2010), where for instance VP3 138 is position 138 on the VP3
protein. Selected branches are not stated.
Variable Plausibility
VP2 72 Proven
VP1 149 Proven
VP1 144 Proven
VP3 138 Proven
VP3 72 Proven
VP3 171 Plausible
VP1 164 Proven
VP1 209 Proven
VP3 77 Proven
VP1 102 Implausible
146
B.3 Influenza Data
This section gives a complete list of results for H1N1 dataset discussed in the main paper.
Table B.14 gives the full list of results for the H1N1 dataset described in Section 4.5 of
the main paper based on taking the top Jpˆi variables from the model.
Table B.14: Selected variables using the conjugate SABRE method on the
reduced H1N1 dataset using challenge strain as a random effects factor. The
table gives a list of the variables selected using the conjugate SABRE method with a
cut-off of Jpˆi. Residues are given by their position of the H1 common alignment (Harvey
et al., 2016). Selected branches are not stated except where they have have a correlation
coefficient of 1 with a selected residue variable. In this case the branch is given simply
as ‘branch’ as a phylogenetic tree is not given.
Variable Inclusion Prob. Plausibility Complete Correlations
187 1 Proven -
190 1 Proven -
43 1 Implausible -
141 1 Proven -
252 0.73 Plausible branch
142 0.68 Proven branch
313 0.65 Implausible branch
189 0.64 Proven -
323 0.51 Implausible -
66 0.50 Plausible branch
310 0.45 Implausible branch
130 0.42 Proven -
146 0.38 Plausible -
139 0.36 Proven branch
153 0.35 Proven -
74 0.34 Proven -
327 0.33 Implausible -
69 0.33 Proven branch
72 0.28 Proven branch
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Table B.15: Selected variables using the eSABRE method on the full H1N1
data using challenge strain and the date of the experiment as random effect
factors. The table gives a list of the variables selected using the eSABRE method with a
cut-off of Jpˆi. Residues are given by their position of the H1 common alignment (Harvey
et al., 2016). Selected branches are not stated except where they have have a correlation
coefficient of 1 with a selected residue variable. In this case the branch is given simply
as ‘branch’ as a phylogenetic tree is not given.
Variable Inclusion Prob. Plausibility Complete Correlations
187 1 Proven -
43 1 Implausible -
141 1 Proven -
190 1 Proven -
153 0.91 Plausible -
142 0.86 Proven branch
313 0.69 Implausible branch
324 0.64 Implausible 325, 326
130 0.54 Proven -
193 0.47 Plausible 54, 125, 127, branch
146 0.44 Plausible -
72 0.43 Proven branch
310 0.43 Implausible branch
74 0.39 Proven -
189 0.37 Proven -
170 0.35 Proven -
66 0.35 Plausible 134, branch
252 0.33 Plausible branch
327 0.33 Implausible -
69 0.31 Proven branch
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Table B.16: Selected variables using the eSABRE method on the full H3N2
data using challenge strain, protective strain and the date of the experiment
as random effect factors. The table gives a list of the variables selected using the
conjugate SABRE method with a cut-off of Jpˆi. Residues are given by their position of
the H1 common alignment (Harvey et al., 2016). Selected branches are not stated except
where they have have a correlation coefficient of 1 with a selected residue variable. In
this case the branch is given simply as ‘branch’ as a phylogenetic tree is not given. ∗
indicates that the residue was removed from the results due to the recorded genetic code
being inaccurate.
Variable Inclusion Prob. Plausibility Complete Correlations
135 1 Proven -
138 1 Plausible -
144 1 Proven -
145 1 Proven -
156 1 Proven -
158 1 Proven -
164 1 Proven -
189 1 Proven -
193 1 Proven -
197 1 Proven -
262 1 Proven -
276 0.98 Proven -
25 0.97 Plausible 75, branch
155 0.97 Proven -
279 0.89 Plausible -
183 0.87 Proven -
212 0.64 Plausible -
269 0.57 Implausible∗ -
159 0.56 Proven -
14 0.54 Implausible 43, branch
142 0.47 Proven -
2 0.45 Implausible -
190 0.41 Proven -
207 0.40 Proven -
194 0.37 Plausible -
131 0.37 Proven -
196 0.34 Proven -
126 0.34 Proven -
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Table B.16 Selected variables using the H3N2 data
Variable Inclusion Prob. Plausibility Complete Correlations
58 0.32 Implausible -
140 0.30 Plausible -
27 0.28 Implausible -
57 0.26 Proven -
318 0.25 Implausible -
18 0.23 Implausible -
3 0.23 Implausible -
242 0.22 Proven -
147 0.22 Implausible -
216 0.22 Plausible -
34 0.20 Implausible -
150
References
Aderhold, A., Husmeier, D., and Grzegorczyk, M. (2014). Statistical inference of reg-
ulatory networks for circadian regulation. Statistical Applications in Genetics and
Molecular Biology, 13(3):227–273. 64
Aktas, S. and Samuel, A. R. (2000). Identification of antigenic epitopes on the foot
and mouth disease virus isolate O-1/Manisa/Turkey/69 using monoclonal antibodies.
Scientific and Technical Review of the Office International des Epizooties, 19(3):744–
753. 17, 74, 81
Andrieu, C. and Doucet, A. (1999). Joint bayesian model selection and estimation of
noisy sinusoids via reversible jump MCMC. IEEE Transactions on Signal Processing,
47(10):2667–2676. 53, 91
Barbieri, L. and Berger, J. (2004). Optimal predictive model selection. Annals of Statis-
tics, 32(3):870–897. 60
Barnett, P., Ouldridge, E., Rowlands, D., Brown, F., and Parry, N. (1989). Neutralizing
epitopes of type O Foot-and-Mouth disease virus. I. Identification and characterization
of three functionally independent, conformational sites. The Journal of general virology,
70 (Pt 6):1483–1491. 17
Barr, I. G., Russell, C., Besselaar, T. G., Cox, N. J., Daniels, R. S., Donis, R., En-
gelhardt, O. G., Grohmann, G., Itamura, S., Kelso, A., McCauley, J., Odagiri, T.,
Schultz-Cherry, S., Shu, Y., Smith, D., Tashiro, M., Wang, D., Webby, R., Xu, X., Ye,
Z., and Zhang, W. (2014). WHO recommendations for the viruses used in the 2013-2014
Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic charac-
teristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from
October 2012 to January 2013. Vaccine, 32(37):4713–25. 16
Bates, D., Maechler, M., and Bolker, B. (2013). lme4: Linear mixed-effects models using
S4 classes. 59
151
REFERENCES
Baxt, B., Vakharia, V., Moore, D., Franke, A., and Morgan, D. (1989). Analysis of
neutralizing antigenic sites on the surface of type A12 Foot-and-Mouth disease virus.
Journal of Virology, 63(5):2143–2151. 17, 74
Bayes, T. (1763). An essay towards solving a problem in the doctrine of chances. Philo-
sophical Transactions of the Royal Society of London, 53:370–418. 26
BBC (2016). When foot-and-mouth disease stopped the UK in its tracks. http://www.
bbc.co.uk/news/magazine-35581830. BBC article author: Claire Bates. 1
Bishop, C. M. (2006). Pattern Recognition and Machine Learning. Springer. 22, 23, 24,
50, 115, 119
Bolwell, C., Brown, A., Barnett, P., Campbell, R., Clarke, B., Parry, N., Ouldridge,
E., Brown, F., and Rowlands, D. (1989). Host cell selection of antigenic variants of
Foot-and-Mouth disease virus. The Journal of general virology, 70 ( Pt 1):45–57. 17,
74
Bush, R. M., Fitch, W. M., Bender, C. A., and Cox, N. J. (1999). Positive selection on
the h3 hemagglutinin gene of human influenza virus a. Molecular biology and evolution,
16(11):1457–1465. 19
Caton, A. J., Brownlee, G. G., Yewdell, J. W., and Gerhard, W. (1982). The antigenic
structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell, 31(2 Pt
1):417–427. 18
Crowther, J., Farias, S., Carpenter, W., and Samuel, A. (1993a). Identification of a fifth
neutralizable site on type O Foot-and-Mouth disease virus following characterization
of single and quintuple monoclonal antibody escape mutants. The Journal of general
virology, 74 ( Pt 8):1547–1553. 17, 74
Crowther, J., Rowe, C., and Butcher, R. (1993b). Characterization of monoclonal anti-
bodies against a type SAT 2 Foot-and-Mouth disease virus. Epidemiology and Infection,
111(2):391–406. 18, 74, 79, 80
Davies, V., Reeve, R., Harvey, W., Maree, F. F., and Husmeier, D. (2014). Sparse
Bayesian variable selection for the identification of antigenic variability in the Foot-
and-Mouth Disease Virus. Journal of Machine Learning Research: Workshop and
Conference Proceedings (AISTATS), 33:149–158. iv, xii, xiii, 3, 13, 29, 37, 38, 42, 50,
57, 58, 60, 61, 63, 71, 72, 77, 79, 93, 108, 110, 111, 119
152
REFERENCES
Davies, V., Reeve, R., Harvey, W., Maree, F. F., and Husmeier, D. (2016a). A sparse
hierarchical Bayesian model for detecting relevant antigenic sites in virus evolution.
Computational Statistics (Under Revision). iv, 3, 11, 13, 21, 25, 29, 37, 42, 44, 46, 48,
57, 60, 62, 73, 74, 79, 85, 86, 89, 90, 91, 92, 93, 98, 99, 108, 109, 125, 128
Davies, V., Reeve, R., Harvey, W. T., and Husmeier, D. (2016b). Selecting random effect
components in a sparse hierarchical Bayesian model for identifying antigenic variability.
In Angelini, C., Rancoita, P. M. V., and Rovetta, S., editors, Computational Intelligence
Methods for Bioinformatics and Biostatistics, pages 14–27. iv, 3, 13, 56, 58, 62, 70
Efron, B., Hastie, T., Johnstone, I., and Tibshirani, R. (2004). Least angle regression.
Annals of Statistics, 32(2):407–499. 23
Filippone, M., Zhong, M., and Girolami, M. (2013). A comparative evaluation of
stochastic-based inference methods for Gaussian process models. Machine Learning,
93:93–114. 113
Gelman, A. (2004). Parameterization and bayesian modeling. Journal of the American
Statistical Association, 99(466):537–545. 48
Gelman, A. (2006). Prior distributions for variance parameters in hierarchical models.
Bayesian Analysis, 1(3). 38, 47, 48, 62, 90
Gelman, A., Carlin, J. B., Stern, H. S., Dunson, D. B., Ventari, A., and Rubin, D. B.
(2013a). Bayesian Data Analysis. Chapman & Hall, third edition. 3, 28, 30, 34, 37,
44, 54
Gelman, A., Hwang, J., and Vehtari, A. (2013b). Understanding predictive information
criteria for Bayesian models. Statistics and Computing, 24(6):997–1016. 35
Gelman, A. and Rubin, D. (1992). Inference from iterative simulation using multiple
sequences. Statistical Science, 7:457–511. 28, 59, 98
Geman, S. and Geman, D. (1984). Stochastic relaxation, Gibbs distributions, and the
Bayesian restoration of images. IEEE Transactions on Pattern Analysis and Machine
Intelligence, 6(6):721–741. 27
George, E. I. and McCulloch, R. E. (1993). Variable selection via Gibbs sampling. Journal
of the American Statistical Association, 88(423):881–889. 29, 30, 31
George, E. I. and McCulloch, R. E. (1997). Approaches for Bayesian variable selection.
Statistica Sinica, 7:339–373. 29, 30, 31
153
REFERENCES
Geweke, J. (2004). Getting it right: Joint distribution tests of posterior simulators.
Journal of the American Statistical Association, 99(467):799–804. 29
Grazioli, S., Fallacara, F., and Brocchi., E. (2013). Mapping of antigenic sites of foot-
and-mouth disease virus serotype Asia 1 and relationships with sites described in other
serotypes. The Journal of general virology, 94(3):559–569. 17, 74, 75, 80
Grazioli, S., Moretti, M., Barbieri, I., Crosatti, M., and Brocchi, E. (2006). Use of
monoclonal antibodies to identify and map new antigenic determinants involved in
neutralisation on FMD viruses type SAT 1 and SAT 2. In Report of the Session of the
Research Group of the Standing Technical Committee of the European Commission for
the Control of Foot-and-Mouth Disease, pages 287–297. Appendix 43. 17, 18, 73, 74,
75, 76, 79, 80, 81, 83
Grzegorczyk, M. and Husmeier, D. (2013). Regularization of non-homogeneous dynamic
Bayesian networks with global information-coupling based on hierarchical Bayesian
models. Machine Learning, 91:105–151. 28, 60, 79
Haario, H., Laine, M., Mira, A., and Saksman, E. (2006). DRAM: Efficient adaptive
MCMC. Statistics and Computing, 16(4). 114
Hanley, J. A. and McNeil, B. J. (1982). The meaning and use of the area under a receiver
operating characteristic (ROC) curve. Radiology, 143:29–36. 33, 64
Harvey, W. T. (2016). Quantifying the genetic basis of antigenic variation among human
influenza A viruses. PhD thesis, University of Glasgow. 23, 106, 113
Harvey, W. T., Benton, D. J., Gregory, V., Hall, J. P. J., Daniels, R. S., Bedford, T.,
Haydon, D. T., Hay, A. J., McCauley, J. W., and Reeve, R. (2016). Identification of
low- and high-impact hemagglutinin amino acid substitutions that drive antigenic drift
of influenza A(H1N1) viruses. PLoS Pathog, 12(4):1–23. 10, 16, 23, 59, 81, 82, 105,
106, 113, 147, 148, 149
Hastie, T., Tibshirani, R., and Friedman, J. (2009). The Elements of Statistical Learning.
Springer. 23, 43, 89
Hastings, W. (1970). Monte Carlo sampling methods using Markov chains and their
applications. Biometrika, 57(1):97–109. 27
Heydari, J., Lawless, C., Lydall, D. A., and Wilkinson, D. J. (2016). Bayesian hierarchical
modelling for inferring genetic interactions in yeast. Journal of the Royal Statistical
Society: Series C (Applied Statistics), 65(3):367–393. 55, 110
154
REFERENCES
Hirst, G. K. (1942). The quantitative determination of influenza virus and antibodies by
means of red cell agglutination. The Journal of experimental medicine, 75(1):49–64. 7
Holland, J., Spindler, K., Horodyski, F., Grabau, E., Nichol, S., and VandePol, S. (1982).
Rapid evolution of RNA genomes. Science, 215:1577–1585. 6
Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian
Journal of Statistics, 6:65–70. 22
Hurvich, C. M. and Tsai, C.-L. (1989). Regression and time series model selection in
small samples. Biometrika, 76(2):297–307. 25
Ishwaran, H. and Rao, J. S. (2005). Spike and slab variable selection: frequentist and
Bayesian strategies. Annals of Statistics, pages 730–773. 30
Jow, H., Boys, R. J., and Wilkinson, D. J. (2014). Bayesian identification of protein dif-
ferential expression in multi-group isobaric labelled mass spectrometry data. Statistical
Applications in Genetics and Molecular Biology, 13(5):531–551. 31, 68
Kitson, J., McCahon, D., and Belsham, G. (1990). Sequence analysis of monoclonal
antibody resistant mutants of type O Foot and Mouth disease virus: evidence for
the involvement of the three surface exposed capsid proteins in four antigenic sites.
Virology, 179(1):26–34. 17, 74, 80
Knowles, N. and Samuel, A. (2003). Molecular epidemiology of Foot-and-Mouth disease
virus. Virus Res, 91:65–80. 10
Lea, S., Hernandez, J., Blakemore, W., Brocchi, E., Curry, S., Domingo, E., Fry, E.,
Abu Ghazaleh, R., King, A., Newman, J., Stuart, D., and Mateu, M. (1994). The struc-
ture and antigenicity of a type C Foot-and-Mouth disease virus. Structure, 2(2):123–
139. 17, 74, 76, 80, 81
Li, L., Qiu, S., Zhang, B., and Feng, C. X. (2015). Approximating cross-validatory
predictive evaluation in Bayesian latent variable models with integrated IS and WAIC.
Statistics and Computing, pages 1–17. 85, 94, 111
Maree, F. F., Borley, D. W., Reeve, R., Upadhyaya, S., Lukhwareni, A., Mlingo, T.,
Esterhuysen, J. J., Harvey, W. T., Fry, E. E., Parida, S., Paton, D. J., and Mahapatra,
M. (2015). Tracking the antigenic evolution of foot-and-mouth disease virus. (In
Submission). xi, 12, 13, 14, 22, 58, 59, 71, 76, 77, 83, 98, 112, 113, 146
Mateu, M. (1995). Antibody recognition of picornaviruses and escape from neutralization:
a structural view. Virus Research, 38(1):1–24. 17, 74, 75, 76, 80
155
REFERENCES
Mattion, N., Ko¨nig, G., Seki, C., Smitsaart, E., Maradei, E., Robiolo, B., Duffy, S., Leo´n,
E., Piccone, M., Sadir, A., Bottini, R., Cosentino, B., Falczuk, A., Maresca, R., Periolo,
O., Bellinzoni, R., Espinoza, A., Torre, J., and Palma, E. (2004). Reintroduction of
Foot-and-Mouth disease in Argentina: characterisation of the isolates and development
of tools for the control and eradication of the disease. Vaccine, 22:4149–4162. 2, 7
McDonald, N. J., Smith, C. B., and Cox, N. J. (2007). Antigenic drift in the evolution
of H1N1 influenza A viruses resulting from deletion of a single amino acid in the
haemagglutinin gene. The Journal of General Virology, 88(Pt 12):3209–3213. 18
Metropolis, N., Rosenbluth, A., Rosenbluth, M., Teller, A., and Teller, E. (1953). Equa-
tions of state calculations by fast computing machines. Journal of Chemical Physics,
21(6):1087–1092. 27
Mitchell, T. and Beauchamp, J. (1988). Bayesian variable selection in linear regression.
Journal of the American Statistical Association, 83(404):1023–1032. 3, 29, 30, 31, 40,
89
Mohamed, S., Heller, K., and Ghahramani, Z. (2012). Bayesian and l1 approaches for
sparse unsupervised learning. In Proceedings of the 29th International Conference on
Machine Learning (ICML-12), pages 751–758. 3, 29, 30, 37, 40, 109
Murphy, K. P. (2012). Machine learning: a probabilistic perspective. MIT Press, Cam-
bridge, MA. 29, 33, 55, 64, 68, 110, 124
Park, T. and Casella, G. (2008). The Bayesian lasso. Journal of the American Statistical
Association, 103(482). 29
Paton, D., Valarcher, J., Bergmann, I., Matlho, O., Zakharov, V., Palma, E., and Thom-
son, G. (2005). Selection of Foot and Mouth disease vaccine strains - a review. Rev
Sci Tech, 24:981–993. 2, 7
Pinheiro, J. C. and Bates, D. (2000). Mixed-Effects Models in S and S-PLUS. Springer.
22
Plummer, M., Best, N., Cowles, K., and Vines, K. (2006). CODA: Convergence diagnosis
and output analysis for MCMC. R News, 6(1):7–11. 59
R Core Team (2013). R: A Language and Environment for Statistical Computing. R
Foundation for Statistical Computing, Vienna, Austria. 25, 59
156
REFERENCES
Reeve, R., Blignaut, B., Esterhuysen, J. J., Opperman, P., Matthews, L., Fry, E. E.,
de Beer, T. A. P., Theron, J., Rieder, E., Vosloo, W., O’Neill, H. G., Haydon, D. T.,
and Maree, F. F. (2010). Sequence-based prediction for vaccine strain selection and
identification of antigenic variability in Foot-and-Mouth disease virus. PLoS Comput
Biol, 6(12). 1, 3, 9, 10, 12, 13, 14, 15, 17, 21, 22, 23, 37, 58, 59, 71, 72, 74, 76, 77, 79,
83, 101, 111, 112, 113, 137, 139, 144, 146
Ripley, B. (1979). Algorithm AS 137: Simulating spatial patterns: Dependent sam-
ples from a multivariate density. Journal of the Royal Statistical Society. Series C,
28(1):109–112. 27
Ruyssinck, J., Huynh-Thu, V., Geurts, P., Dhaene, T., Demeester, P., and Saeys, Y.
(2014). NIMEFI: Gene regulatory network inference using multiple ensemble feature
importance algorithms. PLoS ONE, 9(3). 24, 64
Sabatti, C. and James, G. M. (2005). Bayesian sparse hidden components analysis for
transcription networks. Bioinformatics, 22(6):739–746. 41, 50, 92, 119
Saiz, J. C., Gonzalez, M. J., Borca, M. V., Sobrino, F., and Moore, D. M. (1991).
Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 Foot-and-
Mouth disease virus, defined by neutralization-resistant variants. Journal of Virology,
65(5):2518–2524. 17, 74, 80, 81
Schelldorfer, J., Bu¨hlmann, P., and van de Geer, S. (2011). Estimation for high-
dimensional linear mixed-effects models using `1-penalization. Scandinavian Journal
of Statistics, 38(2):197–214. 21, 24, 25, 59, 60, 61, 63, 71, 72, 109
Shih, A. C.-C., Hsiao, T.-C., Ho, M.-S., and Li, W.-H. (2007). Simultaneous amino acid
substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proceedings
of the National Academy of Sciences, 104(15):6283–6288. 19
Skehel, J. J. and Wiley, D. C. (2000). Receptor binding and membrane fusion in virus
entry: the influenza hemagglutinin. Annual review of biochemistry, 69(1):531–569. 18
Spiegelhalter, D. J., Best, N. G., Carlin, B. P., and Van Der Linde, A. (2002). Bayesian
measures of model complexity and fit. Journal of the Royal Statistical Society: Series
B (Statistical Methodology), 64(4):583–639. 35
Thomas, A., Woortmeijer, R., Barteling, S., and Meloen, R. (1988a). Evidence for more
than one important, neutralizing site on Foot-and-Mouth disease virus. Brief report.
Archives of virology, 99(3-4):237–242. 17
157
REFERENCES
Thomas, A., Woortmeijer, R., Puijk, W., and Barteling, S. (1988b). Antigenic sites on
Foot-and-Mouth disease virus type A10. Journal of Virology, 62(8):2782–2789. 17
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the
Royal Statistical Society: Series B, 58:267–288. 23
Tibshirani, R. (2011). Regression shrinkage and selection via the lasso: a retrospective
(with comments). Journal of the Royal Statistical Society: Series B, 73(3):273–282. 23
Vehtari, A. and Ojanen, J. (2012). A survey of Bayesian predictive methods for model
assessment, selection and comparison. Statistics Surveys, 6:142–228. 93
Watanabe, S. (2010). Asymptotic equivalence of Bayes cross validation and widely appli-
cable information criterion in singular learning theory. Journal of Machine Learning
Research, 11:3571–3594. 34, 35, 56, 64, 85, 93, 95
WHO (2005). Ten things you need to know about pandemic influenza.
https://web.archive.org/web/20091008223707/http://www.who.int/csr/
disease/influenza/pandemic10things/en/index.html. 1
WHO (2009). WHO Influenza fact sheet. 1, 16
WHO (2011). Manual for the laboratory diagnosis and virological surveillance of
influenza. http://whqlibdoc.who.int/publications/2011/9789241548090_eng.
pdf. 7
Wiley, D. C. and Skehel, J. J. (1987). The structure and function of the hemagglutinin
membrane glycoprotein of influenza virus. Annual Review of Biochemistry, 56:365–394.
18
Zou, H. and Hastie, T. (2005). Regularization and variable selection via the elastic net.
Journal of the Royal Statistical Society: Series B, 67(2):301–320. 24
158
